"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID"
"CHEMBL1630742";"";"0";"220.29";"0";"2.98";"5784";"NCCCCCc1c[nH]c2ccc(F)cc12";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177916";"";"0";"410.45";"0";"4.3";"4817";"COc1ccc(cc1)C2(N=C(N)c3c(F)cccc23)c4cccc(c4)c5cncnc5";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL549344";"";"0";"361.47";"0";"2.06";"4753";"CCc1nc2c(N)nc3ccccc3c2n1CCCCNS(=O)(=O)C";"PPB";"";"66.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2333941";"";"0";"320.37";"0";"3.09";"5587";"C[C@]1(CCSC(=N1)N)c2cc(c(F)cc2F)c3cncnc3";"PPB";"";"54.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071498";"";"0";"306.37";"0";"3.2";"4724";"CC(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(cc2)C#N";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950856";"";"0";"481.48";"0";"2.71";"5336";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(Br)cc2)C1)C(C)(C)C";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL257006";"";"0";"366.4";"0";"2.3";"2152";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3[nH]c(N)nc13";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164746";"";"0";"480.53";"0";"0.36";"4217";"COc1ccc2N=CC(=O)N(CCN3CC[C@H](NCc4ccc5OCC(=O)Nc5n4)[C@H](O)C3)c2c1";"PPB";"";"86.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1077827";"";"0";"625.67";"2";"5.81";"5862";"CCOc1ccc(cc1)N2C(=O)c3cccnc3N=C2[C@@H](C)N(CC4CCN(C)CC4)C(=O)Cc5ccc(F)c(c5)C(F)(F)F";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178935";"";"0";"366.47";"0";"3.01";"4701";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)N)CC3";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331751";"";"0";"536.4";"1";"3.13";"5539";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(O)c(Oc4cccc(Br)c4)c3)C(=O)NC1=O";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL398748";"";"0";"439.56";"1";"5.04";"3200";"COc1ccc2c(C)cc(N[C@H]3CC[C@@H](C3)NCc4cn(C)c5ccc(cc45)C#N)nc2c1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916286";"";"0";"446.62";"0";"4.42";"5141";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)C2CCCCC2)c3ccccc3)C(C)(C)C";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335864";"";"0";"399.45";"0";"3.81";"3217";"COCCNC(=O)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934421";"";"0";"543.66";"1";"4.66";"5542";"C[C@H](NC(=O)c1c(C)nn(C2CCN(CC(F)(F)F)CC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1087399";"";"0";"427.47";"1";"2.49";"4380";"C[C@H](Nc1nc(Nc2ncc(C#N)s2)cc(n1)N3CCOCC3)c4ncc(F)cn4";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL413065";"";"0";"268.36";"0";"3.39";"2320";"CCc1nc2c(N)nc3ccccc3c2n1CC(C)C";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL256963";"";"0";"299.77";"0";"2.43";"5943";"Clc1ccc2ncc(c3cccc(NC4CNC4)n3)n2c1";"PPB";"";"83.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL576068";"";"0";"327.37";"0";"3.27";"4419";"C[C@H](Nc1cnc(C)c(Nc2cc(C)[nH]n2)n1)c3ccc(F)cn3";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL48966";"";"0";"262.32";"0";"3.22";"423";"C(Cc1nc2ccccc2[nH]1)c3nc4ccccc4[nH]3";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL208825";"";"0";"422.32";"0";"2.22";"4973";"C[C@@H](CC(=O)OC(C)(C)C)NC(=O)C1=NOC(C1)C(O)(C(F)(F)F)C(F)(F)F";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL174107";"";"0";"263.37";"0";"1.59";"709";"CSc1ccc(cc1)N2C(=NC(=NC2(C)C)N)N";"PPB";"";"33.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164566";"";"0";"378.35";"0";"3.97";"5494";"CCN(CCO)C(=O)c1oc2cccnc2c1c3cccc(c3)C(F)(F)F";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158390";"";"0";"286.34";"0";"1.22";"4992";"O=C1NC(=NC(=C1)N2CCOCC2)NCc3ccccc3";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL495575";"";"0";"448.49";"0";"2.57";"5397";"FC(F)(F)c1ccc(cc1S(=O)(=O)NC2CCNCC2)S(=O)(=O)c3ccccc3";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL109980";"";"0";"610.58";"1";"2.32";"5444";"CC(C)(N)C(=O)N[C@H](COCc1ccc(F)cc1F)C(=O)N2CCC3=NN(CC(F)(F)F)C(=O)[C@]3(Cc4ccccn4)C2";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560423";"";"0";"392.84";"0";"1.39";"3338";"OC1(CNC(=O)c2cc(ccc2Cl)N3N=CC(=O)NC3=O)CCCCCC1";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1232461";"";"0";"423.9";"0";"3.66";"5921";"CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c3cc(OC)ccc3n4c(C)nnc14";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL139036";"";"0";"416.58";"0";"4.85";"2661";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)C3CC[C@@]4(C)C(CC[C@@]45CCC(=O)O5)C13";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2170994";"";"0";"493.98";"0";"1.63";"5755";"Nc1ncnc2c1ncn2[C@@H]3O[C@H](CSCCCNC(=O)Nc4ccc(Cl)cc4)[C@@H](O)[C@H]3O";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1625921";"";"0";"320.48";"0";"3.6";"2831";"O=C(NC12CC3CC(CC(C3)C1)C2)OCCNC4CCCCC4";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1610669";"";"0";"179.26";"0";"2.69";"5852";"CC(C)CCOc1ccc(N)cc1";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164364";"";"0";"456.42";"0";"3.43";"5083";"FC(F)(F)Oc1ccc(CNC(=O)C2N(CCc3ncccn3)C(=O)c4ccccc24)cc1";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950850";"";"0";"446.61";"0";"2.62";"5290";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(CCc3ccc(F)cc3)C2";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951077";"";"0";"478.52";"0";"2.27";"3894";"COc1cc(OC)c(cc1NC(=O)COCC(=O)O)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950729";"";"0";"428.58";"0";"2.08";"5264";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(C2)C(=O)c3ccccc3";"PPB";"";"44.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2322164";"";"0";"242.24";"0";"1.31";"5232";"COc1ccc(cc1C#N)c2cc(O)nc(N)n2";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1900528";"TIOTROPIUM";"4";"392.52";"0";"2.35";"2996";"C[N+]1(C)[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)C(O)(c4cccs4)c5cccs5";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1221702";"";"0";"182.25";"0";"1.23";"2616";"C[C@H]1CN=C(N)c2sccc2O1";"PPB";"";"51.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950722";"";"0";"414.59";"0";"2.09";"5223";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCN(CCc3ccccc3)C2";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1322893";"";"0";"297.34";"0";"2.46";"3803";"COc1ccccc1c2csc(n2)n3ncc(C#N)c3N";"PPB";"";"40.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1779512";"";"0";"480.95";"0";"0.87";"3582";"COC[C@@H](O)CN1C(=O)C=NN(C1=O)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"41.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778642";"";"0";"375.23";"0";"3.53";"3015";"CS(=O)(=O)c1ccc(c(Cl)c1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL335744";"";"0";"291.35";"0";"3.89";"2731";"CC(C)C(=O)Nc1nc(cc2ccccc12)c3ccccn3";"PPB";"";"97.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950728";"";"0";"442.65";"0";"2.87";"5252";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(CCCc3ccccc3)C2";"PPB";"";"66.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL190243";"";"0";"394.42";"0";"2.23";"5454";"C[C@@H](C(=O)NCCN1CCCC1)c2ccc(OS(=O)(=O)C(F)(F)F)cc2";"PPB";"";"67.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL235581";"";"0";"400.99";"0";"4.83";"1593";"Clc1ccc(CC2CCNCC2)cc1C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059870";"";"0";"426.52";"1";"5.24";"4634";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4c(C)nn(C)c4C";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164045";"";"0";"490.41";"0";"3.28";"5309";"Oc1cccc2C(N(CCc3ncc(F)cn3)C(=O)c12)C(=O)NCc4ccc(OC(F)(F)F)cc4";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179668";"";"0";"453.47";"0";"3.31";"5413";"CC1=CN([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(F)c4)c3)C2)C(=O)NC1=O";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152914";"";"0";"412.54";"0";"4.24";"5687";"CO[C@@H]1CC[C@@]2(CC1)Cc3ccc(cc3C24N=C(C)C(=N4)N)c5cncc(c5)C#CC";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177173";"";"0";"536.66";"1";"1.91";"1930";"CN1CCN(CC1)S(=O)(=O)c2ccc(cc2)c3cnc(N)c(n3)C(=O)Nc4cnccc4CN5CCCC5";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807820";"";"0";"498.67";"0";"4.45";"3500";"O[C@@H](CNCCCSCCOCCc1cccc2ccccc12)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"99.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1290383";"";"0";"458.95";"1";"5.35";"5644";"Clc1ccc(cc1)c2oc3C=CN(C(=O)c3c2)c4ccc5c(cnn5CCN6CCCC6)c4";"PPB";"";"99.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165058";"";"0";"475.55";"0";"1.92";"4449";"CO[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@@H]1NCc4cc5OCCOc5cn4";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL154709";"APOCIDEINE";"0";"281.36";"0";"3.15";"1545";"COc1ccc2C[C@H]3N(C)CCc4cccc(c34)c2c1O";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1300857";"";"0";"418.52";"0";"4.91";"2745";"Cc1[nH]c2ccc(cc2c1C)c3oc(SCC(=O)N4CCCc5ccccc45)nn3";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1829174";"FASIGLIFAM";"3";"524.64";"2";"5.31";"5681";"Cc1cc(OCCCS(=O)(=O)C)cc(C)c1c2cccc(COc3ccc4[C@H](CC(=O)O)COc4c3)c2";"PPB";"";"99.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL401158";"";"0";"396.52";"0";"1.21";"1888";"CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164567";"";"0";"377.37";"0";"3.5";"5499";"CCN(CCO)C(=O)c1cc2cccnc2n1c3cccc(c3)C(F)(F)F";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL401874";"";"0";"439.52";"0";"3.82";"1113";"CC(C)CN1C(=O)N(C)C(=O)c2c1nn(Cc3cccc4ccccc34)c2c5ccncc5";"PPB";"";"98.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207225";"";"0";"499.56";"0";"3.95";"4496";"COc1cc(OC)c(cc1NC(=O)Cc2ccnc(F)c2)S(=O)(=O)N3C(C)CCc4ccccc34";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL379866";"";"0";"340.33";"0";"4.45";"3431";"CC(C)c1nnc2ccc(cn12)c3ocnc3c4cc(F)ccc4F";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316382";"";"0";"495.6";"0";"3.53";"3934";"COc1ccc(NC(=O)c2ccc(C[S+](C)[O-])c3ccccc23)c(n1)C(=O)NCC4CCOCC4";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL463981";"BEGACESTAT";"1";"391.74";"0";"2.78";"5590";"OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F";"PPB";"";"90.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181927";"FINERENONE";"3";"378.43";"0";"2.99";"5874";"CCOc1ncc(C)c2NC(=C([C@@H](c3ccc(cc3OC)C#N)c12)C(=O)N)C";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL235789";"";"0";"401.98";"0";"3.69";"1583";"Clc1ccc(CN2CCNCC2)cc1C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951075";"";"0";"463.51";"0";"2.44";"3939";"COc1cc(OC)c(cc1NC(=O)NCC(=O)O)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165057";"";"0";"494.55";"0";"1.01";"4111";"CO[C@H]1CN(CCN2C(=O)C=Nc3ccc(OC)cc23)CC[C@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL416";"METHOXSALEN";"4";"216.19";"0";"2.55";"891";"COc1c2OC(=O)C=Cc2cc3ccoc13";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062565";"";"0";"372.39";"0";"2.47";"4883";"CC(=O)Nc1cnc2ccn(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL477548";"";"0";"485.56";"0";"2.01";"2939";"CC(C)Cc1c(C(=O)C(=O)N)c2c(OCC(=O)NS(=O)(=O)C)cccc2n1Cc3ccccc3";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921939";"";"0";"491.7";"0";"4.8";"5002";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCOCCc4ccccc4)CCC2CC3)c5ccccc5";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2153435";"";"0";"423.9";"0";"3.66";"5937";"CCNC(=O)C[C@H]1N=C(c2ccc(Cl)cc2)c3cc(OC)ccc3n4c(C)nnc14";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1080151";"";"0";"434.48";"0";"3.06";"4381";"C[C@H](Nc1nc(Nc2ncc(C)s2)c(F)c(n1)N3CCOCC3)c4ncc(F)cn4";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062576";"";"0";"442.53";"0";"3.4";"4910";"CC(=O)Nc1ccc2ccn(c3cc(NCCCN4CCCC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062557";"";"0";"265.28";"0";"1.86";"2958";"COc1ccc(cc1)c2cc(N)n3ncc(C#N)c3n2";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957367";"";"0";"378.39";"0";"4.44";"5026";"Oc1c(C#N)c(nc2ccncc12)c3ccc(cc3)c4ccccc4OCC#N";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957840";"";"0";"379.25";"0";"2.69";"5196";"Clc1cccc(CN2C=CN3C(=O)C=C(N=C23)N4CCOCC4)c1Cl";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683033";"";"0";"458.93";"0";"3.42";"4317";"CCOc1cc2nnc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1N4CCN(C)CC4";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1287892";"";"0";"388.44";"0";"3.5";"3525";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccc(F)c(F)c4";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683026";"";"0";"356.36";"0";"2.94";"4265";"COc1cc2nnc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1OC";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL403656";"";"0";"403.41";"0";"2.55";"2311";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3NC(=O)C(=Cc13)C#N";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481606";"";"0";"518.45";"1";"4.55";"4007";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(CCOC)CC4";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL83597";"";"0";"351.41";"0";"3.85";"1846";"CN1CCC[C@@H]1Cc2c[nH]c3ccc(Nc4ncccc4[N+](=O)[O-])cc23";"PPB";"";"86.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL21731";"MAPROTILINE";"4";"277.41";"0";"4.21";"1372";"CNCCCC12CCC(c3ccccc13)c4ccccc24";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL981";"FENOFIBRIC ACID";"4";"318.76";"0";"3.81";"441";"CC(C)(Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2)C(=O)O";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL461574";"";"0";"419.43";"1";"5.28";"3665";"Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1C(=O)Nc3cnc(C)s3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934418";"";"0";"478.68";"0";"4.53";"5495";"C[C@H](NC(=O)c1c(C)nn(C2CCSCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800659";"";"0";"485.65";"0";"3.71";"3492";"CCCCN(CCNCCc1ccc(O)c2NC(=O)Sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1774056";"";"0";"355.35";"0";"3.57";"3593";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(F)cc1C#N)c3ccc(F)cn3";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288306";"";"0";"355.26";"0";"2.32";"3473";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(Br)sc13";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1077458";"";"0";"389.46";"0";"3.68";"4630";"CC(=O)Nc1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011920";"";"0";"390.29";"0";"2.89";"4781";"CNc1c(Br)cnc2[nH]c(nc12)c3cnn(c3)C4CCN(C)CC4";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818302";"";"0";"579.79";"1";"4.84";"4761";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC4CCOCC4)CC3)c5ccccc5n2";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207654";"";"0";"609.53";"1";"2.86";"2546";"O[C@H](CNC(=O)C1=CNC(=O)c2cc(ccc12)S(=O)(=O)N3CCC3)CN4CCC(CC4)Oc5ccc(Cl)c(Cl)c5";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916283";"";"0";"454.6";"0";"4.45";"5086";"C[C@@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3)C(C)(C)C";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916532";"";"0";"453.52";"0";"2.74";"3457";"COc1ccc2ncc(F)c(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2n1";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778644";"";"0";"372.8";"0";"3.4";"2685";"CCS(=O)(=O)c1ccc(c(F)c1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924049";"";"0";"465.63";"0";"4.92";"4712";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCc4ccccc4F)CCC2CC3)c5ccccc5";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059875";"";"0";"395.46";"1";"5.28";"4490";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ccccn4";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL24646";"PIMOBENDAN";"0";"334.38";"0";"3.1";"2268";"COc1ccc(cc1)c2nc3cc(ccc3[nH]2)C4=NNC(=O)CC4C";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178939";"";"0";"444.56";"0";"2.6";"4686";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)NS(=O)(=O)C)CC3";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950860";"";"0";"470.58";"0";"2.97";"5345";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(cc2)C(F)(F)F)C1)C(C)(C)C";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338409";"";"0";"415.37";"0";"3.14";"5574";"CC(C)(C)NC(=O)NCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335896";"";"0";"383.46";"0";"4.63";"4511";"C[C@@H](NC(=O)C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"97.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2057371";"";"0";"500.59";"1";"1.61";"5670";"CC(C)(C)NS(=O)(=O)c1cncc(c1)c2ccc3nc(NC(=O)NCC(=O)N4CCCC4)nn3c2";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1949685";"";"0";"428.62";"0";"2.48";"5169";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(CCc3ccccc3)C2";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1381135";"";"0";"230.27";"0";"1.61";"1739";"COc1cnc(nc1N(C)C)c2ccccn2";"PPB";"";"83.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL304087";"MERIMEPODIB";"2";"452.47";"0";"4.01";"4929";"COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1c4ocnc4";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171022";"";"0";"507.41";"1";"4.6";"1548";"OC(=O)COc1cccc(c1)C(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683028";"";"0";"376.78";"0";"3.28";"4269";"COc1cc2nnc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1OC";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207670";"";"0";"559.04";"1";"2.09";"2545";"CS(=O)(=O)c1ccc2C(=CNC(=O)c2c1)C(=O)NC[C@@H](O)CN3CCC(CC3)Oc4ccc(C#N)c(Cl)c4";"PPB";"";"68.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158836";"";"0";"491.46";"1";"5.24";"2530";"OC(=O)[C@@H](Cc1ccccc1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"68.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL520431";"";"0";"455.51";"0";"3.9";"4055";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCCN(C)CC4";"PPB";"";"69.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2031227";"";"0";"478.56";"0";"3.57";"928";"CN1CCN(CC1)c2ccc3N=CN(C(=O)c3c2)c4cc(NC(=O)c5ccc(cc5)C#N)ccc4C";"PPB";"";"68.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1762530";"";"0";"490.61";"0";"3.46";"4100";"CN(c1ccnc(Nc2cc(cc(c2)N3CCOCC3)N4CCOCC4)n1)c5cc(CO)ccc5C";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL236788";"";"0";"489.6";"0";"2.93";"5306";"CCOc1cc(CN2CCC(CC2)Nc3oc4ccc(cc4n3)S(=O)(=O)N)cc(OCC)c1N";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL87543";"LORCAINIDE";"0";"370.92";"0";"4.79";"62";"CC(C)N1CCC(CC1)N(C(=O)Cc2ccccc2)c3ccc(Cl)cc3";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1087898";"";"0";"331.38";"0";"3.09";"4407";"C[C@H](Nc1cncc(Nc2ncc(C)s2)n1)c3ncc(F)cn3";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207665";"";"0";"522.35";"1";"3.35";"2689";"CN1C=C(C(=O)NC[C@@H](O)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3)C(=CC1=O)C(F)(F)F";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL578194";"";"0";"364.39";"0";"3.4";"4472";"C[C@H](Nc1nc(Nc2cc([nH]n2)C3CC3)cnc1C#N)c4ccc(F)cn4";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2170975";"";"0";"440.53";"1";"0.68";"5733";"CC(C)(C)OC(=O)NCCCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)ncnc23";"PPB";"";"76.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818295";"";"0";"524.71";"1";"4.89";"4471";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)N4CCC(CCO)CC4)CC1";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957462";"";"0";"355.4";"0";"3.89";"4905";"Cc1nn(C)c(C)c1c2ccc(cc2)c3nc4ccncc4c(O)c3C#N";"PPB";"";"99.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1703518";"";"0";"472.59";"0";"3.45";"2790";"CCN(CC)S(=O)(=O)c1ccc(cc1)c2oc(SCC(=O)N3CCc4ccccc34)nn2";"PPB";"";"99.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951074";"";"0";"479.58";"0";"2.6";"3926";"COc1cc(OC)c(cc1NC(=S)NCC(=O)O)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481557";"";"0";"428.44";"0";"3.59";"3940";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCOCC4";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1852508";"";"0";"434.97";"0";"2.65";"3703";"Cc1cc(nn1C[C@H](O)CN)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"69.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL375293";"";"0";"316.32";"0";"3.33";"5259";"N(c1cccnc1)c2ncc(c3ccncn3)c(n2)c4occc4";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL494505";"";"0";"422.46";"0";"2.35";"4140";"CCC(=O)N1CCN(CC1)C(=O)c2cc(CC3=NNC(=O)c4ccccc34)ccc2F";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1450473";"";"0";"418.5";"0";"1.14";"3111";"Cc1ccc(cc1)S(=O)(=O)NCCSc2nnnn2c3ccc(cc3)C(=O)N";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL163870";"";"0";"409.46";"0";"3.43";"3311";"Cc1nccn1c2ccc(COc3cc(F)cc(c3)C4(CCOCC4)C(=O)N)cc2";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824044";"";"0";"467.53";"0";"1.4";"3613";"COc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1468264";"";"0";"336.39";"0";"3.96";"4617";"COc1cc(OC)c2nc(C)c3CCN(c4ccc(O)cc4)c3c2c1";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL8809";"RACLOPRIDE";"1";"347.24";"0";"2.92";"1842";"CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331738";"";"0";"441.51";"0";"2.66";"5111";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3cccc(Oc4ccccc4)c3)C(=O)NC1=O";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL49247";"";"0";"336.44";"0";"2.75";"4349";"C1COc2c(O1)cccc2N3CCN(CC3)C4Cc5ccccc5C4";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL51";"KETANSERIN";"4";"395.43";"0";"2.42";"804";"Fc1ccc(cc1)C(=O)C2CCN(CCN3C(=O)Nc4ccccc4C3=O)CC2";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1076";"DESGLYMIDODRINE";"0";"197.23";"0";"0.7";"421";"COc1ccc(OC)c(c1)C(O)CN";"PPB";"";"21.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916541";"";"0";"465.55";"0";"2.13";"4260";"COc1ccc2C(=NC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2c1)C";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1770469";"";"0";"327.41";"0";"2.58";"5092";"CSCCC(NC(=O)c1cnccn1)c2nc3ccccc3[nH]2";"PPB";"";"60.22";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818300";"";"0";"579.79";"1";"4.58";"4863";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)N4CCC(CCN5CC(O)C5)CC4)CC1";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL151592";"";"0";"254.29";"0";"2.35";"5167";"Cc1cccc(C(=O)N)c1NC(=O)c2ccccc2";"PPB";"";"55.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL51594";"";"0";"210.28";"0";"2.64";"5065";"C1Cc2ccccc2CN1c3ccncc3";"PPB";"";"56.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916546";"";"0";"451.53";"0";"1.83";"4329";"COc1cc2N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)C(=O)C=Cc2cn1";"PPB";"";"83.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481612";"";"0";"518.4";"1";"3.42";"4025";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(CC4)C(=O)CO";"PPB";"";"83.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1962896";"";"0";"542.1";"1";"3.75";"5612";"COc1ccc(CCC[N+](C)(CCCc2ccc(OC)cc2)CCNC(=O)c3nc(Cl)c(N)nc3N)cc1";"PPB";"";"83.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165189";"";"0";"394.48";"0";"2.15";"5282";"C[C@H]1CN(CCO1)C2=NC(=O)NC(=C2)N(CCO)Cc3cccc4ccccc34";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL173706";"";"0";"316.43";"0";"0.5";"748";"CC(C)(C)NCC(O)COc1nsnc1N2CCOCC2";"PPB";"";"40.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1789155";"";"0";"302.83";"0";"4.39";"2303";"NCC[C@@H](Sc1cc(Cl)ccc1C#N)c2ccccc2";"PPB";"";"41.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778641";"";"0";"354.81";"0";"3.26";"2419";"CCS(=O)(=O)c1ccc(cc1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689119";"";"0";"438.93";"0";"2.7";"3454";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1S(=O)(=O)c3ccccc3";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1938680";"";"0";"381.86";"0";"4.26";"5757";"Clc1ccc(cc1)c2oc(cc2)C(=O)Nc3ccc(cc3)N4CCNCC4";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950724";"";"0";"414.55";"0";"1.69";"5226";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCN(C2)C(=O)c3ccccc3";"PPB";"";"33.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1309609";"";"0";"338.48";"0";"4.69";"2743";"O=C(CN1CCCCCC1)N2c3ccccc3Sc4ccccc24";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL559968";"";"0";"405.24";"0";"2.2";"2844";"Clc1ccccc1CCNC(=O)c2cc(ccc2Cl)N3N=CC(=O)NC3=O";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335884";"";"0";"411.51";"0";"4.91";"4261";"C(CN1CCCC1)Oc2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1231206";"";"0";"374.47";"0";"4.36";"5382";"C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)c5ccc(C)nc5)C(=O)N1";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL233263";"";"0";"337.43";"0";"2.35";"2302";"C[C@H](CO)Nc1nc(SCc2occc2)nc3nc(N)sc13";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921946";"";"0";"477.63";"0";"3.57";"5016";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CC(=O)Nc4ccccn4)CCC2CC3)c5ccccc5";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950723";"";"0";"428.62";"0";"2.48";"5224";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCN(CCCc3ccccc3)C2";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1933593";"";"0";"389.33";"0";"0.77";"3637";"C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)nc(OC(C4CC4)C(F)(F)F)nc23";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1378202";"";"0";"274.28";"0";"1.03";"3093";"CNC(=O)c1[nH]cnc1C(=O)Nc2ccc(OC)cc2";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL186995";"";"0";"338.79";"0";"4.46";"2449";"Clc1ccccc1CNC(=O)c2cccnc2Oc3ccccc3";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934417";"";"0";"464.63";"0";"4.06";"5519";"COCCC(C)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824036";"";"0";"515.59";"1";"0.8";"3708";"CS(=O)(=O)c1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916278";"";"0";"454.55";"0";"3.2";"5078";"Cc1ccc(cc1)S(=O)(=O)Nc2c(C(=O)NC3CCOCC3)c(C)nn2c4ccccc4";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288164";"";"0";"370.45";"0";"3.37";"3357";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccc(F)cc4";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1598315";"";"0";"219.27";"0";"1.56";"1141";"CNC(=O)c1snnc1c2ccccc2";"PPB";"";"43.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL218628";"";"0";"512.59";"2";"1.61";"2324";"CNc1nc2ccccc2n1Cc3sc4N(CC(C)C)C(=O)N(C)C(=O)c4c3C(=O)N5C[C@H](O)CO5";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1309980";"";"0";"454.94";"0";"3.73";"3396";"Clc1ccc(cc1)S(=O)(=O)C2=CC3=C(N=C4C=CC=CN4C3=O)N(C5CCCC5)C2=N";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL375166";"";"0";"461.54";"0";"1.1";"1924";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3c(C)n[nH]c3C)c2C(=O)N4C[C@H](O)CO4";"PPB";"";"51.15";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165054";"";"0";"475.55";"0";"1.92";"4230";"CO[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4cc5OCCOc5cn4";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207281";"";"0";"613.52";"1";"1.74";"2543";"OCCNS(=O)(=O)c1ccc2C(=CNC(=O)c2c1)C(=O)NC[C@@H](O)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL148674";"VARESPLADIB";"2";"380.4";"0";"2.38";"1785";"CCc1c(C(=O)C(=O)N)c2c(OCC(=O)O)cccc2n1Cc3ccccc3";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1078411";"";"0";"311.41";"0";"2.18";"5079";"N[C@@H](Cc1cccs1)C(=O)N[C@@]2(C[C@@H]2c3ccccc3)C#N";"PPB";"";"54.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207662";"";"0";"508.32";"1";"3.33";"2458";"O[C@H](CNC(=O)C1=CNC(=O)C=C1C(F)(F)F)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL934";"METYRAPONE";"4";"226.28";"0";"2.64";"526";"CC(C)(C(=O)c1cccnc1)c2cccnc2";"PPB";"";"11.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216859";"NEMIRALISIB";"0";"440.55";"0";"4.89";"5882";"CC(C)N1CCN(Cc2oc(nc2)c3cc(cc4[nH]ncc34)c5cccc6[nH]ccc56)CC1";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778635";"";"0";"339.24";"0";"3.85";"2853";"OC(=O)COc1ccc(cc1c2cc(ccc2F)C#N)C(F)(F)F";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4";"240.31";"0";"2.82";"4110";"CC(C)Cn1cnc2c(N)nc3ccccc3c12";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1294";"QUINIDINE";"4";"324.42";"0";"3.17";"1231";"COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL646";"TRIAZOLAM";"4";"343.22";"0";"4.23";"865";"Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL576257";"";"0";"338.35";"0";"2.83";"4386";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)cnc1C#N)c3ccc(F)cn3";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL178737";"";"0";"496.53";"0";"2.12";"4745";"O=C(N1CCOCC1)N2CCn3cc(C4=C(C(=O)NC4=O)c5cnc6ccccn56)c7cccc(C2)c37";"PPB";"";"85.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1353474";"";"0";"290.39";"0";"2.49";"1013";"Cc1cc(C)c(c(C)c1)S(=O)(=O)NCc2ccncc2";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1385850";"";"0";"230.15";"0";"2.28";"515";"OC(=O)c1ccc2[nH]c(nc2c1)C(F)(F)F";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1789187";"";"0";"312.25";"0";"2.43";"1303";"NCC[C@@H](Oc1nc(ccc1C#N)C(F)(F)F)c2oncc2";"PPB";"";"44.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL215295";"";"0";"505.62";"2";"1.86";"3173";"NC(=N)c1ccc(CNC(=O)C2(Cc3ccccc3C2)NC(=O)[C@H](NCC(=O)O)C4CCCCC4)cc1";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059867";"";"0";"398.47";"0";"4.92";"4849";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4c[nH]c(C)n4";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069411";"";"0";"459.42";"0";"3.31";"4678";"OCc1ccc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(OCC(F)(F)F)nc4";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062559";"";"0";"281.34";"0";"2.9";"4527";"N#Cc1cnn2c(NC3CC3)cc(nc12)c4cccs4";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2324355";"";"0";"378.31";"0";"3.78";"5635";"Cc1nocc1C(=O)Nc2ccc(c(N)n2)c3ccccc3OC(F)(F)F";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179269";"";"0";"483.95";"0";"4.39";"5381";"C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL380732";"";"0";"397.48";"0";"3.42";"137";"CC[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(N)sc13";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147317";"";"0";"500.4";"1";"4.29";"5594";"COc1cnc(cn1)c2cccc(F)c2C(F)(F)CNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338404";"";"0";"454.68";"0";"1.65";"5546";"CC(C)(C)CS(=O)(=O)NCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151177";"";"0";"470.58";"0";"3.66";"5255";"COc1cc(Nc2nc(Cc3ccccc3)c4CN(CCO)CCc4n2)ccc1n5cnc(C)c5";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207666";"";"0";"490.39";"0";"3.47";"2089";"O[C@H](CNC(=O)C1=CNC(=O)c2ccccc12)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL211631";"";"0";"360.41";"0";"4.57";"2555";"COc1cccc2c(ccnc12)c3c(C)n(CC(=O)O)c4ccc(C)cc34";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL216981";"NAVARIXIN";"2";"397.43";"0";"2.9";"4044";"CC[C@@H](NC1=C(Nc2cccc(C(=O)N(C)C)c2O)C(=O)C1=O)c3oc(C)cc3";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062579";"";"0";"406.47";"0";"2.66";"4957";"CS(=O)(=O)Cc1ccc2ccn(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950848";"";"0";"446.61";"0";"2.62";"5307";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(CCc3ccccc3F)C2";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL384536";"";"0";"483.55";"0";"1.63";"2476";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3c[nH]c4ncccc34)c2C(=O)N5C[C@H](O)CO5";"PPB";"";"75.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL378730";"";"0";"364.83";"1";"5.21";"2464";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(Cl)cccc34";"PPB";"";"99.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650731";"";"0";"361.36";"0";"2.25";"4126";"C[C@H](Nc1ncc(F)c(Nc2cc([nH]n2)N(C)C)n1)c3ncc(F)cn3";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957845";"";"0";"328.35";"0";"1.52";"5158";"Fc1cccc(CN2C=CN3C(=O)C=C(N=C23)N4CCOCC4)c1";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178579";"ELUBRIXIN";"2";"463.32";"0";"3.08";"3413";"Oc1c(NC(=O)Nc2cccc(F)c2Cl)ccc(Cl)c1S(=O)(=O)N3CCNCC3";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147033";"";"0";"477.59";"0";"3.45";"5849";"O=C1COC2(CCN(CC2)S(=O)(=O)c3ccc(cc3)c4ccc5cnccc5c4)CN1C6CC6";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1077979";"";"0";"362.38";"0";"1.6";"4446";"COc1cc(O)c2C(=O)O[C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)C\C=C\c2c1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL259081";"";"0";"297.38";"0";"2.97";"5898";"O=C1N=C(NCc2ccccc2)SN1Cc3ccccc3";"PPB";"";"99.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824035";"";"0";"544.63";"1";"0.64";"3725";"CN(C)S(=O)(=O)c1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207603";"";"0";"498.51";"0";"4.14";"4307";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)N2c3ccccc3Oc4ccccc24";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147307";"";"0";"478.45";"0";"4.05";"5428";"COc1cnc(cn1)c2c(C)ccc(F)c2CCNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048863";"";"0";"323.81";"0";"2.2";"4763";"N[C@H]1CCN(C1)c2c(Cl)cccc2\C=C\3/SC(=O)NC3=O";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2017291";"";"0";"415.45";"0";"4.16";"5890";"COc1cc2c3N([C@H](C)c4ccccn4)C(=O)Nc3cnc2cc1c5c(C)onc5C";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778638";"";"0";"422.81";"0";"4.28";"2741";"CCS(=O)(=O)c1ccc(c(Cl)c1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059377";"";"0";"425.37";"0";"3.45";"5367";"CCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C#N)n4ccc(n4)C(F)(F)F";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4";"267.31";"0";"1.67";"99";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934415";"";"0";"460.64";"0";"4.97";"5433";"C[C@H](NC(=O)c1c(C)nn(C2CCCCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171278";"";"0";"409.51";"0";"3.64";"5909";"Cc1ccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c3cccc4cccnc34)c(C)c1";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062582";"";"0";"415.46";"0";"2.75";"4935";"CC(=O)Nc1ccc2c(c1)c(cn2CCO)c3cc(NC4CC4)n5ncc(C#N)c5n3";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335887";"";"0";"399.45";"0";"4.41";"4434";"COCCC(=O)Nc1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062561";"";"0";"345.37";"0";"2.75";"4526";"COc1ccc(cc1)c2cc(Nc3ccn(C)n3)n4ncc(C#N)c4n2";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916085";"";"0";"452.58";"0";"4.39";"3667";"CN(C1CCCCC1)C(=O)c2cnn(c2NS(=O)(=O)c3ccc(C)cc3)c4ccccc4";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL213495";"";"0";"355.4";"0";"4.43";"2677";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(cccc34)C#N";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL461950";"";"0";"386.24";"0";"4.89";"3384";"Clc1cccc(c1)C(=O)Nc2ccc(Cl)c(c2)C(=O)Nc3cccnc3";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180027";"";"0";"371.44";"0";"3.49";"5448";"COc1ccc(cc1C)C2(N=C(C)C(=N2)N)c3cccc(c3)c4cncnc4";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL538936";"";"0";"568.59";"2";"6.68";"3351";"Fc1ccc(cc1)C(NC(=O)CC2CCN(Cc3ccn(c3)c4ccc(cn4)C(F)(F)F)CC2)c5ccc(F)cc5";"PPB";"";"99.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689120";"";"0";"438.93";"0";"2.7";"3455";"C[C@@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1S(=O)(=O)c3ccccc3";"PPB";"";"99.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950843";"";"0";"442.65";"0";"2.82";"5311";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N(C)[C@H]2CCCN(CCc3ccccc3)C2";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335883";"";"0";"398.51";"0";"4.09";"4366";"CN(C)CCNCc1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2206784";"";"0";"400.85";"0";"3.25";"4105";"Cc1csc(NC(=O)COc2ncnc3c2cnn3c4ccccc4Cl)n1";"PPB";"";"99.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL397647";"";"0";"408.35";"1";"5";"5301";"C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C3CCOCC3";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4";"407.51";"0";"4.95";"871";"CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048500";"";"0";"576.74";"1";"3.14";"5013";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(c3ccccc3)c4ccccc4)C(=O)OC";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325635";"";"0";"547.45";"1";"4.92";"5639";"Clc1ccc(Oc2ccc(cc2C#N)S(=O)(=O)Nc3ncc(Cl)s3)c(c1)c4ccnn4C5CNC5";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335897";"";"0";"452.56";"0";"4.75";"4682";"C[C@@H](NC(=O)[C@H]1CCCCN1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062555";"";"0";"241.28";"0";"1.91";"2840";"Nc1cc(nc2c(cnn12)C#N)c3cccs3";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480027";"";"0";"471.96";"0";"4.41";"4063";"CC(C)Oc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1N4CCN(C)CC4";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL495383";"";"0";"314.77";"0";"3.61";"5934";"OCCc1cccc(NC(=O)c2cc3cc(Cl)ccc3[nH]2)c1";"PPB";"";"99.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1327979";"";"0";"285.25";"0";"2.45";"4129";"Nc1nc2nc(cc(n2n1)C(F)(F)F)c3cccs3";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL518760";"";"0";"455.51";"0";"4.26";"3693";"COc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1NCCN4CCCCC4";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152917";"";"0";"369.51";"0";"3.84";"5772";"CO[C@@H]1CC[C@@]2(CC1)Cc3ccc(OCC(C)C)cc3C24N=C(C)C(=N4)N";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1496905";"";"0";"325.32";"0";"2.06";"4779";"COc1ccc2N(CC3COc4ccccc4O3)C(=O)C(=O)c2c1";"PPB";"";"99.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207669";"";"0";"480.95";"0";"2.69";"2417";"O[C@H](CNC(=O)C1=CNC(=O)c2ccccc12)CN3CCC(CC3)Oc4ccc(C#N)c(Cl)c4";"PPB";"";"80.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950720";"";"0";"454.66";"0";"2.82";"5040";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CC[C@H]3CCN(CCc4ccccc4)C[C@@H]23";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1981917";"";"0";"244.29";"0";"3.33";"1578";"NC1=Nc2ccccc2Sc3cccc(F)c13";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650724";"";"0";"374.81";"0";"3.58";"3914";"C[C@H](Nc1ncc(Cl)c(Nc2cc([nH]n2)C3CC3)n1)c4ncc(F)cn4";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2042018";"";"0";"298.34";"0";"2.01";"5631";"NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc2ccccc2";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1762538";"";"0";"504.64";"1";"3.85";"4335";"CN(c1ccnc(Nc2cc(cc(c2)N3CCOCC3)N4CCCOCC4)n1)c5cc(CO)ccc5C";"PPB";"";"94.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4";"314.37";"0";"2.26";"512";"Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3";"PPB";"";"99.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331753";"";"0";"525.51";"1";"3.39";"5507";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(O)c(Oc4cccc(c4)C(F)(F)F)c3)C(=O)NC1=O";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL29384";"";"0";"381.41";"0";"2.3";"585";"OC(=O)C1=CN(Cc2ccccc2)c3cc(N4CCNCC4)c(F)cc3C1=O";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL896";"HYDROXYZINE";"4";"374.91";"0";"3.06";"1335";"OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205092";"";"0";"481.58";"0";"2.09";"2100";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3c[nH]c4ncccc34)c2C(=O)N5CC[C@@H](O)C5";"PPB";"";"68.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570899";"";"0";"314.33";"0";"2.35";"4351";"C[C@H](Nc1cncc(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL391565";"";"0";"244.25";"0";"1.32";"3145";"COc1ccc(NC(=O)c2ccnc(N)n2)cc1";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2017259";"";"0";"289.3";"0";"2.39";"5769";"O=C(Nc1ccc(nc1)n2ccnc2)c3ccc(cc3)C#N";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL321590";"";"0";"292.19";"0";"1.5";"2953";"ONC(=O)C1COC(=N1)c2ccc(F)c(c2)C(F)(F)F";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824038";"";"0";"529.62";"1";"1.19";"3658";"CCS(=O)(=O)c1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"69.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1313956";"";"0";"235.67";"0";"2.93";"3438";"Clc1ccccc1OCC(=O)c2ccc[nH]2";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216902";"";"0";"580.72";"2";"2.3";"5826";"CC(C)c1nc2ccccc2n1c3nc(N4CCOCC4)c5nc(OC6CN(C6)C7CCS(=O)(=O)CC7)n(C)c5n3";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480032";"";"0";"488.42";"0";"4.92";"4006";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCCN(C)CC4";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521509";"";"0";"406.45";"0";"3.07";"4170";"O=C(NC1CC1)C2=CN(c3cccc(c3)C#Cc4cccnc4)c5ncccc5C2=O";"PPB";"";"98.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1740000";"";"0";"378.42";"0";"4.93";"1195";"FC(F)(F)c1ccc2Sc3ccccc3N(C(=O)CN4CCCC4)c2c1";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957481";"";"0";"474.46";"0";"3.6";"4850";"COCCC#Cc1cccc(c1)C2(N=C(N)N3CC(F)(F)CN=C23)c4ccc(OC(F)F)cc4";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481596";"";"0";"415.42";"0";"3.25";"3819";"CN1CCN(CC1)c2cc3c(Nc4ccc(F)cc4F)c(cnc3cc2F)C(=O)N";"PPB";"";"75.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2348651";"";"0";"462.58";"0";"3.62";"5940";"CNc1nc(C)c(s1)c2nc(Nc3cccc(c3)N4CCCN(CC4)C(=O)C)ncc2C#N";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059876";"";"0";"395.46";"1";"5.28";"4491";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ccncc4";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650725";"";"0";"328.36";"0";"2.66";"4122";"C[C@H](Nc1ncc(C)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL193240";"ROFLUMILAST";"4";"403.21";"1";"5.03";"2902";"FC(F)Oc1ccc(cc1OCC2CC2)C(=O)Nc3c(Cl)cncc3Cl";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338408";"";"0";"431.36";"0";"2.52";"5563";"CC(C)(C)NC(=O)NCCN1CCOC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207278";"";"0";"508.38";"1";"3.61";"2603";"O[C@H](CNC(=O)C1=CNC(=O)c2cc(F)ccc12)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL20210";"RUPINTRIVIR";"0";"598.67";"1";"2.82";"5858";"CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c2cc(C)on2)C(C)C)Cc3ccc(F)cc3";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288103";"";"0";"404.9";"0";"4.02";"3496";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccc(Cl)c(F)c4";"PPB";"";"98.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179278";"";"0";"584.51";"2";"5.91";"5628";"CC1=CN([C@H]2CCCN(C2)[C@@H](CC(C)(C)C)c3ccc(C(=O)O)c(Oc4cccc(Br)c4)c3)C(=O)NC1=O";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL461384";"";"0";"505.53";"2";"3.56";"4416";"CC(C)c1noc(n1)C2CCN(CC2)c3ncnc(Nc4ccc(cc4F)S(=O)(=O)C)c3[N+](=O)[O-]";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL257991";"";"0";"469.57";"0";"3.66";"4919";"O=C(Nc1ccccc1c2cn3c(CN4CCNCC4)csc3n2)c5cnc6ccccc6n5";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4";"360.37";"0";"2.57";"564";"CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL54429";"";"0";"257.29";"0";"2.31";"5256";"ONC(=O)Cc1ccc(OCc2ccccc2)cc1";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059868";"";"0";"398.47";"0";"4.92";"4885";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4[nH]cnc4C";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1381233";"";"0";"248.29";"0";"3.49";"234";"O=C(Nc1ccncc1)c2cccc3ccccc23";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL439871";"";"0";"509.55";"1";"3.23";"2135";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3ccccc3C(F)(F)F)c2C(=O)N4CC(C)(O)C4";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1525826";"SULFALENE";"4";"280.31";"0";"0.87";"1188";"COc1nccnc1NS(=O)(=O)c2ccc(N)cc2";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1221681";"";"0";"400.5";"0";"3.06";"5108";"O[C@@H](CN[C@H]1CCC[C@@H]1OCc2ccccc2)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778621";"";"0";"374.34";"0";"3.24";"2409";"CS(=O)(=O)c1ccc(cc1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2208430";"";"0";"462.38";"0";"4.11";"2092";"O[C@H](CNC(=O)c1c[nH]c2ccccc12)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090940";"";"0";"1159.45";"";"";"5917";"CCCCCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950841";"";"0";"442.65";"0";"2.87";"5316";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCCN(CCc3ccccc3)C2";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1929039";"";"0";"391.32";"0";"4.34";"5819";"Cc1cc(F)ccc1n2nc(cc2c3ccc4OCC(=O)Nc4c3)C(F)(F)F";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916538";"";"0";"467.53";"0";"2.13";"3746";"COc1ccc2COC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331754";"";"0";"505.98";"1";"2.81";"5434";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(CO)c(Oc4cccc(Cl)c4)c3)C(=O)NC1=O";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349335";"";"0";"389.55";"0";"3.78";"1830";"CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2)nc3nc(N)sc13";"PPB";"";"99.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2064327";"";"0";"354.38";"0";"3.6";"4204";"Cc1cc(F)ccc1Oc2cccc3C(=O)C=C(Nc23)N4CCOCC4";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337981";"";"0";"459.42";"0";"2.9";"5582";"CC(C)(C)NC(=O)NCCN1CCC(CO)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL559696";"";"0";"234.31";"0";"2.71";"169";"O=C1NC=Nc2scc(c3cccs3)c12";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL254497";"";"0";"553.59";"2";"5.25";"5110";"CC(C)(C)OC(=O)N[C@H](Cc1ccccc1C(F)(F)F)C(=O)NCc2nc3cccnc3n2Cc4ccccc4";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1698351";"";"0";"351.41";"0";"1.28";"1848";"CN1C(C(=O)Nc2ncc(C)s2)C(=O)c3ccccc3S1(=O)=O";"PPB";"";"99.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1770298";"";"0";"394.5";"0";"4.49";"1672";"Cc1ccc(s1)C(NC(=O)c2ccccc2O)C(=O)Nc3c(C)cccc3C";"PPB";"";"99.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2103828";"ELINOGREL";"2";"523.96";"1";"3.09";"4842";"CNc1cc2NC(=O)N(C(=O)c2cc1F)c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178573";"";"0";"495.87";"0";"4.37";"5637";"Cc1cnc(C(=O)c2ncnc3[nH]ccc23)c(NS(=O)(=O)c4ccc(Cl)c(c4)C(F)(F)F)c1";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1257491";"";"0";"439.38";"1";"5.76";"5156";"Oc1ccc2cc(CNCCc3ccc(Br)cc3)c(nc2c1)c4ccsc4";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325601";"";"0";"533.92";"2";"5.52";"5711";"Nc1n[nH]cc1c2cc(ccc2Oc3cc(F)c(cc3Cl)S(=O)(=O)Nc4cscn4)C(F)(F)F";"PPB";"";"99.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1188966";"";"0";"616.5";"2";"5.55";"5884";"CN(C)c1nc(NC[C@@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc4ccccc14";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924046";"";"0";"425.64";"0";"4.9";"4870";"CC(=CCC[N+]12CCC(CC1)[C@H](C2)OC(=O)[C@@](C)(N3CCCCC3)c4ccccc4)C";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151323";"";"0";"383.39";"0";"2.43";"4202";"CC(C)Oc1cc(n[nH]1)n2cnc3cnc(N[C@@H](C)c4ncc(F)cn4)nc23";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158772";"";"0";"505.49";"2";"5.55";"2688";"Cc1ccccc1C[C@H](N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2)C(=O)O";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL426823";"";"0";"382.46";"0";"4.01";"4819";"CCOc1oc2cc(OCCC3CCN(CC3)c4ccc(C)nn4)ccc2n1";"PPB";"";"99.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL239767";"";"0";"352.14";"0";"3.71";"1817";"Oc1cc(ccc1NC(=O)Nc2ccccc2Br)[N+](=O)[O-]";"PPB";"";"99.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165175";"";"0";"342.4";"0";"3.91";"5145";"Cc1cc(ccn1)C2=CC(=O)NC(=N2)NCc3cccc4ccccc34";"PPB";"";"99.75";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312113";"";"0";"441.52";"0";"4.16";"5886";"COc1cc(O)c(C(CC(=O)N2CC(C)CC(C)C2)c3ccc4OCOc4c3)c(OC)c1";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059378";"";"0";"484.4";"0";"2.92";"5302";"CCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C4=NNC(=O)O4)n5ccc(n5)C(F)(F)F";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180028";"";"0";"385.47";"0";"3.8";"5228";"COc1c(C)cc(cc1C)C2(N=C(C)C(=N2)N)c3cccc(c3)c4cncnc4";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179270";"";"0";"483.95";"0";"4.39";"5380";"C[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2031562";"";"0";"348.29";"0";"2.72";"5835";"Nc1cc(cc(c1)C(F)(F)F)C(=O)Nc2cccc(c2)c3nnn[nH]3";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL196707";"";"0";"425.46";"0";"2.36";"3742";"Cc1c(CC(=O)O)c2cc(F)ccc2n1S(=O)(=O)c3ccc(cc3)S(=O)(=O)C";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1773082";"";"0";"371.81";"0";"4.09";"3769";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(Cl)cc1C#N)c3ccc(F)cn3";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL455920";"";"0";"392.83";"0";"3.49";"3705";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090630";"";"0";"1160.43";"";"";"5903";"CCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL98406";"";"0";"168.2";"0";"2.02";"1669";"Nc1nc2ccc(F)cc2s1";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1363";"ARFORMOTEROL";"4";"344.41";"0";"2.22";"1800";"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1";"PPB";"";"31.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL652";"FLECAINIDE";"4";"414.35";"0";"3.44";"1623";"FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2";"PPB";"";"38.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1352372";"";"0";"282.3";"0";"1.5";"4587";"Nc1nc2OC(COc3ccccc3)Cc2c(N)c1C#N";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171013";"";"0";"540.51";"2";"5.05";"1567";"CN(C(=O)N1CCC(CC1)N2CCC(CC2)Oc3ccc(Cl)c(Cl)c3)S(=O)(=O)c4ccc(C)cc4";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337980";"";"0";"445.39";"0";"2.65";"5585";"CC(C)(C)NC(=O)NCCN1CCC(O)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337977";"";"0";"387.31";"0";"2.51";"5575";"CC(C)(C)NC(=O)NCCN1CC(C1)NC(=O)c2cc(Cl)cc(Cl)c2";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178384";"";"0";"369.49";"0";"3.83";"4524";"Cc1ncc(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=S)N";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807827";"";"0";"482.07";"0";"3.53";"3871";"O[C@@H](CNCCSCCCNCCc1cccc(Cl)c1)c2ccc(O)c3NC(=O)Sc23";"PPB";"";"84.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1963462";"";"0";"330.49";"0";"3.92";"3737";"C[C@@](C1CCCC1)(C(=O)OC2CC[N+](C)(C)CC2)c3ccccc3";"PPB";"";"57.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950846";"";"0";"438.59";"0";"1.09";"5359";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(C1)S(=O)(=O)c2ccccc2)C(C)(C)C";"PPB";"";"59.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683038";"";"0";"444.9";"0";"3.03";"4431";"COc1cc2nnc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1N4CCN(C)CC4";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650737";"";"0";"449.88";"0";"2.54";"4092";"COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N4CCOCC4)c2Cl)n[nH]1";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481564";"";"0";"467.52";"0";"4.04";"4049";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(CC4)C5CC5";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916271";"";"0";"519.63";"2";"5.12";"5041";"CCN(C1CCCCC1)C(=O)c2cnn(c2NS(=O)(=O)c3ccc(cc3)c4ocnc4)c5ccccc5";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338020";"";"0";"453.96";"0";"2.9";"5812";"CCc1[nH]c2nc(Sc3cnc4ccc[n+]([O-])c4c3)nc(N5C[C@@H]6[C@@H](N)[C@@H]6C5)c2c1Cl";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312920";"";"0";"360.4";"0";"4.7";"5104";"CCCN(c1cccc(c1)C#N)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"99.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048864";"";"0";"323.81";"0";"2.07";"4795";"Clc1cccc(\C=C\2/SC(=O)NC2=O)c1N3CCNCC3";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178931";"";"0";"395.5";"0";"4.42";"4642";"CC(C)c1nc(C)c(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=O)N";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2361579";"";"0";"463.56";"0";"3.48";"2774";"Cc1cc2cc(C)c3nnc(SCC(=O)N4CCN(CC4)C(=O)c5occc5)n3c2cc1C";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481595";"";"0";"488.42";"1";"5.29";"3691";"COc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1NCCN4CCCCC4";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2070125";"";"0";"270.34";"0";"2.9";"4552";"COc1cnc(nc1NC2CCCC2)c3ccccn3";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152523";"";"0";"348.53";"1";"5.44";"4820";"C1CCN(CC1)[C@@H]([C@H](N2CCCCC2)c3ccccc3)c4ccccc4";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951165";"";"0";"392.48";"0";"3.27";"3798";"COc1cc(OC)c(cc1NC(=O)C)S(=O)(=O)N(C(C)C)c2ccccc2";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957380";"";"0";"324.34";"0";"3.94";"4836";"Oc1c(C#N)c(nc2ccncc12)c3ccc(cc3)c4cccnc4";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL235357";"";"0";"402.97";"0";"4.42";"2618";"Clc1ccc(O[C@@H]2CCCNC2)cc1C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL516601";"";"0";"355.37";"0";"3.54";"808";"COc1cc2ncc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1OC";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1198335";"";"0";"350.42";"0";"3.97";"5808";"COc1cccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)c1";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152525";"";"0";"320.48";"0";"4.66";"4805";"C1CCN(C1)[C@@H]([C@H](N2CCCC2)c3ccccc3)c4ccccc4";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480813";"";"0";"488.42";"1";"5.29";"3692";"COc1cc2c(Nc3cccc(Cl)c3Cl)c(cnc2cc1NCCN4CCCCC4)C(=O)N";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147316";"";"0";"482.41";"0";"4.15";"5583";"COc1cnc(cn1)c2ccccc2C(F)(F)CNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL551924";"";"0";"567.06";"2";"7.05";"3465";"FC(F)(F)c1ccc(cc1)n2ccc(CN3CCC(CC(=O)NC(c4ccncc4)c5ccc(Cl)cc5)CC3)c2";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569720";"";"0";"353.37";"0";"2.53";"4384";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(C)nc1C#N)c3ncc(F)cn3";"PPB";"";"69.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL13976";"";"0";"370.43";"0";"2.55";"4232";"CN(C)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL457393";"";"0";"357.37";"0";"3.67";"3558";"C[C@H](Nc1ncc(F)c(Nc2cc([nH]n2)C3CC3)n1)c4ccc(F)cn4";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147309";"";"0";"466.41";"0";"4.18";"5442";"Cc1cnc(cn1)c2c(F)ccc(F)c2CCNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL370492";"";"0";"411.46";"1";"6.06";"5802";"CCc1nc2cc(O)ccc2c(Oc3ccc(\C=C\C(=O)O)cc3)c1c4ccccc4";"PPB";"";"99.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180033";"";"0";"324.82";"0";"3.8";"5411";"CC1=NC(N=C1N)(C2CC2)c3cccc(c3)c4cncc(Cl)c4";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335904";"";"0";"421.5";"1";"5.33";"4672";"C[C@@H](NC1=CC(=O)CC1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180037";"";"0";"328.42";"0";"3.51";"5412";"CC#Cc1cncc(c1)c2cccc(c2)C3(N=C(C)C(=N3)N)C4CC4";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL550902";"";"0";"424.93";"1";"5.05";"3297";"OC(=O)c1cncc(c1)c2ccc(Cl)c(c2)C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151176";"";"0";"435.53";"0";"4.25";"5385";"COc1cc(Nc2nc(COC3CCCC3)c4COCCc4n2)ccc1n5cnc(C)c5";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL213854";"";"0";"348.38";"0";"4.7";"2465";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(F)cccc34";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2057336";"";"0";"411.47";"0";"4.26";"4495";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ccc(N)nn4";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338405";"";"0";"430.38";"0";"2.65";"5532";"CC(C)(C)NC(=O)NCCN1CCN(CC(=O)Nc2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"4330";"C[C@H](CN(C(=O)c1ccc(cc1)C#N)c2ccccn2)N3CCN(CC3)c4cccc5OCCOc45";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL235579";"";"0";"402.97";"0";"4.42";"2619";"Clc1ccc(O[C@H]2CCCNC2)cc1C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171033";"";"0";"512.46";"1";"4.4";"1560";"Clc1ccc(OC2CCN(CC2)C3CCN(CC3)C(=O)NS(=O)(=O)c4ccccc4)cc1Cl";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL123798";"";"0";"320.27";"0";"4.03";"5425";"COc1cccc2c(O)nc(nc12)c3ccc(cc3)C(F)(F)F";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL343199";"";"0";"325.37";"0";"3.17";"5720";"CCOC(=O)Nc1cc2NCCC(=Nc2c(N)n1)c3ccccc3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL239336";"";"0";"328.39";"0";"3.12";"3975";"CC1=C(C(NC(=O)N1)c2cccs2)C(=O)OCc3ccccc3";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2094588";"";"0";"311.77";"0";"3.22";"1708";"Clc1ccc(cc1)C(=O)CN2C3=NCCN3c4ccccc24";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778652";"";"0";"400.42";"0";"4.49";"2807";"CCS(=O)(=O)c1ccc(c(C)c1)c2cc(ccc2CCC(=O)O)C(F)(F)F";"PPB";"";"97.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650728";"";"0";"409.22";"0";"2.82";"4082";"COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Br)n[nH]1";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2070241";"BREMELANOTIDE";"3";"1025.18";"";"";"4684";"CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC1=O)C(=O)O";"PPB";"";"27.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1460615";"";"0";"295.4";"0";"1.02";"5857";"OC1CS(=O)(=O)CC1N2CCC(CC2)c3ccccc3";"PPB";"";"43.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479445";"";"0";"415.44";"0";"3.34";"3648";"COc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1NCCN(C)C";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481";"IRINOTECAN";"4";"586.69";"1";"4.09";"2980";"CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4";"PPB";"";"57.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2088413";"";"0";"326.42";"0";"3.07";"3444";"Cc1ccc(CCNC(=O)c2ccc3sc(CO)nc3c2)cc1";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951073";"";"0";"404.49";"0";"3.19";"3694";"COc1cc(OC)c(cc1NC(=O)C)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL78628";"NEGAMYCIN";"0";"248.28";"0";"-2.54";"3151";"CN(CC(=O)O)NC(=O)C[C@H](N)C[C@@H](O)CN";"PPB";"";"12.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950855";"";"0";"437.03";"0";"2.6";"5327";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(Cl)cc2)C1)C(C)(C)C";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL284237";"DIZOCILPINE";"0";"221.3";"0";"3.15";"1735";"C[C@]12N[C@H](Cc3ccccc13)c4ccccc24";"PPB";"";"47.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2018953";"";"0";"500.43";"1";"3.73";"3317";"Clc1ccc(CNc2nc(nc3ncccc23)N4CCN(CC4)C(=O)[C@H]5CCCCN5)c(Cl)c1";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1645107";"";"0";"227.29";"0";"2.94";"4585";"Nc1nc2ccc(cc2s1)c3ccncc3";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059196";"";"0";"444.37";"0";"3.28";"5240";"CCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C(=O)O)n4ccc(n4)C(F)(F)F";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312185";"";"0";"420.55";"0";"3.37";"5942";"CNc1nc(C)c(s1)c2nc(Nc3cccc(c3)N4CCCNCC4)ncc2C#N";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1645496";"";"0";"328.37";"0";"3.67";"5283";"OC(c1ccccc1)c2ccc3C(=O)C=C(Nc3c2)c4cccnc4";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778646";"";"0";"389.26";"0";"3.92";"2679";"CCS(=O)(=O)c1ccc(c(Cl)c1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178385";"";"0";"338.41";"0";"3.6";"4586";"NC(=O)c1cncc(c1)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1426782";"";"0";"427.46";"0";"2.88";"2917";"Cc1sc2N(CC(=O)NCc3occc3)C(=O)N(C(=O)c2c1C)c4ccc(F)cc4";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL550410";"";"0";"474.5";"1";"5.1";"3186";"Fc1cccc(CNC(=O)NC2CCN(Cc3ccn(c3)c4ccc(cc4)C(F)(F)F)CC2)c1";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1289545";"";"0";"405.95";"0";"3.61";"3422";"Cc1nc(cs1)C(=O)N2CCOC3(CCN(Cc4ccc(Cl)cc4)CC3)C2";"PPB";"";"56.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1431736";"";"0";"292.34";"0";"3.43";"5878";"CC(NC(=O)c1cc(O)nc2ccccc12)c3ccccc3";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL523829";"";"0";"362.43";"0";"1.9";"4189";"CN1CCN(CC1)C(=O)c2cccc(CC3=NNC(=O)c4ccccc34)c2";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL210887";"";"0";"340.34";"0";"2.58";"5766";"OCCCn1c(NC(=O)c2cccc(c2)[N+](=O)[O-])nc3ccccc13";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL296035";"BUFURALOL";"0";"261.37";"0";"3.42";"1362";"CCc1cccc2cc(oc12)C(O)CNC(C)(C)C";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1940832";"MILVETEROL";"2";"435.52";"1";"2.97";"4298";"O[C@@H](CNCCc1ccc(NC[C@H](O)c2ccccc2)cc1)c3ccc(O)c(NC=O)c3";"PPB";"";"71.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2170992";"";"0";"501.61";"1";"2.1";"5756";"CC(C)c1ccc(NC(=O)NCCCSC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc4c(N)ncnc34)cc1";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL30054";"";"0";"452.82";"0";"2.35";"2588";"Fc1cccnc1CNC(=O)CN2C(=CN=C(NCC(F)(F)c3ccccn3)C2=O)Cl";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650735";"";"0";"415.43";"0";"1.89";"4091";"COc1cc(Nc2cc(nc(N[C@@H](C)c3ncc(F)cn3)n2)N4CCOCC4)n[nH]1";"PPB";"";"72.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1761870";"";"0";"571.78";"1";"4.23";"5703";"C[C@@H]1CN(C[C@H](C)N1)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)N3CCC(CC3)(C4CCCCC4)C(=O)NC(C)(C)C";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951164";"";"0";"364.42";"0";"2.49";"3690";"COc1cc(OC)c(cc1NC(=O)C)S(=O)(=O)N(C)c2ccccc2";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL211177";"";"0";"422.32";"0";"2.22";"5291";"C[C@@H](CC(=O)OC(C)(C)C)NC(=O)C1=NO[C@H](C1)C(O)(C(F)(F)F)C(F)(F)F";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL49";"BUSPIRONE";"4";"385.51";"0";"2.09";"295";"O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL208943";"";"0";"485.63";"0";"4.17";"3305";"O=C([C@@H]1CCCN(C1)C2CCN(CC2)C(=O)c3c4ccccc4cc5ccccc35)N6CCOCC6";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917443";"";"0";"389.5";"0";"3.9";"2680";"Cc1ccc2c(c1)c(Sc3ccc(cc3)S(=O)(=O)C)c(C)n2CC(=O)O";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL461572";"";"0";"392.27";"0";"4.95";"3635";"Clc1cccc(c1)C(=O)Nc2ccc(Cl)c(c2)C(=O)Nc3cncs3";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL408";"TROGLITAZONE";"4";"441.55";"0";"4.37";"986";"Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179287";"";"0";"391.47";"0";"3.47";"4799";"CC1=CN(C2CCCN(Cc3cccc(Oc4ccccc4)c3)C2)C(=O)NC1=O";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL162203";"";"0";"243.7";"0";"3.59";"4374";"Cc1cccc(n1)c2nc3cc(Cl)ccc3[nH]2";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL192307";"";"0";"296.42";"0";"4.17";"2319";"CCCCc1nc2c(N)nc3ccccc3c2n1CC(C)C";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2088393";"";"0";"356.45";"0";"4.22";"2945";"CC(C)(C)Oc1ccc(cc1)C(=O)Nc2ccc3sc(CO)nc3c2";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL219861";"";"0";"494.57";"0";"2.31";"2521";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3ccnc4ccccc34)c2C(=O)N5C[C@H](O)CO5";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934422";"";"0";"462.62";"0";"3.82";"5462";"C[C@H](NC(=O)c1c(C)nn(C2CCOCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL339053";"";"0";"589.18";"1";"4.56";"2632";"Clc1ccc(C[C@@H](NC(=O)[C@H]2Cc3ccccc3CN2)C(=O)N4CCC(Cn5cncn5)(CC4)C6CCCCC6)cc1";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1486517";"";"0";"480.59";"0";"2.62";"4665";"O=C(C1CCN(CC1)c2nnc(s2)n3cccc3)N4CCN(Cc5ccc6OCOc6c5)CC4";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147569";"";"0";"449.5";"0";"4.35";"5828";"C[C@]12Cc3cnn(c3C=C1CC[C@@]2(O)CCc4ccc(F)cc4C(=O)N)c5ccc(F)cc5";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL407960";"";"0";"376.42";"0";"4.38";"2452";"COc1ccc(OC)c(CNc2n[nH]c3ccnc(Oc4ccccc4)c23)c1";"PPB";"";"98.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921942";"";"0";"476.64";"0";"4.18";"4602";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CC(=O)Nc4ccccc4)CCC2CC3)c5ccccc5";"PPB";"";"98.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL488937";"";"0";"340.45";"0";"3.47";"5416";"Cc1c(N)cccc1CN2C=CC(=CC2=O)OCCc3cccs3";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165055";"";"0";"488.55";"0";"1.48";"4231";"CO[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2021706";"";"0";"450.01";"0";"2.91";"5846";"CCC[C@@H](CNC(=O)c1nc(Cl)c(N)nc1N)[N+](C)(C)CCCc2ccc(OC)cc2";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL577902";"";"0";"341.39";"0";"-0.48";"1889";"CCCSc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165187";"";"0";"407.52";"0";"2.33";"5181";"CN(C)CCN(Cc1cccc2ccccc12)C3=CC(=NC(=O)N3)N4CCOCC4";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683035";"";"0";"428.44";"0";"2.51";"4423";"COc1cc2nnc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151325";"";"0";"401.38";"0";"2.55";"4377";"CCOc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c4ccc(F)cn4)n[nH]1";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL539163";"TANAPROGET";"0";"297.38";"0";"3.53";"5218";"Cn1c(ccc1c2ccc3NC(=S)OC(C)(C)c3c2)C#N";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL550496";"";"0";"419.95";"0";"3.37";"1596";"OC(=O)CNCCNc1ccc(Cl)c(c1)C(=O)NCC23CC4CC(CC(C4)C2)C3";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1922054";"";"0";"488.65";"1";"5.19";"4847";"Cc1ccc2nc(C[N+]34CCC(CC3)[C@H](C4)OC(=O)[C@@](C)(N5CCCCC5)c6ccccc6)oc2c1";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158438";"";"0";"320.78";"0";"1.87";"4993";"Clc1cccc(CNC2=NC(=CC(=O)N2)N3CCOCC3)c1";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2326624";"";"0";"576.1";"1";"3.21";"5669";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)[C@@H]5COCCN5)c4";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165060";"";"0";"481.55";"0";"1.45";"4283";"CO[C@H]1CN(CCN2C(=O)C=Nc3ccc(OC)cc23)CC[C@@H]1NCc4cc5OCCOc5cn4";"PPB";"";"83.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481206";"";"0";"467.55";"0";"3.3";"4242";"COCCOc1cc2ncc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1N4CCN(C)CC4";"PPB";"";"83.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL60066";"";"0";"266.66";"0";"2.36";"5445";"[O-][n+]1cc(ccc1Cl)C(=O)Nc2ccc(F)cc2";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL191553";"";"0";"373.42";"0";"4.32";"1697";"CC(=O)Nc1ccc(CNc2[nH]nc3ccnc(Oc4ccccc4)c23)cc1";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921923";"";"0";"463.65";"0";"3.96";"4930";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCCc4cncnc4)CCC2CC3)c5ccccc5";"PPB";"";"22.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824029";"";"0";"481.55";"0";"1.45";"3860";"CC(O)c1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171020";"";"0";"500.43";"1";"4.98";"1551";"Clc1ccc(OC2CCN(CC2)C3CCN(CC3)C(=O)C4=CNC(=O)c5ccccc45)cc1Cl";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560167";"";"0";"421.97";"0";"3.03";"1624";"OCCCNCCOc1cc(C(=O)NCC23CC4CC(CC(C4)C2)C3)c(Cl)cn1";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048866";"";"0";"337.83";"0";"2.59";"5011";"N[C@@H]1CCCN(C1)c2c(Cl)cccc2\C=C\3/SC(=O)NC3=O";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335911";"";"0";"397.48";"0";"4.94";"4947";"C[C@@H](NC(=O)C)c1ccc(Nc2ncc3cc(c(C)cc3n2)c4ccncc4)cc1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL20921";"";"0";"481.47";"1";"5.06";"2451";"Nc1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL389792";"";"0";"413.48";"0";"2.39";"1744";"CC(CO)(CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(N)sc13";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1526762";"";"0";"197.26";"0";"0.67";"565";"Cc1cc(C)nc(SCC(=O)N)n1";"PPB";"";"21.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL115";"INDINAVIR";"4";"613.8";"1";"2.87";"4173";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc3ccccc3)C(=O)N[C@@H]4[C@H](O)Cc5ccccc45";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921919";"";"0";"476.69";"0";"4.88";"4866";"Cc1cc(CCC[N+]23CCC(CC2)[C@H](C3)OC(=O)[C@@](C)(N4CCCCC4)c5ccccc5)ccn1";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1087269";"";"0";"415.5";"0";"3.53";"4323";"C[C@H](Nc1nc(Nc2ncc(C)s2)cc(n1)N3CCOCC3)c4ccc(F)cn4";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338403";"";"0";"439.67";"0";"2.29";"5426";"CC(C)(C)S(=O)(=O)CCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951187";"";"0";"563.63";"1";"2.68";"4050";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)NCc2ccccc2N3CCC(CC(=O)O)CC3";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062564";"";"0";"372.39";"0";"2.47";"4719";"CC(=O)Nc1ccc2cnn(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1995703";"";"0";"509.68";"1";"4.1";"4365";"CN1CCN(CC1)c2ccc(Nc3ncc(C)c(Nc4cccc(c4)S(=O)(=O)NC(C)(C)C)n3)cc2";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216839";"";"0";"428.5";"0";"4.37";"5717";"C[C@@H]1CN(Cc2oc(nn2)c3cc(cc4[nH]ncc34)c5cccc6[nH]ccc56)C[C@H](C)O1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934423";"";"0";"448.59";"0";"3.43";"5518";"C[C@H](NC(=O)c1c(C)nn(C2CCOC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2111112";"VERNAKALANT";"4";"349.47";"0";"2.64";"3759";"COc1ccc(CCO[C@@H]2CCCC[C@H]2N3CC[C@@H](O)C3)cc1OC";"PPB";"";"37.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824037";"";"0";"482.5";"0";"1.3";"3682";"[O-][N+](=O)c1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313226";"";"0";"385.41";"0";"4.41";"4887";"O=P(N(Cc1ccccn1)c2cccnc2)(c3ccccc3)c4ccccc4";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205742";"";"0";"492.6";"0";"2.76";"1918";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3ccnc4ccccc34)c2C(=O)N5CC[C@@H](O)C5";"PPB";"";"64.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179275";"";"0";"526.03";"2";"5.41";"5489";"CC(C)C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL301554";"";"0";"292.39";"0";"3.27";"712";"CN(C)CCNc1cc(nc2ccccc12)c3ccncc3";"PPB";"";"85.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402501";"";"0";"492.66";"0";"3.77";"4406";"C[C@H](Cc1cccc(CC(=O)NC23CC4CC(CC(C4)C2)C3)c1)NC[C@H](O)c5ccc(O)c(CO)c5";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957848";"";"0";"344.8";"0";"2.03";"5157";"Clc1cccc(CN2C=CN3C(=O)C=C(N=C23)N4CCOCC4)c1";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152920";"";"0";"426.56";"0";"4.63";"5730";"CCC#Cc1cncc(c1)c2ccc3C[C@@]4(CC[C@@H](CC4)OC)C5(N=C(C)C(=N5)N)c3c2";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1473";"FLUTICASONE PROPIONATE";"4";"500.58";"1";"4.43";"1748";"CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1645392";"";"0";"361.42";"0";"3.04";"5918";"Cc1onc(C)c1c2ccc(CNS(=O)(=O)c3c(C)onc3C)cc2";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325014";"";"0";"500.36";"2";"5.15";"5734";"Nc1[nH]ncc1c2cc(Cl)ccc2Oc3cc(F)c(cc3Cl)S(=O)(=O)Nc4cscn4";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1503948";"";"0";"318.42";"0";"3.71";"3755";"Cc1ccc(cc1)S(=O)(=O)Nc2ccc3nc(C)sc3c2";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1539037";"";"0";"339.4";"0";"2.63";"5912";"COc1ccc(NC(=O)CCc2c(C)nc3nc(C)nn3c2C)cc1";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1346";"DARIFENACIN";"4";"426.56";"0";"3.96";"3453";"NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683037";"";"0";"424.48";"0";"2.68";"4430";"COc1cc2nnc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1N4CCN(C)CC4";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL809";"SERTRALINE";"4";"306.24";"1";"5.18";"1847";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689123";"";"0";"452.96";"0";"3.09";"3469";"CC[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1S(=O)(=O)c3ccccc3";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL551813";"ACTIMIS";"0";"501.51";"1";"4.1";"5243";"CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(cc3)C(F)(F)F)cc2)nc(N(C)C)c1CC(=O)O";"PPB";"";"99.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1944693";"";"0";"493.63";"0";"3.5";"3869";"COc1ccccc1CCNCc2cccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)c2";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158785";"";"0";"514.04";"1";"4.91";"3425";"Cc1c(Cl)c(ccc1OC2CCN(CC3CCN(CC3)[C@@H](Cc4ccc(F)cc4)C(=O)O)CC2)C#N";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4";"374.48";"0";"1.8";"2659";"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1087398";"";"0";"426.48";"0";"3.09";"4387";"C[C@H](Nc1nc(Nc2ncc(C#N)s2)cc(n1)N3CCOCC3)c4ccc(F)cn4";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL81324";"NORCHLORCYCLIZINE";"0";"286.81";"0";"3.33";"1916";"Clc1ccc(cc1)C(N2CCNCC2)c3ccccc3";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1091291";"";"0";"1159.45";"";"";"5919";"CCCCCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951186";"";"0";"549.6";"1";"2.29";"4030";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)NCc2ccccc2N3CCC(CC3)C(=O)O";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178951";"";"0";"353.42";"0";"3.3";"4442";"Cc1ncc(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=O)N";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807860";"";"0";"365.82";"0";"1.47";"3621";"C[C@H]1O[C@H]([C@H](O)[C@H]1Cl)n2cnc3c(N)nc(OCC4CC45CC5)nc23";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL230245";"";"0";"505.66";"1";"2.96";"4768";"CC(C)S(=O)(=O)N(C)c1cc(cc(NC[C@H]2C[C@@H]2C)n1)C(=O)N[C@@H](Cc3ccccc3)[C@@H](N)CF";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158436";"";"0";"336.4";"0";"2.37";"4963";"O=C1NC(=NC(=C1)N2CCOCC2)NCc3cccc4ccccc34";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4";"301.73";"0";"4.34";"261";"CC(C(=O)O)c1ccc2oc(nc2c1)c3ccc(Cl)cc3";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207661";"";"0";"453.37";"0";"3.23";"2472";"O[C@H](CNC(=O)c1c[nH]nc1C2CC2)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4";"250.34";"0";"3.57";"168";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917449";"";"0";"420.87";"0";"3.48";"2478";"CC(=O)Nc1cccc2c1c(c(C)n2CC(=O)O)S(=O)(=O)c3ccc(Cl)cc3";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1387923";"";"0";"331.79";"0";"3.9";"1266";"Clc1cccc(NC(=O)Nc2nnc(s2)c3ccncc3)c1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957369";"";"0";"357.8";"1";"5.19";"4832";"Oc1c(C#N)c(nc2ccncc12)c3ccc(cc3)c4ccccc4Cl";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL219046";"";"0";"367.83";"0";"4.76";"4619";"OC(=O)c1c(O)c(Cc2ccc(Cl)cc2)nc3c4CCCCc4ccc13";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1488371";"";"0";"331.79";"0";"3.9";"1267";"Clc1ccc(NC(=O)Nc2nnc(s2)c3ccncc3)cc1";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1322390";"";"0";"372.45";"0";"3.89";"5902";"COc1ccc2nc(NC(=O)CCc3ccc(OC)c(OC)c3)sc2c1";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335907";"";"0";"413.48";"0";"4.64";"4737";"COc1cc(cc2cnc(Nc3ccc(cc3)[C@@H](C)NC(=O)C)nc12)c4ccncc4";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL594671";"";"0";"294.81";"0";"4.17";"5238";"CC(C)[C@H](C(=O)Nc1nccs1)c2ccc(Cl)cc2";"PPB";"";"99.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207658";"";"0";"481.3";"0";"3.37";"2361";"O[C@H](CNC(=O)c1c[nH]nc1C(F)(F)F)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3";"PPB";"";"97.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL411329";"(R,S)-MEFLOQUINE";"0";"378.32";"0";"4.45";"1832";"O[C@@H]([C@@H]1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F";"PPB";"";"97.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934271";"";"0";"448.63";"0";"4.83";"5120";"CCC(CC)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216830";"";"0";"656.62";"2";"6.61";"5885";"CCN(CC)CCCCNc1ncc2CN(C(=O)N(Cc3cccc(NC(=O)C=C)c3)c2n1)c4c(Cl)c(OC)cc(OC)c4Cl";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950852";"";"0";"432.61";"0";"1.96";"5341";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccc2OC)C1)C(C)(C)C";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481400";"";"0";"397.43";"0";"3.11";"3776";"CN1CCN(CC1)c2ccc3ncc(C(=O)N)c(Nc4ccc(F)cc4F)c3c2";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2208428";"";"0";"501.43";"1";"3.03";"2523";"CS(=O)(=O)c1ccccc1C(=O)NC[C@@H](O)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2036958";"";"0";"276.29";"0";"1.29";"5901";"CC1(CCCC2=CC(=O)OC3=C2C(=O)NC(=O)N3)CC1";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1020";"TOLMETIN";"4";"257.29";"0";"2.19";"254";"Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C";"PPB";"";"99.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171024";"";"0";"477.39";"0";"4.84";"1563";"OC(=O)c1cccc(c1)C(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL602180";"";"0";"256.31";"0";"2.15";"1634";"COc1cnc(nc1N2CCCC2)c3ccccn3";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957363";"";"0";"339.35";"0";"4.25";"4834";"Oc1ccccc1c2ccc(cc2)c3nc4ccncc4c(O)c3C#N";"PPB";"";"99.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL514257";"";"0";"388.83";"0";"3.76";"3019";"OC[C@H](Nc1ncc(Cl)c(Nc2cc([nH]n2)C3CC3)n1)c4ccc(F)cc4";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2113096";"";"0";"359.42";"0";"3.71";"4601";"Cc1nccn1c2sc(Nc3cnccn3)nc2c4cccc(c4)C#N";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171036";"";"0";"542.49";"1";"4.41";"2141";"COc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521262";"";"0";"448.35";"0";"4.37";"3651";"COc1cc2c(Nc3cccc(Cl)c3Cl)c(cnc2cc1NCCN(C)C)C(=O)N";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2170989";"";"0";"459.53";"0";"0.97";"5761";"Nc1ncnc2c1ncn2[C@@H]3O[C@H](CSCCCNC(=O)Nc4ccccc4)[C@@H](O)[C@H]3O";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1532611";"";"0";"213.28";"0";"2.89";"653";"Nc1ccc(OCCc2ccccc2)cc1";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921925";"";"0";"517.76";"2";"6.39";"4920";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCCc4cc5ccccc5s4)CCC2CC3)c6ccccc6";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1718800";"";"0";"276.34";"0";"3.61";"1774";"C(Cc1nc2ccccc2[nH]1)Cc3nc4ccccc4[nH]3";"PPB";"";"99.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL510386";"";"0";"419.79";"1";"5.26";"3385";"FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(Cl)c(c2)C(=O)Nc3cccnc3";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL562308";"";"0";"422.57";"0";"3.77";"1621";"OCCNCCNc1ccc2c(NC(=O)CC34CC5CC(CC(C5)C3)C4)cccc2n1";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059862";"";"0";"412.49";"0";"4.93";"4604";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ncc(C)n4C";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171277";"";"0";"409.51";"0";"3.64";"5906";"Cc1ccc(NC(=O)[C@H]2CCCN2S(=O)(=O)c3cccc4cccnc34)c(C)c1";"PPB";"";"97.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL551170";"";"0";"414.89";"0";"2.52";"2838";"Clc1ccc(cc1C(=O)NCC23CC4CC(CC(C4)C2)C3)N5N=CC(=O)NC5=O";"PPB";"";"98.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479840";"";"0";"488.42";"0";"4.92";"3984";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(CC)CC4";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL516758";"";"0";"488.42";"0";"4.92";"4081";"CC(C)Oc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(C)CC4";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062580";"";"0";"385.43";"0";"3.29";"4826";"CC(=O)Nc1ccc2c(c1)c(cn2C)c3cc(NC4CC4)n5ncc(C#N)c5n3";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1956334";"";"0";"409.49";"0";"2.81";"5891";"CC(=O)c1ncccc1NC(=O)[C@@H]2CC[C@H](CC2)N3C(=O)[C@@H]4[C@@H]5CC[C@@H](C5)[C@@H]4C3=O";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011910";"";"0";"318.18";"0";"3.01";"4816";"CNc1c(Br)cnc2[nH]c(nc12)c3cccc(N)c3";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL392559";"";"0";"413.99";"0";"3.83";"2537";"Clc1ccc(CN2C[C@@H]3C[C@H]2CN3)cc1C(=O)NCC45CC6CC(CC(C6)C4)C5";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957370";"";"0";"358.79";"0";"4.59";"4835";"Oc1c(C#N)c(nc2ccncc12)c3ccc(cc3)c4ccncc4Cl";"PPB";"";"99.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917446";"";"0";"377.85";"0";"3.83";"2134";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)S(=O)(=O)c3ccc(Cl)cc3";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934419";"";"0";"510.68";"1";"3.21";"5504";"C[C@H](NC(=O)c1c(C)nn(C2CCS(=O)(=O)CC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL517437";"";"0";"425.82";"1";"5.32";"3622";"FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(Cl)c(c2)C(=O)Nc3cncs3";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288221";"";"0";"404.9";"0";"4.02";"3490";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccc(F)c(Cl)c4";"PPB";"";"99.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL213494";"";"0";"408.48";"0";"3.96";"2681";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(cccc34)S(=O)(=O)C";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180015";"";"0";"344.42";"0";"3.22";"5601";"CC#Cc1ccnc(c1)c2cc(ccc2O)C3(N=C(C)C(=N3)N)C4CC4";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL571353";"";"0";"391.78";"1";"5.38";"4473";"Cc1nc(ccc1C(=O)Nc2ccc(Cl)c(c2)c3ccccn3)C(F)(F)F";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1097062";"";"0";"362.84";"0";"2.82";"5609";"CC(C)NC(=O)C1=NN(C(=O)c2c(N)scc12)c3ccc(Cl)cc3";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560219";"";"0";"424.81";"0";"3.85";"4738";"OCCN1C=Cc2c(NC(=O)Cc3ccc(Cl)c(c3)C(F)(F)F)cccc2C1=O";"PPB";"";"99.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164670";"";"0";"492.6";"0";"3.67";"2660";"COc1ccccc1C(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N3CCN(Cc4ccc(F)cc4)CC3)C#N";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147474";"";"0";"468.96";"0";"4.93";"5586";"COc1cc(ccc1OC[C@H](O)C2CC2)N3C=Nc4cc(sc4C3=O)c5ccc(Cl)cc5";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL190747";"";"0";"364.4";"0";"3.82";"2448";"COc1ccc(OC)c(CNC(=O)c2cccnc2Oc3ccccc3)c1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL376632";"";"0";"420.47";"0";"2.03";"2171";"Cc1cc(nc(n1)n2ccnc2)N3CCC[C@@H]3C(=O)NCCc4ccc5OCOc5c4";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1289717";"";"0";"384.48";"0";"3.95";"5646";"O=C1C=C(C=CN1c2ccc3c(cnn3CCN4CCCC4)c2)c5ccccc5";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL464081";"";"0";"445.51";"0";"2.95";"2943";"CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N3CCN(CC3)c4ccc(cn4)C(F)(F)F)C(=O)C2";"PPB";"";"99.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2103846";"ULIPRISTAL";"4";"433.59";"0";"4.97";"5938";"CN(C)c1ccc(cc1)[C@H]2C[C@@]3(C)[C@@H](CC[C@]3(O)C(=O)C)[C@@H]4CCC5=CC(=O)CCC5=C24";"PPB";"";"99.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456390";"";"0";"274.32";"0";"3.79";"5287";"O=C1CCc2cc(ccc2N1)c3cncc4ccccc34";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048870";"";"0";"375.49";"0";"2.97";"5271";"CC(C)COc1cccc(\C=C\2/SC(=O)NC2=O)c1N3CCC[C@@H](N)C3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL168899";"";"0";"238.06";"";"";"5805";"OB1N(C(=O)Nc2ccccc12)c3ccccc3";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL256668";"";"0";"379.39";"0";"2.08";"2284";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3NC(=O)C=Nc13";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL429682";"";"0";"461.54";"0";"2.82";"2176";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(NS(=O)(=O)C)sc13";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL515062";"";"0";"481.92";"0";"2.82";"3594";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc(OC(CO)CO)c2Cl)n[nH]1";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521096";"";"0";"437.52";"0";"3.68";"4112";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062574";"";"0";"428.5";"0";"3.01";"4909";"CC(=O)Nc1ccc2ccn(c3cc(NCCN4CCCC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"94.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689117";"";"0";"442.9";"0";"2.45";"3329";"OC(=O)COc1ccc(Cl)cc1CN2CCN(CC2)S(=O)(=O)c3ccc(F)cc3";"PPB";"";"98.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL213029";"";"0";"380.83";"0";"4.78";"1339";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2c3ccnc4cc(Cl)ccc34";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL421236";"";"0";"463.48";"0";"3.51";"2974";"C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)NC2C(=O)N(C)c3ccccc3c4ccccc24";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011932";"";"0";"473.38";"0";"3.05";"4902";"COc1ccc(cc1)c2nc3c(NCCCNC(=O)C4(CN)CC4)c(Br)cnc3[nH]2";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951081";"";"0";"513.64";"1";"4.36";"3896";"COc1cc(OC)c(cc1NC(=O)CSc2ccncc2)S(=O)(=O)N3C(C)CCc4ccccc34";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921917";"";"0";"462.66";"0";"4.57";"4857";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCCc4ccncc4)CCC2CC3)c5ccccc5";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL149434";"";"0";"379.42";"0";"1.78";"5905";"CCc1c(C(=O)C(=O)N)c2c(OCC(=O)N)cccc2n1Cc3ccccc3";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951184";"";"0";"635.69";"1";"2.61";"3965";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)NCc2ccccc2N3CCC(COC(=O)CCC(=O)O)CC3";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650698";"";"0";"358.36";"0";"3.06";"3915";"C[C@H](Nc1ncc(F)c(Nc2cc([nH]n2)C3CC3)n1)c4ncc(F)cn4";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2324423";"";"0";"488.91";"0";"4.25";"5679";"Fc1cc(c(Oc2ccc(cc2C#N)S(=O)(=O)Nc3ncns3)cc1Cl)c4ccnnc4";"PPB";"";"99.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL206200";"";"0";"314.35";"0";"1.22";"2290";"COCCNc1nc(N)c2nc(O)n(Cc3ccccc3)c2n1";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683036";"";"0";"424.48";"0";"2.68";"4432";"COc1cc2nnc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151319";"";"0";"364.39";"0";"3.12";"4077";"C[C@H](Nc1ccc2ncn(c3cc([nH]n3)C4CC4)c2n1)c5ncc(F)cn5";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL271012";"";"0";"366.44";"0";"2.6";"2328";"C[C@H](CO)Nc1nc(SCc2ccccc2F)nc3NC(=O)Sc13";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2021721";"";"0";"756.97";"2";"6.34";"5178";"COc1ccc2cc(ccc2c1)S(=O)(=O)N[C@H](CC(=O)N[C@H](Cc3ccc(CN4[C@H](C)CCC[C@@H]4C)cc3)C(=O)N(C)C(C)C)c5ccc6OCOc6c5";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL249789";"";"0";"546.52";"1";"2.79";"2622";"OC[C@H]1C[C@H]([C@H](O)[C@@H]1O)n2nnc3c(N[C@@H]4C[C@H]4c5ccc(F)c(F)c5)nc(SCCC(F)(F)F)nc23";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL88712";"VELIFLAPON";"3";"361.44";"1";"5.17";"3720";"OC(=O)[C@H](C1CCCC1)c2ccc(OCc3ccc4ccccc4n3)cc2";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179667";"";"0";"449.51";"0";"3.48";"5308";"CC1=CN([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(C)c4)c3)C2)C(=O)NC1=O";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689109";"";"0";"424.91";"0";"2.31";"3323";"OC(=O)COc1ccc(Cl)cc1CN2CCN(CC2)S(=O)(=O)c3ccccc3";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL319136";"";"0";"399.88";"0";"2.61";"236";"CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c2cc3cc(Cl)ccc3[nH]2";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152918";"";"0";"453.38";"0";"4.63";"5721";"CO[C@@H]1CC[C@@]2(CC1)Cc3ccc(cc3C24N=C(C)C(=N4)N)c5cncc(Br)c5";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2206789";"";"0";"448.48";"0";"2.95";"4437";"COCCC(Oc1ncnc2c1cnn2c3ccccc3OC)C(=O)Nc4ccc(C)cn4";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916535";"";"0";"424.5";"0";"1.83";"3598";"O=C1COc2ccccc2N1CCN3CCC(CC3)NCc4cc5OCCOc5cn4";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL212521";"";"0";"307.4";"0";"2.64";"3931";"CC[C@H](N)C(=O)N[C@@H](Cc1ccc(cc1)c2ccccc2)C#N";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521248";"";"0";"355.37";"0";"3.54";"814";"COc1cc2ncc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1OC";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481223";"";"0";"460.37";"0";"4.14";"3744";"COc1cc2ncc(C(=O)N)c(Nc3ccc(Cl)cc3Cl)c2cc1N4CCN(C)CC4";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL214304";"";"0";"398.38";"1";"5.58";"2554";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4cc(ccc34)C(F)(F)F";"PPB";"";"99.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570192";"";"0";"353.36";"0";"3.11";"4451";"C[C@H](Oc1nc(Nc2cc(C)[nH]n2)c(C)nc1C#N)c3ccc(F)cn3";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071493";"";"0";"299.35";"0";"3.46";"4809";"CC(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(F)cc2";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480057";"";"0";"337.38";"0";"3.4";"809";"COc1cc2ncc(C(=O)N)c(Nc3ccccc3C)c2cc1OC";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1766081";"";"0";"386.45";"0";"3.67";"4458";"CC(C)OC(=O)N1CCC(CC1)Oc2ncnc(Oc3cccnc3C)c2C";"PPB";"";"99.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL564607";"";"0";"423.94";"1";"5.65";"3172";"OC(=O)c1ccc(cc1)c2ccc(Cl)c(c2)C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921931";"";"0";"498.09";"1";"5.27";"4671";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCOc4ccc(Cl)cc4)CCC2CC3)c5ccccc5";"PPB";"";"99.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1734492";"";"0";"309.37";"0";"2.52";"5880";"NC(=O)NC(=O)C(Nc1ccc2CCCc2c1)c3ccccc3";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL497963";"";"0";"453.61";"0";"4.25";"4997";"Cc1ccc2c(OCCN3CCC(Cc4cccc(NS(=O)(=O)C)c4)CC3)cccc2n1";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824031";"";"0";"516.4";"1";"2.15";"3848";"Brc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL110999";"";"0";"430.57";"0";"3.85";"1879";"CN(CCCOCCOCCc1ccccc1)CCc2ccc(O)c3nc(O)sc23";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL914";"FEXOFENADINE";"4";"501.67";"2";"5.51";"2145";"CC(C)(C(=O)O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL165330";"";"0";"382.36";"0";"0.96";"2250";"CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)N2CCOCC2)C(F)(F)F";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL522460";"";"0";"404.56";"0";"3.94";"5236";"Cc1ccccc1CN2CCC(CC2)N3CCC(CC3)N4C(=O)Nc5ccccc45";"PPB";"";"64.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1939414";"";"0";"305.14";"0";"2.44";"1715";"Nc1nc(Nc2cccc(Br)c2)c3nc[nH]c3n1";"PPB";"";"64.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2141746";"";"0";"343.47";"0";"1.48";"4976";"CCCNC(=O)CSc1ccc(cn1)S(=O)(=O)N2CCCC2";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2170985";"";"0";"473.56";"0";"0.65";"5762";"Nc1ncnc2c1ncn2[C@@H]3O[C@H](CSCCCNC(=O)NCc4ccccc4)[C@@H](O)[C@H]3O";"PPB";"";"84.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL427851";"";"0";"371.53";"0";"2.94";"1649";"Cc1oc(CN2CCNCC2)cc1C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059374";"";"0";"458.4";"0";"3.59";"5410";"CCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C(=O)O)n4nc(cc4C)C(F)(F)F";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916547";"";"0";"465.51";"0";"0.78";"4033";"COc1ccc2N=NC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL603584";"";"0";"414.53";"0";"3.37";"2634";"COc1ccc(cc1)C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(=O)C";"PPB";"";"35.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL558";"MEXILETINE";"4";"179.26";"0";"2.03";"1369";"CC(N)COc1c(C)cccc1C";"PPB";"";"36.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4";"263.38";"0";"3.83";"429";"CNCCC=C1c2ccccc2CCc3ccccc13";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171038";"";"0";"526.49";"1";"4.71";"1559";"Cc1ccccc1S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL578288";"";"0";"258.31";"0";"1.66";"1349";"NC(=NC#N)c1sc(Nc2ccccc2)nc1N";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1938681";"";"0";"472.98";"1";"5.25";"5759";"Clc1ccc(cc1)c2oc(cc2)C(=O)N(Cc3ccccn3)c4ccc(cc4)N5CCNCC5";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062577";"";"0";"385.43";"0";"3.1";"5008";"CN(C(=O)C)c1ccc2ccn(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL279898";"ENPROFYLLINE";"0";"194.19";"0";"-0.18";"207";"CCCN1C(=O)NC(=O)c2[nH]cnc12";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL549";"CITALOPRAM";"4";"324.4";"0";"3.81";"717";"CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1868114";"";"0";"332.4";"0";"3.5";"5930";"COCCNc1nc(NCc2ccccc2F)c3sccc3n1";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL393717";"";"0";"387.96";"0";"3.7";"1646";"Clc1ccc(cc1C(=O)NCC23CC4CC(CC(C4)C2)C3)N5CCNCC5";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4";"369.37";"0";"3.52";"1766";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1359777";"";"0";"388.39";"0";"4.22";"5908";"Cc1cc(C(=O)CN2C=C(C=CC2=O)C(F)(F)F)c(C)n1Cc3ccccc3";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2326623";"";"0";"576.1";"1";"3.21";"5668";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)[C@H]5COCCN5)c4";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570015";"";"0";"518.6";"1";"3.93";"5161";"COc1cccc(Nc2c(cnc3c(C)cc(cc23)S(=O)(=O)c4cccc(c4)C(=O)N(C)C)C(=O)N)c1";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1487253";"";"0";"388.31";"0";"2.99";"2928";"Brc1ccc(cc1)S(=O)(=O)CCC(=O)NCc2cccs2";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934416";"";"0";"450.61";"0";"3.67";"5487";"COCC(C)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL561368";"";"0";"428.92";"0";"4";"1594";"CC(C)NC(=O)c1cnc(N2CCC(CC2)N3C(=O)OCc4ccccc34)c(Cl)c1";"PPB";"";"99.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481212";"";"0";"437.52";"0";"3.68";"4109";"CCOc1cc2ncc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1N4CCN(C)CC4";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181928";"";"0";"325.37";"0";"2.38";"5831";"C[C@@H]1CN([C@@H](CO1)c2ccccc2)c3ccc4OCC(=O)Nc4n3";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1645495";"";"0";"312.37";"0";"4.18";"5142";"O=C1C=C(Nc2cc(Cc3ccccc3)ccc12)c4cccnc4";"PPB";"";"99.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1308362";"";"0";"449.54";"0";"3.17";"2775";"Cc1ccc2cc(C)c3nnc(SCC(=O)N4CCN(CC4)C(=O)c5occc5)n3c2c1";"PPB";"";"99.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4";"615.4";"1";"3.94";"5699";"CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1Nc4ccc(I)cc4F)c5cccc(NC(=O)C)c5)C";"PPB";"";"99.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1797410";"";"0";"474.27";"1";"5.15";"4626";"Cc1onc(c1CC(=O)NCc2ccc(OCC(F)(F)F)nc2)c3c(Cl)cccc3Cl";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479848";"";"0";"441.48";"0";"3.51";"4114";"CCOc1cc2ncc(C(=O)N)c(Nc3cc(F)ccc3F)c2cc1N4CCN(C)CC4";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650736";"";"0";"433.42";"0";"2.03";"4146";"COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N4CCOCC4)c2F)n[nH]1";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL379350";"";"0";"259.3";"0";"2.84";"1611";"CCN(CC)c1ccc2C=C(C(=O)C)C(=O)Oc2c1";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL212432";"";"0";"451.92";"1";"0.09";"4421";"N\C(=N/C(=O)c1nc(Cl)c(N)nc1N)\NCCCCc2ccc(OCC(O)CO)cc2";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL520278";"";"0";"457.94";"0";"4.02";"4096";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1N4CCN(C)CC4";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158822";"";"0";"463.41";"1";"5.45";"2418";"OC(=O)c1ccccc1N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147475";"";"0";"548.94";"2";"5.04";"5704";"COc1cc(ccc1OC[C@H](OP(=O)(O)O)C2CC2)N3C=Nc4cc(sc4C3=O)c5ccc(Cl)cc5";"PPB";"";"99.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1359986";"";"0";"311.37";"0";"3.55";"2832";"Cc1ccc(NC(=O)Nc2nnc(s2)c3ccncc3)cc1";"PPB";"";"99.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1412533";"";"0";"309.76";"0";"4.11";"1657";"Clc1ccc(OCc2cn3ccccc3n2)c4ncccc14";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL282479";"";"0";"343.69";"0";"3.25";"3695";"Oc1ccc(Cl)cc1C2(O)C(=O)Nc3cc(ccc23)C(F)(F)F";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011917";"";"0";"432.32";"0";"3.14";"4599";"CNc1c(Br)cnc2[nH]c(nc12)c3ccc(OCCN4CCOCC4)cc3";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1210207";"";"0";"491.61";"1";"5.39";"5636";"CCOc1cc(CN2CCC(CC2)NC(=O)c3cncc(C)c3)cc(OCC)c1c4ccc(F)cc4";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL257830";"";"0";"400.44";"0";"2.49";"5616";"NS(=O)(=O)NC(=O)CCCc1c([nH]c2ccc(cc12)C#N)c3ccc(F)cc3";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480031";"";"0";"502.45";"2";"5.31";"4001";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(CC4)C(C)C";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916082";"";"0";"426.54";"0";"3.9";"3668";"CCC(CC)NC(=O)c1cnn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335892";"";"0";"427.51";"0";"4.65";"4475";"COCCC(=O)NC(C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778643";"";"0";"334.39";"0";"2.78";"2414";"CCc1ccc(OCC(=O)O)c(c1)c2ccc(cc2)S(=O)(=O)C";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL193836";"";"0";"282.34";"0";"3.28";"3304";"CC(C)c1ccc(\C=N\NC(=O)c2ccc(O)cc2)cc1";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL213556";"";"0";"422.32";"0";"2.22";"4886";"CC(CC(=O)OC(C)(C)C)NC(=O)C1=NOC(C1)C(O)(C(F)(F)F)C(F)(F)F";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165177";"";"0";"350.42";"0";"2.4";"4994";"CN(Cc1cccc2ccccc12)C3=CC(=NC(=O)N3)N4CCOCC4";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL168634";"";"0";"300.15";"";"";"747";"Cc1ccc(cc1)S(=O)(=O)N2N=Cc3ccccc3B2O";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650733";"";"0";"417.42";"0";"2.33";"4078";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(F)c(n1)N3CCOCC3)c4ncc(F)cn4";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951182";"";"0";"505.59";"1";"2.98";"3950";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)NCc2ccccc2N3CCCCC3";"PPB";"";"69.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179291";"";"0";"421.5";"0";"3.48";"5043";"COc1ccc(Oc2cccc(CN3CCCC(C3)N4C=C(C)C(=O)NC4=O)c2)cc1";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521407";"";"0";"430.34";"0";"4.14";"3802";"CN1CCN(CC1)c2ccc3ncc(C(=O)N)c(Nc4ccc(Cl)cc4Cl)c3c2";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL226646";"";"0";"389.82";"0";"3.68";"4577";"Cc1oc(nn1)c2ccc(nn2)N3CCC(CC3)Oc4cc(F)ccc4Cl";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177305";"";"0";"515.98";"1";"4.63";"5698";"CCN1C=C(C=C(C)C1=O)[C@@]2(N=C(N)c3c(F)cccc23)c4cccc(NC(=O)c5ccc(Cl)cn5)c4";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178933";"";"0";"353.47";"0";"3.52";"4702";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CCO)CC3";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480830";"";"0";"469.54";"0";"4.28";"4035";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(CC4)C(C)C";"PPB";"";"85.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL589586";"METHYL FUMARATE";"0";"130.1";"0";"-0.2";"128";"COC(=O)\C=C\C(=O)O";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1402150";"";"0";"365.41";"0";"2.66";"4908";"Fc1ccc(cc1F)N2C=CN=C(SCC(=O)NC3CCCC3)C2=O";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479446";"";"0";"457.48";"0";"3.11";"3799";"COc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1NCCN4CCOCC4";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950851";"";"0";"420.57";"0";"2.09";"5326";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(F)cc2)C1)C(C)(C)C";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1621884";"";"0";"318.34";"0";"3.2";"1342";"COCCCCC(=NOCCN)c1ccc(cc1)C(F)(F)F";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207283";"";"0";"582.51";"1";"3.18";"2444";"Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)C3=CNC(=O)c4ccc(cc34)S(=O)(=O)C)CC2)c1Cl";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062566";"";"0";"373.42";"0";"2.83";"4726";"CC(=O)Nc1ccc2CCN(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1945044";"";"0";"479.6";"0";"3.46";"4053";"COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)c2)c1";"PPB";"";"86.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL447183";"";"0";"382.37";"0";"1.99";"1783";"NC1=NC2(CCN(CC2)C(=O)c3ccc(nc3)C#N)Nc4c(F)ccc(F)c14";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207599";"";"0";"484.53";"0";"4.03";"4233";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)N(c2ccccc2)c3ccccc3";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934420";"";"0";"475.66";"0";"3.73";"5543";"C[C@H](NC(=O)c1c(C)nn(C2CCN(C)CC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL605846";"OLODATEROL";"4";"386.45";"0";"2.38";"5606";"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3NC(=O)COc23)cc1";"PPB";"";"59.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951183";"";"0";"535.62";"1";"2.19";"3964";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)NCc2ccccc2N3CCC(CO)CC3";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL73048";"";"0";"345.73";"0";"2";"2559";"C[C@@](O)(C(=O)Nc1ccc(cc1Cl)S(=O)(=O)C)C(F)(F)F";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062569";"";"0";"385.43";"0";"3.39";"5128";"CC(=O)Nc1cc2c(ccn2c3cc(NC4CC4)n5ncc(C#N)c5n3)cc1C";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950845";"";"0";"454.66";"0";"3.32";"5263";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(C2)[C@@H]3CCCc4ccccc34";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916279";"";"0";"440.57";"0";"4.07";"5133";"Cc1ccc(cc1)S(=O)(=O)Nc2c(C(=O)NCC(C)(C)C)c(C)nn2c3ccccc3";"PPB";"";"99.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147221";"";"0";"460.46";"0";"4.16";"5018";"COc1ncc(cn1)c2cccc(C)c2CCNC(=O)c3ccc(OCCC(F)(F)F)nc3";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL209689";"";"0";"344.41";"0";"4.87";"2189";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(C)cccc34";"PPB";"";"99.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179285";"";"0";"568.07";"2";"5.18";"5620";"CC1=CN([C@H]2CCCN(C2)[C@H](CC3CCOCC3)c4ccc(C(=O)O)c(Oc5cccc(Cl)c5)c4)C(=O)NC1=O";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683032";"";"0";"438.51";"0";"3.07";"4309";"CCOc1cc2nnc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1N4CCN(C)CC4";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL323776";"";"0";"443.57";"0";"2.95";"1878";"CN(CCNCCc1ccc(O)c2nc(O)sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2029721";"";"0";"423.56";"0";"3.06";"4322";"CN(CC(=O)NC1CC1)C(=O)c2ccc3c(c2)c4CC(CCc4n3C)C5CCOCC5";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011923";"";"0";"396.45";"0";"1.48";"4637";"CNc1c(cnc2[nH]c(nc12)c3ccc(OCCN4CCOCC4)cc3)C(=O)N";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179280";"";"0";"554.09";"2";"6.19";"5630";"CCC(CC)C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1605684";"";"0";"352.37";"0";"2.45";"1156";"CC(=O)C1=CN(Cc2ccccc2)C(=O)N(Cc3ccc(F)cc3)C1=O";"PPB";"";"97.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171014";"";"0";"569.56";"1";"4.77";"2150";"CN(C)c1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(C)c4Cl";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778647";"";"0";"422.81";"0";"4.28";"2682";"CCS(=O)(=O)c1ccc(c2cc(Cl)ccc2OCC(=O)O)c(c1)C(F)(F)F";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335504";"";"0";"383.46";"0";"4.63";"4504";"C[C@H](NC(=O)C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207284";"";"0";"583.49";"1";"2.38";"2441";"CNS(=O)(=O)c1ccc2C(=CNC(=O)c2c1)C(=O)NC[C@@H](O)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916539";"";"0";"450.54";"0";"2.43";"3556";"COc1ccc2C=CC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2c1";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164850";"";"0";"451.53";"0";"3.66";"5915";"O=C(NC1=CC(=CNC1=O)c2ccncc2)[C@H](Cc3ccccc3)NC4(CC4)c5ccccn5";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934268";"";"0";"406.55";"0";"3.49";"5485";"CCn1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL195309";"";"0";"393.51";"0";"3.87";"3863";"Cc1nccn1c2ccc(Sc3cccc(c3)C4(CCOCC4)C(=O)N)cc2";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337984";"";"0";"390.57";"0";"1.6";"5440";"CC(C)(C)NC(=O)CN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1668935";"";"0";"355.5";"0";"1.68";"5270";"CS(=O)(=O)N1CCC(CC1)NC(=O)NC23CC4CC(CC(C4)C2)C3";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL93484";"";"0";"237.69";"0";"1.14";"97";"CC1N=C(N)N=C(N)N1c2ccc(Cl)cc2";"PPB";"";"25.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207671";"";"0";"568.48";"1";"2.87";"2454";"CS(=O)(=O)c1ccc2C(=CNC(=O)c2c1)C(=O)NC[C@@H](O)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL511115";"CILOMILAST";"3";"343.42";"0";"4.05";"2664";"COc1ccc(cc1OC2CCCC2)[C@@]3(CC[C@H](CC3)C(=O)O)C#N";"PPB";"";"98.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL254832";"FENDILINE";"0";"315.46";"1";"5.56";"1476";"CC(NCCC(c1ccccc1)c2ccccc2)c3ccccc3";"PPB";"";"98.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1945033";"";"0";"464.59";"0";"2.89";"3883";"O[C@@H](CNCCc1cccc(CNCCc2ccccn2)c1)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179276";"";"0";"526.03";"2";"5.41";"5490";"CC(C)C[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL171951";"";"0";"286.55";"";"";"5824";"CCCS(=O)(=O)N1N=Cc2cc(Cl)ccc2B1O";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1352569";"";"0";"359.86";"0";"3.24";"2729";"CC(C)(Oc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccccn3";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1835918";"";"0";"337.38";"0";"2.66";"5060";"Cc1onc(n1)c2ccc(OCC3CN(C3)c4ccc(C)nn4)cc2";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062556";"";"0";"235.25";"0";"1.85";"2857";"Nc1cc(nc2c(cnn12)C#N)c3ccccc3";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207280";"";"0";"508.38";"1";"3.61";"2446";"O[C@H](CNC(=O)C1=CNC(=O)c2ccc(F)cc12)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1770464";"";"0";"511.71";"2";"7.01";"2624";"C[C@H](Oc1ccc(SCCCCCc2ccccc2)cc1)C(=O)c3nc(C)c(CCCC(=O)O)s3";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335895";"";"0";"383.46";"0";"4.63";"4503";"CC(NC(=O)C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480924";"";"0";"481.55";"0";"4.43";"4056";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCCN(CC4)C5CC5";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934414";"";"0";"446.62";"0";"4.58";"5460";"C[C@H](NC(=O)c1c(C)nn(C2CCCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"97.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818291";"";"0";"502.66";"2";"5.42";"4359";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)c4cccc(CN)c4)CC1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069422";"";"0";"474.44";"0";"3.61";"4467";"COc1ncc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(OCCC(F)(F)F)nc4";"PPB";"";"98.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL274737";"";"0";"361.5";"0";"3.14";"136";"CC[C@H](CO)Nc1nc(SCc2ccccc2)nc3nc(N)sc13";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL406366";"";"0";"308.38";"0";"2.57";"2796";"OC(=O)CSCC(=O)Nc1nc(cs1)c2ccccc2";"PPB";"";"99.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL563498";"";"0";"212.21";"0";"1.3";"3043";"Nc1nc(O)c(C#N)c(n1)c2ccccc2";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL482552";"";"0";"463.55";"0";"3.83";"5408";"O=C(Nc1ccc(CN2CCNCC2)cc1c3nc4ccccc4[nH]3)c5cnc6ccccc6n5";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207659";"";"0";"460.88";"0";"3.02";"2411";"Cc1cc(Cl)ccc1OC2CCN(C[C@H](O)CNC(=O)c3c[nH]nc3C(F)(F)F)CC2";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456324";"";"0";"479.94";"1";"3.46";"3347";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc(NC(CO)CO)c2Cl)n[nH]1";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165178";"";"0";"364.45";"0";"2.79";"5132";"CCN(Cc1cccc2ccccc12)C3=CC(=NC(=O)N3)N4CCOCC4";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456237";"LXR-623";"1";"422.78";"1";"6.7";"4632";"Fc1ccc(cc1)c2c3cccc(c3nn2Cc4ccc(F)cc4Cl)C(F)(F)F";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313229";"";"0";"399.43";"0";"4.41";"4955";"O=P(N(Cc1ccccn1)Cc2ccccn2)(c3ccccc3)c4ccccc4";"PPB";"";"99.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916534";"";"0";"454.53";"0";"1.84";"3601";"COc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2c1";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335878";"";"0";"412.5";"0";"3.73";"4171";"CN(C)CCNC(=O)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1091678";"DEACYL POLYMYXIN B";"0";"1105.31";"";"";"5892";"CC(C)C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC(=O)[C@H](CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)C)[C@@H](C)O";"PPB";"";"64.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1526610";"";"0";"208.24";"0";"1.92";"3828";"O=C(Cc1cccs1)Nc2ccon2";"PPB";"";"43.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335871";"";"0";"413.48";"0";"4.12";"3218";"COCCNC(=O)c1ccc(Nc2ncc3cc(ccc3n2)c4cnccc4C)cc1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181926";"";"0";"381.43";"0";"3.49";"5861";"CCOC(=O)C1=C(C)NC(=C([C@H]1c2cccc3C(=O)C=C(C)Oc23)C(=O)C)C";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165180";"";"0";"380.45";"0";"1.76";"5140";"OCCN(Cc1cccc2ccccc12)C3=CC(=NC(=O)N3)N4CCOCC4";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650697";"";"0";"332.32";"0";"2.49";"3913";"C[C@H](Nc1ncc(F)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3";"PPB";"";"52.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1914480";"";"0";"452.52";"0";"1.22";"3947";"COc1ccc2N=CC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2n1";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177908";"";"0";"467.4";"0";"4.85";"4953";"NC1=NC(c2ccnc(c2)C(F)(F)F)(c3ccc(F)c(c3)c4cncnc4)c5cccc(F)c15";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151141";"";"0";"338.44";"0";"2.78";"5674";"CC#Cc1cncc(c1)c2csc(c2)[C@]3(C)CC(=O)N(C)C(=N)N3";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916540";"";"0";"464.57";"0";"2.74";"4290";"COc1ccc2C(=CC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2c1)C";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479447";"";"0";"415.44";"0";"3.34";"3650";"COc1cc2c(Nc3ccc(F)cc3F)c(cnc2cc1NCCN(C)C)C(=O)N";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL141157";"";"0";"523.55";"1";"1.09";"5851";"CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC#C)N2C=CC=C(NC(=O)c3cc(C)on3)C2=O";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL591931";"";"0";"252.34";"0";"3.85";"1675";"NC(=N)c1cc2c(cccc2s1)c3ccccc3";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062575";"";"0";"416.49";"0";"2.87";"4911";"CN(C)CCCNc1cc(nc2c(cnn12)C#N)n3ccc4ccc(NC(=O)C)cc34";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL387125";"";"0";"488.4";"0";"2.91";"2088";"CON(C)C(=O)c1c(Cn2c(C)nc(Cl)c2Cl)sc3N(CC(C)C)C(=O)N(C)C(=O)c13";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335905";"";"0";"436.52";"0";"4.49";"4875";"C[C@@H](NC1=CC(=O)NCC1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689127";"";"0";"434.9";"0";"3.22";"3502";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1C(=O)Cc3ccc(F)cc3";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800658";"";"0";"471.62";"0";"3.31";"4715";"CC(C)N(CCNCCc1ccc(O)c2NC(=O)Sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158841";"";"0";"509.45";"2";"5.38";"3056";"OC(=O)[C@H](Cc1ccc(F)cc1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950730";"";"0";"442.6";"0";"2.01";"5265";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(C2)C(=O)Cc3ccccc3";"PPB";"";"62.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059909";"";"0";"346.42";"0";"1.45";"5671";"CC(C)(C)NS(=O)(=O)c1cncc(c1)c2ccc3nc(N)nn3c2";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL519442";"";"0";"487.96";"0";"3.65";"4249";"COCCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1N4CCN(C)CC4";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335881";"";"0";"385.47";"0";"4.17";"4355";"COCCNCc1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088029";"";"0";"361.41";"0";"3.1";"4414";"COc1cc(Nc2ncc(C)s2)nc(N[C@@H](C)c3ncc(F)cn3)n1";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158829";"";"0";"493.43";"1";"5.22";"3147";"OC(=O)COc1cccc(c1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147222";"";"0";"464.42";"0";"3.99";"4942";"COc1ncc(cn1)c2cccc(F)c2CCNC(=O)c3ccc(OCCC(F)(F)F)nc3";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312933";"";"0";"336.38";"0";"4.23";"4881";"CCCN(c1cccnc1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"97.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325642";"";"0";"524.96";"1";"4.07";"5654";"Fc1cc(c(F)cc1Oc2ccc(Cl)cc2c3ccnn3C4CNC4)S(=O)(=O)Nc5ncns5";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1880028";"";"0";"243.26";"0";"2.53";"5257";"ONC(=O)Cc1ccc(Oc2ccccc2)cc1";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950849";"";"0";"446.61";"0";"2.62";"5321";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(CCc3cccc(F)c3)C2";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916543";"";"0";"452.52";"0";"1.22";"4293";"COc1ncc2C=CC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2n1";"PPB";"";"72.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165059";"";"0";"488.55";"0";"1.48";"4450";"CO[C@@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"72.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059197";"";"0";"458.4";"0";"3.67";"5373";"CCCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C(=O)O)n4ccc(n4)C(F)(F)F";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1431751";"";"0";"377.85";"0";"3.69";"3233";"COc1cccc(c1)C(=O)N2C(CSC2c3ccccc3Cl)C(=O)O";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818303";"";"0";"565.8";"2";"5.71";"4889";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OCC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917440";"";"0";"409.9";"1";"5.3";"2686";"Cc1c(Sc2ccc(Cl)cc2)c3c(cccc3n1CC(=O)O)c4cnccn4";"PPB";"";"98.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480825";"";"0";"359.33";"0";"3.37";"803";"COc1cc2ncc(C(=O)N)c(Nc3cc(F)ccc3F)c2cc1OC";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL396043";"";"0";"423.51";"0";"4.02";"2181";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(NC4CC4)sc13";"PPB";"";"98.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179273";"";"0";"512.01";"2";"5.17";"5481";"CCC[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL127066";"";"0";"222.25";"0";"3";"878";"Oc1nc(nc2ccccc12)c3ccccc3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062583";"";"0";"429.48";"0";"3.14";"4936";"CC(=O)Nc1ccc2c(c1)c(cn2CCCO)c3cc(NC4CC4)n5ncc(C#N)c5n3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL475865";"";"0";"433.82";"1";"5.57";"3458";"Cc1ccc(NC(=O)c2ccc(Cl)c(c2)C(F)(F)F)cc1C(=O)Nc3cccnc3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1813048";"";"0";"516.52";"1";"4.97";"5771";"CC(=O)Nc1cccc(Nc2ncnc(n2)N3CCC(CC3)OCc4ccc(OC(F)(F)F)cc4)c1C";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059863";"";"0";"452.44";"1";"5.63";"4903";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ncc([nH]4)C(F)(F)F";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071601";"";"0";"428.79";"0";"4.9";"5266";"CC(C)C(NC(=O)c1cc(Cl)ccc1C(F)(F)F)C(=O)c2ccc(cc2)[N+](=O)[O-]";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331743";"";"0";"518.98";"1";"2.42";"5375";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(C(=O)N)c(Oc4cccc(Cl)c4)c3)C(=O)NC1=O";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL7662";"";"0";"359.71";"0";"4.53";"5497";"COc1ccc(Cl)cc1C2(F)C(=O)Nc3cc(ccc23)C(F)(F)F";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171037";"";"0";"555.53";"1";"4.47";"2149";"CN(C)c1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2326523";"";"0";"517.07";"2";"5.59";"4248";"CC(C)[C@H](N(CCCN)C(=O)c1ccc(C)cc1)C2=Nc3cc(Cl)ccc3C(=O)N2Cc4ccccc4";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683027";"";"0";"356.36";"0";"2.94";"4270";"COc1cc2nnc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1OC";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916289";"";"0";"526.56";"2";"5.3";"5189";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(cc2)C(F)(F)F)c3ccc(F)cc3)C(C)(C)C";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011895";"";"0";"430.35";"0";"4.29";"4574";"CNc1c(Br)cnc2[nH]c(nc12)c3ccc(OCCN4CCCCC4)cc3";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090941";"";"0";"1160.43";"";"";"5910";"CCCCCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1939560";"";"0";"651.08";"2";"5.55";"5811";"C[C@@H](N(CC1CCS(=O)(=O)CC1)C(=O)Cc2ccc(c(F)c2)C(F)(F)F)C3=Nc4ncccc4C(=O)N3c5ccc(Cl)cc5";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164564";"";"0";"351.41";"0";"2.61";"5569";"COc1ccc(cc1)c2c(cc3cccnn23)C(=O)N4CCC[C@H]4CO";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL275955";"";"0";"258.27";"0";"2.97";"1890";"NC1=NC(Cc2ccc(F)cc12)c3ccc(F)cc3";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179665";"";"0";"469.93";"0";"3.83";"5242";"CC1=CN([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3)C2)C(=O)NC1=O";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL460102";"";"0";"451.55";"0";"3.89";"3722";"CC(C)n1c(C)ncc1c2nc(Nc3ccc(cc3)C(=O)N4CC[C@@H](C4)N(C)C)ncc2F";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL511444";"";"0";"478.64";"0";"3.09";"5419";"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CC[C@H](NC(=O)c3cccc4ccccc34)[C@@H]12)C(C)(C)C";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088030";"";"0";"416.49";"0";"2.92";"4371";"C[C@H](Nc1nc(Nc2ncc(C)s2)cc(n1)N3CCOCC3)c4ncc(F)cn4";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480445";"";"0";"427.46";"0";"3.12";"3815";"COc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924047";"";"0";"447.64";"0";"4.78";"4605";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCc4ccccc4)CCC2CC3)c5ccccc5";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181808";"";"0";"354.41";"0";"4.37";"2159";"Cc1c(CC(=O)O)c2cc(F)ccc2n1Cc3nc4ccccc4s3";"PPB";"";"98.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950725";"";"0";"428.58";"0";"1.62";"5227";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCN(C2)C(=O)Cc3ccccc3";"PPB";"";"32.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL855";"TRIPROLIDINE";"4";"278.4";"0";"3.92";"2534";"Cc1ccc(cc1)\C(=C/CN2CCCC2)\c3ccccn3";"PPB";"";"35.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1871428";"";"0";"217.23";"0";"1.5";"906";"Oc1ncc(NCc2ccccc2)c(O)n1";"PPB";"";"36.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL225519";"";"0";"213.24";"0";"1.36";"5230";"O=C1NCCc2[nH]c(cc12)c3ccncc3";"PPB";"";"41.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1369722";"";"0";"228.28";"0";"3.06";"1029";"Oc1ncnc2scc(c3ccccc3)c12";"PPB";"";"86.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011927";"";"0";"417.31";"0";"3.77";"4845";"COc1ccc(cc1)c2nc3c(OCC4CCNCC4)c(Br)cnc3[nH]2";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL473622";"";"0";"428.49";"0";"4.7";"3602";"COc1cncc(NC(=O)c2cc(NC(=O)c3cccc(c3)C(C)(C)C#N)ccc2C)c1";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1922048";"";"0";"478.62";"0";"2.97";"4699";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CC(=O)Nc4ccncn4)CCC2CC3)c5ccccc5";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951181";"";"0";"477.58";"0";"2.35";"3949";"COc1cc(OC)c(cc1NC(=O)C)S(=O)(=O)NCc2ccccc2N3CCC(CO)CC3";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337979";"";"0";"415.37";"0";"3.29";"5576";"CC(C)(C)NC(=O)NCCN1CCCC(C1)NC(=O)c2cc(Cl)cc(Cl)c2";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325622";"";"0";"538.99";"1";"4.41";"5659";"CN1CC(C1)n2nccc2c3cc(Cl)ccc3Oc4cc(F)c(cc4F)S(=O)(=O)Nc5ncns5";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165067";"";"0";"482.52";"0";"1.33";"4388";"COc1ccc2N=CC(=O)N(CCN3CC[C@@H](NCc4ccc5OCC(=O)Nc5n4)[C@@H](F)C3)c2c1";"PPB";"";"75.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1831130";"";"0";"355.39";"0";"2.4";"5804";"COc1ccc2nc(C)cc(N3CC(CNC(=O)C4CC4)OC3=O)c2c1";"PPB";"";"67.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158821";"";"0";"477.43";"1";"5.37";"2625";"OC(=O)[C@H](N1CCC(CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3)CC1)c4ccccc4";"PPB";"";"83.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313309";"";"0";"156.21";"0";"0.74";"839";"Cc1csc(N)c1C(=O)N";"PPB";"";"67.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1459588";"";"0";"307.39";"0";"3.09";"1262";"CCCCCOc1ccc(cc1)C(=O)NC(C(C)C)C(=O)O";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090488";"PF-00446687";"2";"470.6";"0";"4.78";"5421";"C[C@@H]1CN(C[C@H](C)[C@@]1(O)c2ccccc2)C(=O)[C@@H]3CN(C[C@H]3c4ccc(F)cc4F)C(C)(C)C";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1381989";"";"0";"281.38";"0";"1.29";"1908";"CC1(C)CNC(=O)c2sc(nc2C1)N3CCOCC3";"PPB";"";"29.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1241590";"FLORFENICOL";"0";"358.22";"0";"1.38";"3715";"CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl";"PPB";"";"32.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL398149";"";"0";"348.37";"0";"2.27";"4720";"CC(=O)Nc1cccc(Nc2nc(NC3CC3)n4ncc(C#N)c4n2)c1";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178934";"";"0";"325.41";"0";"2.9";"4680";"NC(=O)c1cncc(n1)c2ccc(cc2)[C@@H]3CC[C@@H](CCO)CC3";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179666";"";"0";"514.38";"1";"3.94";"5304";"CC1=CN([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(Br)c4)c3)C2)C(=O)NC1=O";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335893";"";"0";"427.51";"0";"4.65";"4486";"COCCC(=O)N[C@H](C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062584";"";"0";"457.49";"0";"3.32";"4984";"COC(=O)CCn1cc(c2cc(NC3CC3)n4ncc(C#N)c4n2)c5cc(NC(=O)C)ccc15";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2070121";"";"0";"272.31";"0";"1.38";"655";"COc1cnc(nc1N2CCOCC2)c3ccccn3";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1762528";"";"0";"476.58";"0";"3.15";"4319";"CN(c1cccc(CO)c1)c2ccnc(Nc3cc(cc(c3)N4CCOCC4)N5CCOCC5)n2";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950847";"";"0";"452.62";"0";"1.24";"5358";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(C1)S(=O)(=O)Cc2ccccc2)C(C)(C)C";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689126";"";"0";"416.91";"0";"3.08";"3463";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1C(=O)Cc3ccccc3";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL507674";"CEFOPERAZONE";"4";"645.68";"2";"-1.11";"3165";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5)C(=O)C1=O";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL202626";"";"0";"388.4";"0";"3.76";"5090";"Fc1ccccc1NC(=O)NC2N=C(c3ccccc3)c4ccccc4NC2=O";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062568";"";"0";"387.45";"0";"3.22";"4764";"CC(=O)Nc1ccc2CCCN(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337982";"";"0";"389.58";"0";"2.51";"5414";"O=C(CN1CCN(CCC2CCOCC2)CC1)NC34CC5CC(CC(C5)C3)C4";"PPB";"";"47.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071507";"";"0";"408.81";"0";"4.87";"5527";"CC(C)C(NC(=O)c1cc(Cl)ccc1C(F)(F)F)C(=O)c2ccc(cc2)C#N";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1489087";"";"0";"325.15";"0";"4.34";"697";"OC(=O)c1ccccc1NC(=O)Nc2ccc(Cl)c(Cl)c2";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL47298";"TILORONE";"0";"410.56";"0";"4.34";"695";"CCN(CC)CCOc1ccc2c(c1)C(=O)c3cc(OCCN(CC)CC)ccc23";"PPB";"";"48.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4";"114.17";"0";"1.08";"488";"CN1C=CNC1=S";"PPB";"";"18.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950721";"";"0";"400.57";"0";"2.05";"5222";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCN(Cc3ccccc3)C2";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL520733";"SEMAGACESTAT";"3";"361.44";"0";"0.38";"5089";"CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc12";"PPB";"";"19.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL496929";"";"0";"314.77";"0";"3.61";"5935";"OCCc1ccc(NC(=O)c2cc3cc(Cl)ccc3[nH]2)cc1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL400585";"";"0";"313.27";"0";"2.12";"1807";"OC(=O)COn1c(nc2ccc(cc12)[N+](=O)[O-])c3ccccc3";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1526668";"";"0";"249.38";"0";"3.25";"3086";"O=C(N1CCCCC1)c2csc3CCCCc23";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207606";"";"0";"496.5";"0";"3.92";"4457";"COc1cc(OC)c(cc1NC(=O)\C=C\C(=O)O)S(=O)(=O)N2c3ccccc3Oc4ccccc24";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1486109";"";"0";"253.26";"0";"2.81";"1901";"COc1ccc(cc1)c2onc(n2)c3ccccn3";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL422649";"";"0";"373.35";"0";"2.77";"2353";"CC(O)(C(=O)Nc1cccc(c1)S(=O)(=O)c2ccccc2)C(F)(F)F";"PPB";"";"90.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL564737";"";"0";"401.89";"0";"4.52";"3447";"OC(=O)c1ccccc1c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1922056";"";"0";"501.65";"1";"4.79";"4739";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(Cc4onc(n4)c5ccccc5)CCC2CC3)c6ccccc6";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1235773";"";"0";"461.59";"0";"3.75";"5696";"COc1ccc2ncc(C#N)c(CCN3CCC(CC3)NCc4cc5SCOc5cn4)c2c1";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL253641";"";"0";"636.71";"1";"4.7";"4650";"CCNc1cc(N2CCCCS2(=O)=O)c(F)c(c1)C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc4cccc(c4)C(F)(F)F";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569185";"";"0";"419.5";"0";"2.19";"5538";"COc1ccc(CCN2[C@@H](CN(NS(=O)(=O)C)C2=O)c3ccc(OC)cc3)cc1";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164742";"";"0";"474.52";"0";"0.82";"4215";"O[C@@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916272";"";"0";"440.57";"0";"4.21";"4995";"CCC(CC)NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"99.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL108922";"";"0";"368.48";"0";"3.84";"5102";"CCO\N=C\c1ccc(OCCC2CCN(CC2)c3ccc(C)nn3)cc1";"PPB";"";"99.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1891338";"";"0";"358.47";"0";"4.14";"5931";"COc1cccc(CNc2nc(NC(C)C)nc3ccsc23)c1OC";"PPB";"";"99.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL271703";"";"0";"378.41";"0";"2.37";"2294";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(N)cnc13";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1364767";"";"0";"255.36";"0";"3.95";"1904";"Cc1nn(C2CCCCC2)c(N)c1c3ccccc3";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916288";"";"0";"483.57";"0";"4.16";"5188";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(cc2)C#N)c3ccc(F)cc3)C(C)(C)C";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011934";"";"0";"472.39";"0";"4.46";"4985";"COc1ccc(cc1)c2nc3c(NCCCN(C)C(=O)C4CCC4)c(Br)cnc3[nH]2";"PPB";"";"99.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1643194";"";"0";"485.37";"1";"5.46";"5295";"Cc1cc(CN2Cc3ccccc3C2C(=O)Nc4ccc(Cl)cc4Cl)ccc1OCC(=O)O";"PPB";"";"99.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011441";"";"0";"384.66";"0";"2.76";"2265";"COc1nc(Br)cnc1NS(=O)(=O)c2ccc(Cl)s2";"PPB";"";"99.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917456";"";"0";"408.86";"0";"3.85";"2934";"Cc1c(Oc2ccc(Cl)cc2)c3c(NS(=O)(=O)C)cccc3n1CC(=O)O";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2205498";"";"0";"259.31";"0";"2.47";"5312";"CC(C)COc1ccc(cc1)c2cc(O)nc(N)n2";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1082376";"";"0";"358.49";"1";"5.34";"2296";"CCCCCCc1nc2c(N)nc3ccccc3c2n1Cc4ccccc4";"PPB";"";"99.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164565";"";"0";"377.37";"0";"3.47";"5427";"CCN(CCO)C(=O)c1cc2cccnn2c1c3cccc(c3)C(F)(F)F";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL62136";"T091317";"0";"481.34";"0";"4.76";"1763";"OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c2ccccc2)(C(F)(F)F)C(F)(F)F";"PPB";"";"99.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957381";"";"0";"338.37";"0";"4.24";"4833";"Cc1cc(ccn1)c2ccc(cc2)c3nc4ccncc4c(O)c3C#N";"PPB";"";"99.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048868";"";"0";"333.41";"0";"1.95";"5023";"COc1cccc(\C=C\2/SC(=O)NC2=O)c1N3CCC[C@@H](N)C3";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205245";"";"0";"514.44";"1";"2.48";"2136";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cn3c(C)nc(Cl)c3Cl)c2C(=O)N4CC[C@@H](O)C4";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951079";"";"0";"462.52";"0";"3.04";"3897";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL218573";"";"0";"511.52";"1";"2.78";"2137";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3ccccc3C(F)(F)F)c2C(=O)N4C[C@H](O)CO4";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1096896";"UK432097";"2";"777.89";"3";"1.92";"4256";"CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCC(c4ccccc4)c5ccccc5)nc(nc23)C(=O)NCCNC(=O)NC6CCN(CC6)c7ccccn7";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059861";"";"0";"398.47";"0";"4.62";"4493";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4nccn4C";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL510780";"";"0";"263.34";"0";"4.05";"5565";"C1C[C@@H](Nc2nc3ccccc3[nH]2)c4ccccc4C1";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL41";"FLUOXETINE";"4";"309.33";"0";"4.44";"605";"CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778639";"";"0";"402.39";"0";"3.94";"2461";"CCS(=O)(=O)c1ccc(c(C)c1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL708";"ZIPRASIDONE";"4";"412.95";"0";"3.81";"1138";"Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335906";"";"0";"436.52";"0";"4.14";"4914";"C[C@@H](NC1=CC(=O)CNC1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171018";"";"0";"423.34";"0";"4.28";"1584";"COc1cccc(c1)C(=O)NCCN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818187";"";"0";"473.62";"1";"5.96";"3904";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)c4ccccc4)CC1";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1078";"FLUVASTATIN";"0";"411.47";"0";"4.63";"3004";"CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)c(c2ccc(F)cc2)c3ccccc13";"PPB";"";"99.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL373751";"GSK-319347A";"0";"469.54";"0";"3.96";"5014";"COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917447";"";"0";"381.81";"0";"3.66";"2809";"Cc1c(c2cc(F)ccc2n1CC(=O)O)S(=O)(=O)c3ccc(Cl)cc3";"PPB";"";"99.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957361";"";"0";"367.41";"0";"4.94";"4782";"CCOc1ccccc1c2ccc(cc2)c3nc4ccncc4c(O)c3C#N";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1684954";"";"0";"378.39";"0";"4.32";"5384";"C[C@@H](NC(=O)Cc1ccc(cc1)C2CC2)c3ccc(OCC(F)(F)F)cn3";"PPB";"";"99.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2010831";"";"0";"468.54";"0";"3.77";"4654";"CN(C1CCN(Cc2ccc(cc2)C(F)(F)F)CC1)C(=O)Cc3ccc(cc3)S(=O)(=O)C";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2107366";"REZATOMIDINE";"0";"232.35";"0";"3.84";"5754";"C[C@H](C1=CNC(=S)N1)c2cccc(C)c2C";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL132227";"";"0";"193.2";"0";"1.02";"5893";"CC(=O)NCc1cccc(c1)C(=O)O";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL235392";"";"0";"444.02";"0";"3.46";"1595";"Clc1ccc(CN2CC3CNCC(C2)O3)cc1C(=O)NCC45CC6CC(CC(C6)C4)C5";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL271013";"";"0";"347.47";"0";"2.75";"2279";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc3nc(N)sc13";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1431692";"";"0";"357.42";"0";"4.41";"3814";"CC(=O)Nc1ccc(Nc2cc(C)nc3c(cnn23)c4ccccc4)cc1";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL574059";"";"0";"415.26";"1";"5.19";"285";"CN1C(=O)C(=Cc2cnc(Nc3ccc(F)cc3)nc12)c4c(Cl)cccc4Cl";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL462132";"";"0";"439.85";"1";"5.63";"3671";"Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2Cl)s1";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2348645";"";"0";"405.53";"0";"4.56";"5939";"CNc1nc(C)c(s1)c2nc(Nc3cccc(c3)N4CCCCC4)ncc2C#N";"PPB";"";"99.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062572";"";"0";"403.45";"0";"2.69";"4689";"CC(=O)Nc1ccc2ccn(c3cc(NCCCCO)n4ncc(C#N)c4n3)c2c1";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2204344";"";"0";"425.5";"";"";"4861";"O[Si]1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cccc(c3)C(F)(F)F";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1367530";"";"0";"394.5";"0";"3.49";"2801";"Cc1ccc(cc1)c2oc(SCC(=O)N3CCN(CC3)c4ccccc4)nn2";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL250774";"";"0";"435.48";"0";"4.29";"4234";"CS(=O)(=O)c1ccc(cc1)c2ccc3c(Nc4ccc(F)cc4)c(cnc3c2)C(=O)N";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011938";"";"0";"481.35";"0";"4.02";"4852";"COc1ccc(cc1)c2nc3c(NCCCNC(=O)c4cccnc4)c(Br)cnc3[nH]2";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165192";"";"0";"350.42";"0";"2.76";"5107";"CC1CN(CCO1)C2=CC(=O)NC(=N2)NCc3cccc4ccccc34";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800656";"";"0";"457.6";"0";"2.93";"4759";"CCN(CCNCCc1ccc(O)c2NC(=O)Sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778649";"";"0";"416.42";"0";"4.33";"2797";"CCS(=O)(=O)c1ccc(c(C)c1)c2cc(ccc2O[C@@H](C)C(=O)O)C(F)(F)F";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335889";"";"0";"355.4";"0";"4.39";"4252";"CC(=O)Nc1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071592";"";"0";"329.83";"0";"4.37";"4922";"CC(C)(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(Cl)cc2";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325021";"";"0";"504.48";"1";"4.48";"5685";"FC(F)(F)c1ccc(Oc2ccc(cc2C#N)S(=O)(=O)Nc3ncns3)c(c1)c4ccnnc4";"PPB";"";"99.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824043";"";"0";"455.49";"0";"1.53";"3633";"Fc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152903";"";"0";"476.56";"0";"4.76";"5441";"CCN1C=C(C=C(C)C1=O)[C@@]2(N=C(N)c3c(F)cccc23)c4cccc(c4)c5cncc(c5)C#CC";"PPB";"";"98.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1289283";"";"0";"414.51";"0";"3.86";"5633";"O=C1C=C(OCc2ccccc2)C=CN1c3ccc4c(cnn4CCN5CCCC5)c3";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152524";"";"0";"320.48";"0";"4.66";"4767";"C1CCN(C1)[C@H]([C@@H](N2CCCC2)c3ccccc3)c4ccccc4";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL143305";"";"0";"355.22";"0";"4.08";"5895";"Cc1cc(CCCOc2c(Cl)cc(cc2Cl)C3=NCCO3)on1";"PPB";"";"99.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069623";"";"0";"359.82";"0";"2.99";"5947";"Nc1ncnc2c1c(COc3cccc(Cl)c3)nn2C4CCOCC4";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1194385";"";"0";"251.33";"0";"2.99";"2235";"COc1cccc2c1CCC23NCc4ccccc34";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177906";"";"0";"449.41";"0";"4.71";"5070";"NC1=NC(c2cccc(c2)c3cncnc3)(c4ccnc(c4)C(F)(F)F)c5cccc(F)c15";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL571";"KETOPROFEN";"4";"254.29";"0";"3.11";"735";"CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2";"PPB";"";"98.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147306";"";"0";"464.42";"0";"3.91";"5231";"COc1ncc(cn1)c2c(C)ccc(F)c2CCNC(=O)c3ccc(OCC(F)(F)F)nc3";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2086675";"";"0";"371.44";"0";"2.51";"4746";"CC(C)(C)OC(=O)N1CCN(CC1)c2ncc(OCc3ccncc3)cn2";"PPB";"";"99.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158441";"";"0";"355.23";"0";"2.53";"5081";"Clc1cccc(Cl)c1CNC2=NC(=CC(=O)N2)N3CCOCC3";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683030";"";"0";"442.47";"0";"2.9";"4299";"CCOc1cc2nnc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147303";"";"0";"482.41";"0";"4.15";"5568";"COc1ncc(cn1)c2ccccc2C(F)(F)CNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL510193";"";"0";"468.5";"1";"6.4";"3423";"Fc1ccc(cc1)c2cnc([nH]2)C3CCN(Cc4ccn(c4)c5ccc(cc5)C(F)(F)F)CC3";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL72292";"";"0";"440.45";"0";"3.3";"1849";"CN1CCN(CC1)C2=Nc3ccccc3Nc4ccc(OS(=O)(=O)C(F)(F)F)cc24";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059860";"";"0";"384.44";"0";"4.61";"4494";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4c[nH]cn4";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689115";"";"0";"452.96";"0";"2.84";"3483";"OC(=O)COc1ccc(Cl)cc1CN2CCCN(CC2)S(=O)(=O)Cc3ccccc3";"PPB";"";"84.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL589543";"";"0";"355.44";"0";"1.09";"5632";"COc1ccc(C[C@H](N)C(=O)N[C@@H](Cc2ccccc2C)C(=O)N)cc1";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1604571";"";"0";"424.5";"0";"2.57";"1874";"CCOC(=O)C(CCc1ccccc1)NC2CCc3ccccc3N(CC(=O)O)C2=O";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171040";"";"0";"542.49";"1";"4.41";"2143";"COc1ccccc1S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800526";"";"0";"333.19";"0";"2.91";"3202";"COc1ccnc(CCc2nc3cc(Br)cnc3[nH]2)c1";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1534781";"";"0";"292.34";"0";"3.32";"1015";"COc1cnc(nc1N(C)c2ccccc2)c3ccccn3";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2323231";"";"0";"472.6";"0";"4.67";"5923";"O=C(CSC1=NC2=C(SCC2)C(=O)N1c3ccccc3)Nc4ccc(cn4)c5ccccc5";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951575";"VIDUPIPRANT";"2";"609.5";"2";"6.76";"5502";"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c3ccc(cc3Cl)C4CC4)c1";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL356687";"";"0";"340.81";"0";"4.6";"1499";"CN(C)c1cc(NC(=O)Nc2cccc(Cl)c2)c3ccccc3n1";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL182997";"";"0";"381.9";"0";"1.81";"3569";"CC(C)(C)[C@@H](O)C(=O)N1CCC[C@H]1C(=O)NCc2cc(Cl)ccc2CN";"PPB";"";"42.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1952147";"";"0";"394.46";"0";"2.09";"3378";"NS(=O)(=O)c1ccc(CCNc2ccc3nnc(c4ccccc4)n3n2)cc1";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL378997";"";"0";"360.44";"0";"3.82";"4200";"COC(=O)N[C@@H](C)C#Cc1cnc(Oc2ccc(OC(C)C)cc2)s1";"PPB";"";"99.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164366";"";"0";"474.41";"0";"3.57";"5185";"Fc1cnc(CCN2C(C(=O)NCc3ccc(OC(F)(F)F)cc3)c4ccccc4C2=O)nc1";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1539841";"";"0";"362.43";"0";"3.18";"3754";"Cc1nc2ccc(NS(=O)(=O)c3ccc4OCCOc4c3)cc2s1";"PPB";"";"99.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917438";"";"0";"407.92";"1";"6.51";"2262";"Cc1c(Sc2ccc(Cl)cc2)c3c(cccc3n1CC(=O)O)c4ccccc4";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL379828";"";"0";"380.83";"0";"4.91";"2130";"COc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4cc(Cl)ccc34";"PPB";"";"99.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1087268";"";"0";"428.54";"0";"3.44";"4397";"C[C@H](Nc1nc(Nc2ncc(C)s2)cc(n1)N3CCN(C)CC3)c4ccc(F)cn4";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL526307";"";"0";"400.22";"0";"3.17";"4685";"COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177911";"";"0";"411.44";"0";"3.7";"5143";"COc1cc(ccn1)C2(N=C(N)c3c(F)cccc23)c4cccc(c4)c5cncnc5";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1417725";"";"0";"287.26";"0";"3.84";"1095";"Cc1nc(sc1C(=O)O)c2cccc(c2)C(F)(F)F";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934267";"";"0";"420.58";"0";"4.05";"5109";"CC(C)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL257025";"";"0";"351.38";"0";"2.72";"2754";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3[nH]ncc13";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177917";"";"0";"439.49";"0";"4.31";"5213";"COc1c(C)cc(nc1C)C2(N=C(N)c3c(F)cccc23)c4cccc(c4)c5cncnc5";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818296";"";"0";"551.78";"2";"5.46";"4535";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158826";"";"0";"477.43";"1";"5.38";"3117";"OC(=O)Cc1cccc(c1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2012204";"";"0";"382.42";"0";"3.16";"5634";"Cc1onc(c1)[C@H](O)[C@](C)(OCc2ccc(cc2)c3ccccc3)C(=O)NO";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL601882";"";"0";"326.78";"0";"4.58";"5405";"CN(C(=O)c1c(C)onc1c2ccccc2)c3ccc(Cl)cc3";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179271";"";"0";"497.98";"0";"4.78";"5429";"CC[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062571";"";"0";"387.4";"0";"2.31";"5126";"CC(=O)Nc1ccc2ccn(c3cc(NC4COC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL473";"DOFETILIDE";"4";"441.58";"0";"1.98";"1615";"CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207663";"";"0";"487.91";"0";"2.99";"2553";"Cc1cc(Cl)ccc1OC2CCN(C[C@H](O)CNC(=O)C3=CNC(=O)C=C3C(F)(F)F)CC2";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147226";"";"0";"471.44";"0";"3.72";"5288";"COc1ncc(cn1)c2cccc(C#N)c2CCNC(=O)c3ccc(OCCC(F)(F)F)nc3";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179669";"";"0";"503.48";"1";"4.19";"5204";"CC1=CN([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(c4)C(F)(F)F)c3)C2)C(=O)NC1=O";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL744";"RILUZOLE";"4";"234.2";"0";"2.78";"670";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL41355";"EZOGABINE";"4";"303.34";"0";"3.59";"1298";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL289330";"";"0";"371.28";"0";"2.68";"2567";"CCN1CCC[C@H]1CNC(=O)c2cc(Br)cc(OC)c2OC";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650732";"";"0";"399.43";"0";"2.19";"4024";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)cc(n1)N3CCOCC3)c4ncc(F)cn4";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL295467";"NISOXETINE";"0";"271.36";"0";"3.42";"1664";"CNCCC(Oc1ccccc1OC)c2ccccc2";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2326864";"";"0";"303.39";"0";"2.19";"5927";"CC(=O)Nc1nc(CCc2ccc(NC(=N)N)cc2)cs1";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158793";"";"0";"486.6";"0";"4.91";"3640";"Cc1cc(F)ccc1OC2CCN(CC3CCN(CC3)[C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC2";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL251701";"";"0";"415.54";"0";"4.56";"3419";"COc1ccc2c(C)cc(N[C@H]3CC[C@@H](C3)NCc4cn(C)c5cccnc45)nc2c1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL189963";"PALBOCICLIB";"4";"447.54";"0";"2.97";"3446";"CC(=O)C1=C(C)c2cnc(Nc3ccc(cn3)N4CCNCC4)nc2N(C5CCCC5)C1=O";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1624302";"";"0";"322.22";"0";"4.76";"4964";"Nc1nc(c2ccc(Cl)c(Cl)c2)c(s1)c3ccncc3";"PPB";"";"99.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL262273";"";"0";"366.36";"0";"1.72";"2251";"CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)N2CCCC2)C(F)(F)F";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569738";"";"0";"313.34";"0";"2.96";"4352";"C[C@H](Nc1cncc(Nc2cc(C)[nH]n2)n1)c3ccc(F)cn3";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177736";"";"0";"393.45";"0";"1.58";"5728";"N[C@H]1CCCC[C@H]1Nc2ncc(C(=O)N)c(Nc3cccc(c3)n4nccn4)n2";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521815";"";"0";"380.42";"0";"2.04";"4191";"CN1CCN(CC1)C(=O)c2cc(CC3=NNC(=O)c4ccccc34)ccc2F";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178937";"";"0";"452.56";"0";"3.5";"4700";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)NC(C)(C)C(=O)O)CC3";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL567";"PERPHENAZINE";"4";"403.98";"0";"3.94";"444";"OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1213082";"";"0";"397.44";"0";"2.77";"2828";"Cc1ccccc1N2C(=Nc3cccc(C)c3C2=O)Cn4cnc5c(N)ncnc45";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL222333";"";"0";"376.4";"0";"3.97";"3747";"CCNC(=O)Nc1nc2cc(cc(c3ncccc3F)c2[nH]1)c4cccnc4";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL440405";"";"0";"399.45";"0";"3.24";"5617";"CS(=O)(=O)NC(=O)CCCc1c([nH]c2ccc(cc12)C#N)c3ccc(F)cc3";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335879";"";"0";"452.56";"0";"4.65";"4196";"CN1CCCC1CCNC(=O)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921944";"";"0";"494.63";"0";"4.32";"4603";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CC(=O)Nc4cccc(F)c4)CCC2CC3)c5ccccc5";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1963231";"";"0";"316.47";"0";"3.53";"3603";"CC(C1CCCC1)(C(=O)O[C@@H]2CC[N+](C)(C)C2)c3ccccc3";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179274";"";"0";"512.01";"2";"5.17";"5483";"CCC[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL655";"MIDAZOLAM";"4";"325.77";"0";"4.32";"1215";"Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1230662";"";"0";"442.6";"0";"2.31";"5325";"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]2CCCc3ccccc23)C(C)(C)C";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL174310";"";"0";"381.39";"0";"2.6";"1547";"NC1=NC2(CCN(CC2)C(=O)c3ccc(cc3)C#N)Nc4c(F)ccc(F)c14";"PPB";"";"71.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1389370";"";"0";"440.62";"0";"3.71";"2830";"CCN(CC)CCNc1ncnc2c1sc3nc(N4CCOCC4)c5CCCCc5c23";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1448843";"";"0";"330.41";"0";"2.36";"3410";"O=C(CSc1ccccc1)N2CCN(CC2)C(=O)c3occc3";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335867";"";"0";"413.48";"0";"4.12";"4354";"COCCNC(=O)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4C)cc1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1963131";"";"0";"520.55";"1";"2.86";"4180";"COc1ccc(cn1)[C@@]2(O)CC[C@H](CC2)N3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171047";"";"0";"540.51";"2";"5.02";"1557";"Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(C)c4Cl";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL470591";"";"0";"441.41";"0";"4.88";"3960";"CNC(=O)c1cc(Oc2ccc3c(c2)nc(Nc4ccc(cc4)C(F)(F)F)n3C)ccn1";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331746";"";"0";"457.51";"0";"2.37";"5506";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(O)c(Oc4ccccc4)c3)C(=O)NC1=O";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2023489";"";"0";"432.48";"0";"4.27";"3997";"COc1ccc2c(Oc3ccc(CC(=O)Nc4cn(C)nc4C)c(OC)c3)ccnc2c1";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL578201";"";"0";"352.38";"0";"3.14";"4385";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(C)nc1C#N)c3ccc(F)cn3";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL436826";"";"0";"586.61";"2";"6.53";"3300";"CCOc1ccc(cc1)N2C(=O)c3ccccc3N=C2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(cc5)C(F)(F)F";"PPB";"";"99.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335876";"";"0";"413.48";"0";"4.12";"4136";"COCCNC(=O)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1C";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL384260";"";"0";"408.46";"0";"3.58";"1085";"COc1cc(OC2CCN(C)CC2)c3c(Nc4cccc5OCOc45)ncnc3c1";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1312533";"";"0";"403.83";"0";"4.41";"3314";"CC(=O)NC1CC2CCCC(C1)N2C(=O)Nc3ccc(Cl)c(c3)C(F)(F)F";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152915";"";"0";"432.96";"0";"4.99";"5781";"CO[C@@H]1CC[C@@]2(CC1)Cc3ccc(cc3C24N=C(C)C(=N4)N)c5cc(Cl)cc(c5)C#N";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1724416";"";"0";"302.36";"0";"3.25";"1541";"Cc1ccc(cc1)S(=O)(=O)Nc2ccc3nc(C)oc3c2";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164373";"";"0";"468.42";"0";"4.98";"4669";"FC(F)(F)Oc1ccc(CNC(=O)C2N(C3CCC(F)(F)CC3)C(=O)c4ccccc24)cc1";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402831";"";"0";"490.82";"0";"4.53";"5159";"C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(cc1F)c2cc(Cl)cc(F)c2c3noc(C)n3";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181753";"AM-211";"1";"500.52";"2";"5.74";"5783";"CCN(Cc1cc(ccc1c2cc(CC(=O)O)ccc2OC)C(F)(F)F)C(=O)NCc3ccccc3";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090771";"AVAGACESTAT";"2";"520.89";"1";"3.92";"5401";"NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3";"PPB";"";"98.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179279";"";"0";"554.09";"2";"6.19";"5648";"CCC(C)(C)C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062570";"";"0";"411.43";"0";"2.98";"4595";"CC(=O)Nc1ccc2ccn(c3cc(Nc4ccn(C)n4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2058280";"";"0";"344.37";"0";"2.06";"5776";"Nc1scc2C(=NN(C(=O)c12)c3ccc(F)cc3)C(=O)NC4CC4";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921922";"";"0";"476.69";"0";"4.88";"4918";"Cc1ccc(CCC[N+]23CCC(CC2)[C@H](C3)OC(=O)[C@@](C)(N4CCCCC4)c5ccccc5)cn1";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924029";"";"0";"345.51";"0";"3.17";"4206";"CC(N1CCCCC1)(C(=O)OC2CC[N+](C)(C)CC2)c3ccccc3";"PPB";"";"21.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480221";"";"0";"504.42";"1";"4.16";"4130";"COCCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(C)CC4";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL782";"TOLBUTAMIDE";"4";"270.35";"0";"1.78";"122";"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1775161";"";"0";"251.28";"0";"3.39";"1160";"OC(=O)c1cn(Cc2ccccc2)c3ccccc13";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689128";"";"0";"451.35";"0";"3.73";"3488";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1C(=O)Cc3ccc(Cl)cc3";"PPB";"";"98.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2208434";"";"0";"490.39";"0";"3.47";"2096";"O[C@H](CNC(=O)C1=CC(=O)Nc2ccccc12)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL320876";"";"0";"588.56";"2";"1.34";"5710";"COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934413";"";"0";"432.59";"0";"4.19";"5496";"C[C@H](NC(=O)c1c(C)nn(C2CCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158831";"";"0";"477.43";"1";"5.45";"2256";"OC(=O)c1ccccc1CN2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2018969";"";"0";"549.07";"1";"4";"5667";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)C(C)(C)O)c4";"PPB";"";"98.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1645135";"";"0";"434.92";"1";"5.09";"5933";"C[C@H](NC(=O)c1cccc2CCN(Cc3ccc(Cl)cc3)c12)c4ccc(cc4)C(=O)O";"PPB";"";"98.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL509973";"";"0";"264.33";"0";"3.66";"3265";"CC(NC(=O)c1cc2ccccc2[nH]1)c3ccccc3";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481905";"";"0";"474.39";"0";"4.53";"3968";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(Cl)c(Cl)c3)c2cc1N4CCN(C)CC4";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313227";"";"0";"352.37";"0";"3.46";"5172";"COCCN(c1cccnc1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL169526";"";"0";"299.33";"0";"2.87";"4079";"CC(C)(C)COc1ccc(cc1C#N)n2cc(cn2)C(=O)O";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570002";"";"0";"339.34";"0";"2.23";"4348";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)cnc1C#N)c3ncc(F)cn3";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL321758";"";"0";"327.42";"0";"2.8";"4624";"C[C@H]([C@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3";"PPB";"";"31.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950844";"";"0";"504.72";"1";"4.07";"5289";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(CC(c3ccccc3)c4ccccc4)C2";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950727";"";"0";"414.59";"0";"2.44";"5249";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCN(Cc3ccccc3)C2";"PPB";"";"63.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL182380";"";"0";"533.74";"2";"5.31";"1110";"CCN(C1CCN(CCC(c2ccccc2)c3ccccc3)CC1)C(=O)NCc4ccc(cc4)S(=O)(=O)C";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171035";"";"0";"546.9";"2";"5.05";"1558";"Clc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL255044";"FLUPIRTINE";"2";"304.32";"0";"2.98";"694";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL458287";"";"0";"346.8";"0";"4.22";"3055";"C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c3ccc(F)cc3";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL430381";"";"0";"439.51";"0";"3";"2174";"OCC(CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(NC4CC4)sc13";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349329";"";"0";"414.56";"0";"3.65";"1855";"CC(C)C[C@H](CO)Nc1nc(SCc2cccc(c2)C#N)nc3nc(N)sc13";"PPB";"";"99.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL385374";"";"0";"612.88";"2";"5";"4651";"CCCC[C@H](NC[C@@H]1Cc2cccc(CCCCc3cc(cc(c3)C(=O)N1)N(CCC)S(=O)(=O)C)c2)C(=O)NCC(C)C";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2088415";"";"0";"388.39";"0";"3.61";"3359";"OCc1nc2cc(ccc2s1)S(=O)(=O)Nc3ccc(cc3)C(F)(F)F";"PPB";"";"99.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2323239";"";"0";"478.62";"0";"4.74";"5924";"O=C(CSC1=NC2=C(SCC2)C(=O)N1c3ccccc3)Nc4ncc(s4)c5ccccc5";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916260";"";"0";"404.54";"0";"3.48";"5000";"CCC(CC)NC(=O)c1cnn(c1NS(=O)(=O)C2CCCC2)c3ccccc3";"PPB";"";"99.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1797387";"";"0";"429.66";"1";"6.5";"1779";"Cc1onc(c1NC(=O)OCc2c(F)cccc2Cl)c3c(Cl)cccc3Cl";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1671897";"";"0";"479.58";"0";"4.59";"3135";"COc1ccc(CC(=O)NCc2ccccc2c3ccccc3C(=O)NCCc4cccnc4)cc1";"PPB";"";"99.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181247";"";"0";"484.37";"1";"5.85";"4427";"Fc1ccccc1c2ccnc3OCC(=O)N(Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)Cc23";"PPB";"";"99.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916280";"";"0";"426.54";"0";"3.82";"5134";"CCC(C)NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"99.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL103482";"";"0";"232.24";"0";"1.7";"77";"CCOC(=O)c1cnc2c(N)cccc2c1O";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2110569";"IOFLUPANE";"0";"431.29";"0";"3.76";"5832";"COC(=O)[C@@H]1C2CCC(C[C@@H]1c3ccc(I)cc3)N2CCCF";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171034";"";"0";"530.45";"1";"4.54";"1556";"Fc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916281";"";"0";"454.6";"0";"4.45";"5057";"CC(NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3)C(C)(C)C";"PPB";"";"98.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL565073";"";"0";"550.6";"2";"6.54";"3481";"Fc1ccc(cc1)C(NC(=O)CC2CCN(Cc3ccn(c3)c4ccc(cc4)C(F)(F)F)CC2)c5cccnc5";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069413";"";"0";"503.48";"1";"3.33";"4692";"OCc1ccc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(OCCOCC(F)(F)F)nc4";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL212777";"";"0";"364.83";"1";"5.21";"2125";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4cc(Cl)ccc34";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331742";"";"0";"519.96";"1";"3.01";"5360";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3)C(=O)NC1=O";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1092240";"";"0";"475.54";"1";"3.87";"3399";"[O-][N+](=O)c1c(Nc2ccc(cc2)n3cncn3)ncnc1N4CCC(CC4)Sc5ccccn5";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL152640";"";"0";"450.54";"1";"5.26";"4398";"Cc1cc(C)c(C)c(Cn2ccc3c(\C=N\NC(=O)c4ccc(O)c(c4)C#N)cccc23)c1C";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180273";"";"0";"415.53";"1";"5.52";"5881";"CCOC(=O)C1=C(C)NC2=C(C1c3ccc(cc3)c4ccccc4)C(=O)CC(C)(C)C2";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL572016";"";"0";"394.78";"1";"5.01";"4679";"Cc1cnc([nH]1)c2cc(NC(=O)c3ccc(nc3C)C(F)(F)F)ccc2Cl";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL249790";"";"0";"576.55";"2";"2.56";"2541";"OCCO[C@H]1C[C@H]([C@H](O)[C@@H]1O)n2nnc3c(N[C@@H]4C[C@H]4c5ccc(F)c(F)c5)nc(SCCC(F)(F)F)nc23";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062774";"";"0";"382.46";"0";"4.01";"4824";"CCOc1noc2cc(OCCC3CCN(CC3)c4ccc(C)nn4)ccc12";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179272";"";"0";"497.98";"0";"4.78";"5430";"CC[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916274";"";"0";"452.58";"0";"4.35";"5022";"Cc1ccc(cc1)S(=O)(=O)Nc2c(C(=O)NC3CCCCC3)c(C)nn2c4ccccc4";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335898";"";"0";"466.59";"1";"5.1";"4896";"C[C@@H](NC(=O)C1CCCCN1C)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069423";"";"0";"474.44";"0";"3.36";"4716";"COc1ncc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(COCC(F)(F)F)nc4";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2070137";"";"0";"362.45";"0";"4.69";"5887";"CCS(=O)(=O)c1ccc2[nH]c(nc2c1)c3cccc(c3)c4ccccc4";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349318";"";"0";"415.54";"0";"3.68";"2408";"CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(c2)C#N)nc3NC(=O)Sc13";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481572";"";"0";"457.94";"0";"4.02";"3967";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)c(Cl)c3)c2cc1N4CCN(C)CC4";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059872";"";"0";"500.62";"2";"5.18";"4492";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ncc(CN5CCOCC5)s4";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL459675";"";"0";"457.84";"1";"5.77";"3727";"Cc1ncc(NC(=O)c2cc(NC(=O)c3cc(F)cc(c3)C(F)(F)F)ccc2Cl)s1";"PPB";"";"99.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164044";"";"0";"476.4";"0";"3.83";"5245";"Fc1cnc(CCN2C(C(=O)NCc3ccc(F)c(c3)C(F)(F)F)c4ccccc4C2=O)nc1";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL301856";"";"0";"221.65";"0";"2.08";"5313";"Nc1nc(O)c(Cl)c(n1)c2ccccc2";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2208427";"";"0";"468.38";"0";"3.22";"2307";"COc1cc(ccc1N)C(=O)NC[C@@H](O)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2206790";"";"0";"452.9";"0";"3.59";"4465";"COCC[C@H](Oc1ncnc2c1cnn2c3ccccc3Cl)C(=O)Nc4ccc(C)cn4";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL172714";"";"0";"304.14";"";"";"387";"Cc1oc2C=NN(B(O)c2c1)S(=O)(=O)c3ccc(C)cc3";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331843";"";"0";"441.95";"0";"3.04";"5813";"CCc1[nH]c2nc(Sc3cnc4ccc[n+]([O-])c4c3)nc(N5CC[C@@H](N)C5)c2c1Cl";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950732";"";"0";"428.62";"0";"2.83";"5315";"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@H]2CCCCN(Cc3ccccc3)C2";"PPB";"";"80.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2153595";"";"0";"448.83";"1";"5.8";"5723";"FC(F)(F)Oc1ccc(cc1Cl)c2oc(CCCCc3ccc4cccnc4n3)nn2";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2153581";"";"0";"458.42";"1";"5.08";"5726";"Fc1ccc(cc1C(F)(F)F)c2cc(CNC(=O)CCCc3ccc4cccnc4n3)on2";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481423";"";"0";"460.37";"0";"4.14";"3797";"COc1cc2ncc(C(=O)N)c(Nc3ccc(Cl)c(Cl)c3)c2cc1N4CCN(C)CC4";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164372";"";"0";"434.41";"0";"3.58";"4396";"FC(F)(F)Oc1ccc(CNC(=O)C2N(C[C@@H]3CCCO3)C(=O)c4ccccc24)cc1";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011440";"";"0";"374.66";"0";"3.31";"2124";"COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c2ccc(Cl)s2";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL184012";"";"0";"523.59";"1";"4.71";"2462";"Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1NC(=O)c4ccc(OCc5ccccn5)cc4";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2070117";"";"0";"270.34";"0";"2.54";"1731";"COc1cnc(nc1N2CCCCC2)c3ccccn3";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916261";"";"0";"427.53";"0";"3.29";"5160";"CCC(CC)NC(=O)c1nnn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"99.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL219098";"";"0";"493.59";"0";"3.57";"1923";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Oc3cccc4ccccc34)c2C(=O)N5CC[C@@H](O)C5";"PPB";"";"99.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL98760";"";"0";"425.92";"0";"4";"348";"CC(C)NC(=O)c1ccc2c(Nc3ccc(Cl)cc3)nc(nc2c1)N4CCOCC4";"PPB";"";"99.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164747";"";"0";"480.53";"0";"0.36";"4216";"COc1ccc2N=CC(=O)N(CCN3CC[C@@H](NCc4ccc5OCC(=O)Nc5n4)[C@@H](O)C3)c2c1";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1598817";"";"0";"422.75";"0";"4.27";"2912";"Cc1ccc(Cl)cc1NC(=O)CCS(=O)(=O)c2ccc(Br)s2";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164360";"";"0";"469.46";"0";"4.42";"4600";"CC(Cc1ccccn1)N2C(C(=O)NCc3ccc(OC(F)(F)F)cc3)c4ccccc4C2=O";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316386";"";"0";"539.65";"1";"3.28";"4205";"C[S+]([O-])Cc1ccc(C(=O)Nc2ccc(OCCOCCO)nc2C(=O)NCC3CCC3)c4ccccc14";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151326";"";"0";"387.35";"0";"2.16";"4331";"COc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c4ccc(F)cn4)n[nH]1";"PPB";"";"78.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164741";"";"0";"461.52";"0";"1.26";"4211";"O[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4cc5OCCOc5cn4";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011112";"";"0";"485.03";"0";"3.6";"4071";"CC(C)N1Cc2c(NC(C)(C)Cc3ccc(Cl)cc3)nc(nc2C1=O)N4CCN(CC4)C(=O)C";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011908";"";"0";"381.26";"0";"2.83";"4673";"CNc1c(Br)cnc2[nH]c(nc12)c3ccc(cc3)S(=O)(=O)C";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481605";"";"0";"504.42";"1";"3.9";"4014";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(CCO)CC4";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL8088";"";"0";"240.28";"0";"2.83";"1881";"NC1=NC(Cc2ccccc12)c3ccc(F)cc3";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1078685";"";"0";"248.25";"0";"1.8";"4825";"N#Cc1cc(ccn1)c2n[nH]c(n2)c3ccncc3";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158790";"";"0";"537.5";"2";"6.08";"3561";"Cc1c(Cl)c(Cl)ccc1OC2CCN(CC3CCN(CC3)[C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC2";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312918";"";"0";"326.34";"0";"3.82";"5091";"CCCN(c1ccon1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1779503";"";"0";"370.8";"0";"1.55";"2871";"Clc1ccc(cc1C(=O)NCCc2ccccc2)N3N=CC(=O)NC3=O";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059866";"";"0";"398.47";"0";"4.62";"4787";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4cn(C)cn4";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL297685";"";"0";"351.39";"0";"2.41";"5217";"Cn1c(nc2c(N)nc(nc12)C#CC3(O)CCCC3)c4cccc(F)c4";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL57531";"";"0";"395.06";"0";"3.38";"5415";"Nc1ncc2cc(c(N)nc2n1)c3c(Br)cccc3Br";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1944694";"";"0";"493.63";"0";"3.5";"3844";"COc1ccccc1CCNCc2ccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)cc2";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011928";"";"0";"418.3";"0";"3.33";"4791";"COc1ccc(cc1)c2nc3c(NCCCNC(=O)C)c(Br)cnc3[nH]2";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178390";"";"0";"395.5";"0";"4.42";"4643";"CC(C)c1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916263";"";"0";"426.54";"0";"3.9";"5021";"CCC(CC)NC(=O)c1cn(nc1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"99.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL27890";"";"0";"425.45";"0";"3.61";"1469";"COc1ccc2C(=CC(=O)N(Cc3ccc(cc3)c4ccccc4c5nn[nH]n5)c2c1)O";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349316";"";"0";"421.57";"0";"4.48";"3074";"CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2F)nc3nc(N)sc13";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349312";"";"0";"404.56";"0";"4.05";"2607";"CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc3NC(=O)Sc13";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1287979";"";"0";"382.49";"0";"3.23";"3485";"COc1cccc(c1)c2cc3c(N[C@H]4CCCNC4)ncc(C(=O)N)c3s2";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1531981";"";"0";"321.33";"0";"4.21";"1949";"Cc1oc(cc1C(=O)Nc2cccc(c2)C(=O)O)c3ccccc3";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1557771";"";"0";"306.36";"0";"3.85";"5622";"O=C(N1CCC(CC1)c2oc3ccccc3n2)c4ccccc4";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481401";"";"0";"448.33";"0";"4.28";"3837";"CN1CCN(CC1)c2cc3c(Nc4cccc(Cl)c4Cl)c(cnc3cc2F)C(=O)N";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921926";"";"0";"518.75";"2";"5.78";"4998";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCCc4ccc5ncsc5c4)CCC2CC3)c6ccccc6";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1738764";"";"0";"511.65";"1";"3.81";"4118";"CC(C)N(c1ccnc(Nc2cc(cc(c2)S(=O)(=O)C)N3CCOCC3)n1)c4cc(CO)ccc4C";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL383235";"";"0";"361.5";"0";"3.14";"2755";"CC[C@@H](CO)Nc1nc(SCc2ccccc2)nc3nc(N)sc13";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335901";"";"0";"452.56";"0";"4.61";"4639";"C[C@@H](NC(=O)C1CCNCC1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL471412";"";"0";"476.55";"1";"5.29";"3560";"COc1ccc(N(C(C(=O)NC2CCCC2)c3ccccc3F)C(=O)c4ccccc4)c(OC)c1";"PPB";"";"99.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480457";"";"0";"430.34";"0";"4.14";"3840";"CN1CCN(CC1)c2ccc3ncc(C(=O)N)c(Nc4cccc(Cl)c4Cl)c3c2";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481807";"";"0";"455.51";"0";"3.9";"4010";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(CC)CC4";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL457608";"";"0";"373.82";"0";"4.18";"3559";"C[C@H](Nc1ncc(Cl)c(Nc2cc([nH]n2)C3CC3)n1)c4ccc(F)cn4";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1454310";"";"0";"355.18";"0";"3.14";"1902";"Cc1cc(I)cc2C3C=CCC3C(Nc12)C(=O)O";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916537";"";"0";"465.55";"0";"1.95";"3718";"COc1ccc2CCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917432";"";"0";"409.92";"0";"4.24";"2177";"Cc1c(Sc2ccc(Cl)cc2)c3c(cccc3n1CC(=O)O)S(=O)(=O)C";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL178835";"";"0";"489.57";"0";"2.57";"4859";"CC(C)[C@H](NC(=O)C[C@H](NC(=O)\C=C\c1ccccc1)c2ccccc2)C(=O)[C@H]3[C@H](C)C(=O)NC3=O";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL272705";"";"0";"338.41";"0";"2.06";"2283";"C[C@H](CO)Nc1nc(SCc2occc2)nc3NC(=O)Sc13";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL514670";"";"0";"448.83";"1";"5.15";"3587";"Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1C(=O)Nc3cnc(N)c(Cl)c3";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778628";"";"0";"321.25";"0";"3.71";"2888";"OC(=O)COc1ccc(cc1c2cccc(c2)C#N)C(F)(F)F";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331749";"";"0";"491.95";"0";"3.02";"5524";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(O)c(Oc4ccc(Cl)cc4)c3)C(=O)NC1=O";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349334";"";"0";"362.48";"0";"2.85";"1834";"CC[C@H](CO)Nc1nc(SCc2ccccc2)nc3NC(=O)Sc13";"PPB";"";"99.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1789186";"";"0";"304.75";"0";"3.82";"2113";"NCC[C@@H](Oc1cc(Cl)c(F)cc1C#N)c2ccccc2";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL360227";"";"0";"469.89";"0";"3.38";"5641";"CCN(CC)CCN1C(=O)[C@@](O)(c2ccccc2Cl)c3c1cc(cc3C(F)(F)F)C(=O)N";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL550637";"";"0";"437.58";"0";"3.35";"2170";"Cc1ccc(cc1NC(=O)CC23CC4CC(CC(C4)C2)C3)C(=O)N5CC6CNCC(C5)O6";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059195";"";"0";"264.28";"0";"3.33";"4823";"OC(=O)\C=C\c1cccc(c1)c2cnc3[nH]ccc3c2";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL571526";"";"0";"353.36";"0";"3.11";"4452";"C[C@@H](Oc1nc(Nc2cc(C)[nH]n2)c(C)nc1C#N)c3ccc(F)cn3";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1904775";"";"0";"367.85";"0";"3.46";"2925";"COc1ccc(Cl)cc1NC(=O)CCS(=O)(=O)c2ccc(C)cc2";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158437";"";"0";"355.23";"0";"2.53";"5080";"Clc1cccc(CNC2=NC(=CC(=O)N2)N3CCOCC3)c1Cl";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1213085";"";"0";"507.53";"1";"4.28";"5652";"Cc1ccccc1N2C(=Nc3cccc(C)c3C2=O)Cn4nc(c5ccc(O)c(F)c5)c6c(N)ncnc46";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158827";"";"0";"477.43";"1";"5.38";"3167";"OC(=O)Cc1ccc(cc1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1922055";"";"0";"500.66";"2";"5.4";"4758";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(Cc4cc(on4)c5ccccc5)CCC2CC3)c6ccccc6";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521809";"";"0";"426.48";"0";"2.27";"4142";"O=C(N1CCN(CC1)c2ncccn2)c3cccc(CC4=NNC(=O)c5ccccc45)c3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062558";"";"0";"253.24";"0";"1.99";"2858";"Nc1cc(nc2c(cnn12)C#N)c3ccc(F)cc3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689111";"";"0";"438.93";"0";"2.45";"3355";"OC(=O)COc1ccc(Cl)cc1CN2CCN(CC2)S(=O)(=O)Cc3ccccc3";"PPB";"";"99.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL284275";"";"0";"218.26";"0";"1.17";"1589";"COc1ccc(Cc2c(N)n[nH]c2N)cc1";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917431";"";"0";"409.92";"0";"4.24";"2173";"Cc1c(Sc2ccc(Cl)cc2)c3cc(ccc3n1CC(=O)O)S(=O)(=O)C";"PPB";"";"98.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL452664";"";"0";"448.35";"0";"4.37";"3649";"COc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1NCCN(C)C";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL606052";"";"0";"429.48";"0";"2.69";"985";"O=C1Nc2cc(ccc2C1c3ncnc4cc(OCCCN5CCOCC5)ccc34)C#N";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062567";"";"0";"389.42";"0";"2.66";"4658";"CC(=O)Nc1ccc2OCCN(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071614";"";"0";"292.34";"0";"3.41";"5946";"CC(C)(O)c1ccc(Nc2nc3ccc(cc3[nH]2)C#N)cc1";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2139925";"";"0";"448.55";"0";"4.25";"5929";"CCc1nc2ccc(cn2c1N(C)Cc3cccs3)C(=O)NCc4ccc5OCOc5c4";"PPB";"";"99.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778612";"";"0";"273.24";"0";"2.73";"1570";"OC(=O)COc1ccc(cc1c2ccccc2)[N+](=O)[O-]";"PPB";"";"99.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL461573";"";"0";"385.88";"0";"4.92";"3636";"Cc1cc(C)cc(c1)C(=O)Nc2ccc(Cl)c(c2)C(=O)Nc3cncs3";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL513588";"";"0";"424.28";"1";"5.4";"3842";"Cc1ncc(NC(=O)c2cc(NC(=O)c3cc(F)cc(Cl)c3)ccc2Cl)s1";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778623";"";"0";"431.43";"0";"3.87";"3035";"CCN(CC)S(=O)(=O)c1ccc(cc1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"98.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1709327";"";"0";"402.41";"0";"1.17";"4026";"CC1CN2C(C(C)O1)C3(Cc4cc(ccc24)[N+](=O)[O-])C(=O)N(C)C(=O)N(C)C3=O";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331752";"";"0";"509.94";"1";"3.16";"5514";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(O)c(Oc4cc(F)cc(Cl)c4)c3)C(=O)NC1=O";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1399574";"";"0";"353.43";"0";"3.02";"5904";"CCOc1ccc(NC(=O)CCc2c(C)nc3nc(C)nn3c2C)cc1";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164748";"";"0";"467.53";"0";"0.8";"4280";"COc1ccc2N=CC(=O)N(CCN3CC[C@@H](NCc4cc5OCCOc5cn4)[C@H](O)C3)c2c1";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165061";"";"0";"494.55";"0";"1.01";"4284";"CO[C@@H]1CN(CCN2C(=O)C=Nc3ccc(OC)cc23)CC[C@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158771";"";"0";"516.47";"2";"5.12";"3159";"OC(=O)[C@H](Cc1ccc(cc1)C#N)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1461208";"";"0";"454.57";"0";"2.18";"2640";"COc1ccc(cc1)S(=O)(=O)N2CC(C)N(CC2C)S(=O)(=O)c3ccc(OC)cc3";"PPB";"";"99.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171041";"";"0";"555.53";"1";"4.47";"2144";"CN(C)c1ccccc1S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2068817";"";"0";"348.4";"0";"4.44";"5778";"COc1ccccc1CN(C(=O)C)c2cnccc2Oc3ccccc3";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481220";"";"0";"455.51";"0";"3.89";"4011";"CC(C)Oc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059198";"";"0";"458.4";"0";"3.67";"5422";"CC(C)NC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C(=O)O)n4ccc(n4)C(F)(F)F";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2017459";"";"0";"409.92";"0";"4.68";"5760";"CCN(C(=O)c1oc(cc1)c2ccc(Cl)cc2)c3ccc(cc3)N4CCNCC4";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683025";"";"0";"360.32";"0";"2.77";"4264";"COc1cc2nnc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1OC";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180031";"";"0";"422.53";"0";"4.78";"5658";"COc1c(C)cc(cc1C)C2(N=C(C)C(=N2)N)c3cccc(c3)c4cncc(c4)C#CC";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1231626";"";"0";"386.91";"0";"3.88";"3484";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccc(Cl)cc4";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL250687";"";"0";"456.57";"0";"1.97";"2613";"CCCSc1nc(N[C@@H]2C[C@H]2c3ccccc3)c4nnn([C@@H]5C[C@H](CO)[C@@H](O)[C@H]5O)c4n1";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL347164";"";"0";"312.33";"0";"1.57";"2647";"COc1ccc(cc1)c2nc(nc(O)c2C#N)N3CCOCC3";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048869";"";"0";"347.44";"0";"2.34";"5261";"CCOc1cccc(\C=C\2/SC(=O)NC2=O)c1N3CCC[C@@H](N)C3";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158818";"";"0";"479.4";"0";"4.36";"2747";"OC(=O)C(N1CCO[C@H](CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3)C1)c4ccccc4";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402728";"";"0";"369.5";"0";"2.23";"2286";"C[C@H](CO)Nc1nc(SCc2csc(C)n2)nc3NC(=O)Sc13";"PPB";"";"99.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL493677";"";"0";"389.34";"0";"4.82";"5254";"CC(C)(C)CCN1CC[C@H](CNC(=O)c2cc(Cl)cc(Cl)c2)[C@H](F)C1";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1091289";"";"0";"1160.43";"";"";"5911";"CCCCCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800657";"";"0";"471.62";"0";"3.32";"4789";"CCCN(CCNCCc1ccc(O)c2NC(=O)Sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151321";"";"0";"381.42";"0";"3.64";"4210";"CC(C)Oc1cc(n[nH]1)n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc23";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800528";"";"0";"268.32";"0";"2.46";"3203";"COc1ccnc(CCc2nc3c(C)ccnc3[nH]2)c1";"PPB";"";"80.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164744";"";"0";"467.53";"0";"0.8";"4214";"COc1ccc2N=CC(=O)N(CCN3CC[C@H](NCc4cc5OCCOc5cn4)[C@H](O)C3)c2c1";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1416617";"";"0";"249.32";"0";"3.43";"1180";"Cc1nn(c(N)c1c2ccccc2)c3ccccc3";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316109";"";"0";"435.55";"0";"3.9";"4401";"C[S+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC3CCC3)c4ccccc14";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL214350";"";"0";"398.38";"1";"5.58";"2347";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(cccc34)C(F)(F)F";"PPB";"";"99.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL403313";"";"0";"428.49";"0";"3.09";"5455";"CN(C)S(=O)(=O)NC(=O)CCCc1c([nH]c2ccc(cc12)C#N)c3ccc(F)cc3";"PPB";"";"99.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL395340";"";"0";"439.56";"0";"4.66";"2179";"CC[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(NC(C)C)sc13";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151322";"";"0";"397.41";"0";"2.61";"4321";"CC(C)Oc1cc(n[nH]1)n2cnc3ccc(N[C@@H](CO)c4ccc(F)cn4)nc23";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1631095";"";"0";"442.32";"0";"3.77";"5655";"NC(=O)c1cc(C(=O)N)n(n1)c2cccc(c2)c3cc(ccc3C(F)(F)F)C(F)(F)F";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL541944";"";"0";"569.58";"2";"5.19";"3435";"Fc1ccc(cc1)C(NC(=O)CN2CCN(Cc3ccn(c3)c4ccc(cn4)C(F)(F)F)CC2)c5ccc(F)cc5";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011918";"";"0";"445.37";"0";"3.06";"4648";"CNc1c(Br)cnc2[nH]c(nc12)c3ccc(OCCN4CCN(C)CC4)cc3";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569184";"";"0";"419.5";"0";"2.19";"5567";"COc1ccc(CCN2[C@H](CN(NS(=O)(=O)C)C2=O)c3ccc(OC)cc3)cc1";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288102";"";"0";"388.44";"0";"3.5";"3456";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccc(F)cc4F";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402986";"";"0";"348.45";"0";"2.46";"1824";"C[C@H](CO)Nc1nc(SCc2ccccc2)nc3NC(=O)Sc13";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL468297";"";"0";"251.29";"0";"2.37";"3328";"C1CC1Nc2ccc3nnc(c4ccccc4)n3n2";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL518770";"";"0";"488.42";"0";"4.92";"4015";"CC(C)Oc1cc2ncc(C(=O)N)c(Nc3ccc(Cl)c(Cl)c3)c2cc1N4CCN(C)CC4";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL426658";"";"0";"328.8";"0";"3.64";"4693";"Clc1cccc(c1)c2cnc3ccc(NC4CCOCC4)nn23";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560993";"OC000459";"2";"348.38";"0";"4.31";"4409";"Cc1c(Cc2ccc3ccccc3n2)c4cc(F)ccc4n1CC(=O)O";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2103856";"ATOPAXAR";"2";"527.64";"1";"4.79";"4188";"CCOc1cc2CN(CC(=O)c3cc(N4CCOCC4)c(OC)c(c3)C(C)(C)C)C(=N)c2c(F)c1OCC";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2058529";"";"0";"366.84";"1";"5.6";"5866";"OC(=O)CCc1ccc(OCc2cc(Cl)ccc2c3ccccc3)cc1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158783";"";"0";"523.48";"2";"5.69";"3440";"Cc1c(Cl)ccc(OC2CCN(CC3CCN(CC3)[C@@H](Cc4ccc(F)cc4)C(=O)O)CC2)c1Cl";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062563";"";"0";"371.4";"0";"3.08";"4594";"CC(=O)Nc1ccc2ccn(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL426851";"";"0";"510.62";"1";"2.06";"2323";"CNc1nc2ccccc2n1Cc3sc4N(CC(C)C)C(=O)N(C)C(=O)c4c3C(=O)N5CC[C@@H](O)C5";"PPB";"";"68.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158819";"";"0";"477.43";"1";"5.37";"2091";"OC(=O)C(N1CCC(CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3)CC1)c4ccccc4";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650729";"";"0";"393.22";"0";"3.12";"4066";"C[C@H](Nc1ncc(Br)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL223166";"";"0";"299.37";"0";"2.8";"5371";"COc1ccccc1O[C@H]([C@@H]2CNCCO2)c3ccccc3";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2107834";"RIOCIGUAT";"4";"422.42";"0";"2.44";"5392";"COC(=O)N(C)c1c(N)nc(nc1N)c2nn(Cc3ccccc3F)c4ncccc24";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921913";"";"0";"486.68";"1";"5.26";"4874";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCc4c[nH]c5ccccc45)CCC2CC3)c6ccccc6";"PPB";"";"99.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL462133";"";"0";"406.29";"1";"5.26";"3670";"Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(Cl)c3)ccc2Cl)s1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071491";"";"0";"326.35";"0";"3.23";"4698";"CC(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(cc2)[N+](=O)[O-]";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349321";"";"0";"390.53";"0";"3.49";"1833";"CC(C)C[C@H](CO)Nc1nc(SCc2ccccc2)nc3NC(=O)Sc13";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL217943";"";"0";"278.31";"0";"2.87";"1130";"Oc1c(ccc2cccnc12)C(=O)NCc3ccccc3";"PPB";"";"96.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152522";"";"0";"348.53";"1";"5.44";"4814";"C1CCN(CC1)[C@H]([C@@H](N2CCCCC2)c3ccccc3)c4ccccc4";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL507700";"";"0";"358.47";"0";"2.99";"1981";"NC(=O)Nc1sc(cc1C(=O)N)c2ccc(CN3CCCCC3)cc2";"PPB";"";"66.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689133";"";"0";"465.38";"0";"4.12";"3503";"C[C@H](Oc1ccc(Cl)cc1CN2CCN([C@@H](C)C2)C(=O)Cc3ccc(Cl)cc3)C(=O)O";"PPB";"";"97.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917457";"";"0";"372.81";"0";"4.44";"2935";"CC(=O)Nc1cccc2c1c(Oc3ccc(Cl)cc3)c(C)n2CC(=O)O";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335885";"";"0";"413.48";"0";"4.43";"4439";"COCCC(=O)N(C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL95804";"SEMATILIDE";"0";"313.42";"0";"1.13";"559";"CCN(CC)CCNC(=O)c1ccc(NS(=O)(=O)C)cc1";"PPB";"";"15.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1956163";"";"0";"417.51";"0";"3.76";"5879";"O=C(Nc1cccc2cccnc12)[C@@H]3CC[C@H](CC3)N4C(=O)[C@@H]5[C@@H]6CC[C@@H](C6)[C@@H]5C4=O";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164042";"";"0";"474.41";"0";"3.57";"5269";"Fc1cnc(CCN2C(C(=O)NCc3cccc(OC(F)(F)F)c3)c4ccccc4C2=O)nc1";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1277809";"";"0";"339.4";"0";"4.23";"1688";"O=C(NCc1ccccn1)c2cc(nc3ccccc23)c4ccccc4";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158825";"";"0";"477.43";"1";"5.38";"3162";"OC(=O)Cc1ccccc1N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1472189";"";"0";"281.31";"0";"2.75";"5889";"COc1ccc(CC(=O)Nc2nc3ccccc3[nH]2)cc1";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL380192";"";"0";"435.59";"0";"4.61";"2168";"CC(C)CC1=NN(C)C(=O)c2c(SCCCO)n(Cc3cccc4ccccc34)cc12";"PPB";"";"99.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957480";"";"0";"460.43";"0";"3.21";"4769";"COCC#Cc1cccc(c1)C2(N=C(N)N3CC(F)(F)CN=C23)c4ccc(OC(F)F)cc4";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL742";"KETAMINE";"4";"237.73";"0";"2.9";"455";"CNC1(CCCCC1=O)c2ccccc2Cl";"PPB";"";"42.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL575448";"BMS-754807";"2";"461.51";"0";"3.61";"5627";"C[C@]1(CCCN1c2nc(Nc3cc(n[nH]3)C4CC4)c5cccn5n2)C(=O)Nc6ccc(F)nc6";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2030402";"";"0";"289.72";"0";"2.75";"5388";"Clc1ccc2oc3C(=O)NC(=Nc3c2c1)[C@@H]4CCCN4";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1309895";"";"0";"326.74";"0";"2.88";"3430";"Clc1ccccc1\C=C\C(=O)Nc2ccc3C(=O)NC(=O)c3c2";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1431112";"";"0";"366.8";"0";"4.12";"3778";"Clc1ccc2NC(=O)CN(C(c3ccccc3)c2c1)C(=O)c4occc4";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456145";"";"0";"176.18";"0";"0.08";"5840";"C1Cc2[nH]nc(c2C1)c3nn[nH]n3";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL48361";"DABIGATRAN";"3";"471.52";"0";"2.99";"1765";"Cn1c(CNc2ccc(cc2)C(=N)N)nc3cc(ccc13)C(=O)N(CCC(=O)O)c4ccccn4";"PPB";"";"47.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950842";"";"0";"402.58";"0";"1.95";"5279";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccccc2)C1)C(C)(C)C";"PPB";"";"49.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1078178";"MOMELOTINIB";"3";"414.47";"0";"2.98";"5472";"O=C(NCC#N)c1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1290284";"LEONURINE";"0";"311.34";"0";"0.83";"5894";"COc1cc(cc(OC)c1O)C(=O)OCCCCNC(=N)N";"PPB";"";"38.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL85";"RISPERIDONE";"4";"410.49";"0";"3.59";"1057";"CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1";"PPB";"";"84.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2170979";"";"0";"499.57";"1";"1.05";"5765";"CC(C)N(CCCNC(=O)OCc1ccccc1)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc4c(N)ncnc34";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL621";"TRAZODONE";"4";"371.87";"0";"2.36";"405";"Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL945";"AMILORIDE";"4";"229.63";"0";"-1.08";"227";"NC(=N)NC(=O)c1nc(Cl)c(N)nc1N";"PPB";"";"27.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1320158";"";"0";"351.37";"0";"2.6";"3394";"COc1cc(\C=C\C)ccc1Oc2nnnn2c3ccc(cc3)C(=O)N";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL87";"";"0";"399.44";"0";"2.87";"46";"COC1=CC=C2C(=CC1=O)C(CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C";"PPB";"";"32.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934426";"";"0";"488.65";"0";"4.39";"5516";"C[C@H](NC(=O)c1c(C)nn(C2CCOCC2)c1NS(=O)(=O)c3ccc(cc3)C4CC4)C(C)(C)C";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205526";"";"0";"468.64";"0";"4.64";"1856";"CC(C)CN1C(=O)N(C)C(=O)c2c(SCCCO)c(Cc3cccc4ccccc34)sc12";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL472524";"";"0";"281.32";"0";"2.77";"4676";"CCNC(=O)Nc1nc2cc(ccc2[nH]1)c3cccnc3";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683031";"";"0";"438.51";"0";"3.07";"4333";"CCOc1cc2nnc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917441";"";"0";"345.85";"1";"5.15";"2157";"Cc1ccc2c(c1)c(Sc3cccc(Cl)c3)c(C)n2CC(=O)O";"PPB";"";"99.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158051";"";"0";"561.73";"1";"2.62";"5393";"CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c3ccccc3)c4ccccc4)C(=O)CC(C)C";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807851";"";"0";"347.38";"0";"0.23";"3566";"C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)nc(OCC4CC45CC5)nc23";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1256568";"";"0";"196.16";"0";"-0.4";"428";"OC(=O)CNC(=O)c1ncccc1O";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL75880";"PERHEXILINE";"4";"277.5";"1";"5.3";"perhexiline";"C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207596";"";"0";"448.5";"0";"2.73";"4347";"COc1cc(O)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL898";"DIFLUNISAL";"4";"250.2";"0";"3.04";"592";"OC(=O)c1cc(ccc1O)c2ccc(F)cc2F";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL589973";"";"0";"581.47";"2";"5.75";"3362";"CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c3ccc(Cl)cc3Cl)c1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1428";"NIMODIPINE";"4";"418.45";"0";"2.97";"1829";"COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062578";"";"0";"344.38";"0";"2.61";"4954";"OCc1ccc2ccn(c3cc(NC4CC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1173055";"RUCAPARIB";"4";"323.37";"0";"2.98";"4507";"CNCc1ccc(cc1)c2[nH]c3cc(F)cc4C(=O)NCCc2c34";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL213100";"";"0";"568.68";"2";"5.94";"5925";"COc1ccc(N(C(=O)Oc2c(C)cccc2C)c3ccnc(Nc4ccc(cc4)N5CCN(C)CC5)n3)c(OC)c1";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331748";"";"0";"475.5";"0";"2.51";"5515";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(O)c(Oc4cccc(F)c4)c3)C(=O)NC1=O";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171039";"";"0";"546.9";"2";"5.05";"1562";"Clc1ccc(OC2CCN(CC2)C3CCN(CC3)C(=O)NS(=O)(=O)c4ccccc4Cl)cc1Cl";"PPB";"";"96.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4";"256.1";"0";"2.01";"152";"Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL331372";"CGS-21680";"0";"499.53";"2";"-0.16";"874";"CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc23";"PPB";"";"57.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481717";"";"0";"442.47";"0";"3.72";"4031";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCC(O)CC4";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4";"236.27";"0";"3.39";"436";"NC(=O)N1c2ccccc2C=Cc3ccccc13";"PPB";"";"70.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1528356";"";"0";"332.45";"0";"3.74";"316";"CN(c1ccc2sc(C)nc2c1)S(=O)(=O)c3ccc(C)cc3";"PPB";"";"99.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916277";"";"0";"466.61";"0";"4.6";"5031";"CC1CCCCC1NC(=O)c2c(C)nn(c2NS(=O)(=O)c3ccc(C)cc3)c4ccccc4";"PPB";"";"99.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1801504";"";"0";"367.36";"0";"3.26";"5672";"Fc1ccc2C(=CC(=O)Nc2c1F)Cn3c(nc4nccnc34)C5CCC5";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2010836";"";"0";"458.49";"0";"3.35";"4711";"CN(C1CCN(Cc2ccc(cc2)C(F)(F)F)CC1)C(=O)Cc3ccc(cc3)n4cnnn4";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1470371";"";"0";"214.27";"0";"2.15";"1897";"NC(=O)c1cccc2c3CCCCc3[nH]c12";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059376";"";"0";"457.42";"0";"2.94";"5280";"CCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C(=O)NC)n4ccc(n4)C(F)(F)F";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171021";"";"0";"525.5";"1";"4.85";"1550";"Cc1c(Cl)ccc(OC2CCN(CC2)C3CCN(CC3)C(=O)c4cccc(c4)S(=O)(=O)C)c1Cl";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2208431";"";"0";"491.38";"0";"2.86";"2415";"O[C@H](CNC(=O)C1=NNC(=O)c2ccccc12)CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178952";"";"0";"339.4";"0";"2.99";"4436";"NC(=O)c1cncc(n1)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2087433";"";"0";"495.69";"0";"2.53";"5767";"COc1cc(C)c(c(C)c1)S(=O)(=O)N(C)CCOCC(=O)N2CCC(CC2)C3CCN(C)CC3";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177919";"";"0";"425.47";"0";"3.3";"5200";"CN1C=C(C=C(C)C1=O)C2(N=C(N)c3c(F)cccc23)c4cccc(c4)c5cncnc5";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4";"170.24";"0";"1.38";"55";"CCCC1=CC(=O)NC(=S)N1";"PPB";"";"40.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059375";"";"0";"443.39";"0";"2.68";"5395";"CCNC(=O)c1cc2c(c(cnc2[nH]1)c3cncc(c3)C(=O)N)n4ccc(n4)C(F)(F)F";"PPB";"";"64.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335908";"";"0";"413.48";"0";"4.64";"4915";"COc1cc2nc(Nc3ccc(cc3)[C@@H](C)NC(=O)C)ncc2cc1c4ccncc4";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1503415";"";"0";"305.29";"0";"2.8";"768";"OC1=CC(=O)C2=C(O1)c3ccccc3N(C2=O)c4ccccc4";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1645105";"";"0";"257.32";"0";"2.95";"3494";"COc1ccc(cn1)c2ccc3nc(N)sc3c2";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1489611";"";"0";"426.5";"0";"3.02";"2776";"Cc1cc(C)cc(c1)c2oc(SCC(=O)N3CCN(CC3)C(=O)c4occc4)nn2";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335888";"";"0";"369.43";"0";"4.42";"4291";"CN(C(=O)C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151138";"";"0";"324.41";"0";"2.89";"5663";"CN1C(=O)C[C@](C)(NC1=N)c2cc(cs2)c3cccc(c3)C#N";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1092926";"";"0";"490.56";"0";"4.2";"5537";"Fc1cc(cc(F)c1CN2CCOCC2)c3cccc4ncc(nc34)c5cnn(c5)C6CCNCC6";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL611";"TERAZOSIN";"4";"387.44";"0";"1.06";"1702";"COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL522771";"";"0";"427.89";"0";"4.93";"5328";"Cc1ncsc1C(=O)N(CC2=CC(=O)Nc3c(F)cccc23)c4cccc(Cl)c4";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL232656";"";"0";"434.9";"0";"3.08";"1822";"C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc3ccc(Cl)cc3NC(=O)N";"PPB";"";"97.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824042";"";"0";"471.95";"0";"2.05";"3643";"Clc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL65693";"";"0";"393.47";"0";"4.32";"5268";"CS(=O)(=O)Nc1ccc2[nH]c(Cc3ccc(Oc4ccccc4)cc3)nc2c1";"PPB";"";"99.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1240967";"";"0";"617.77";"2";"4.64";"5293";"CC(C)(Cc1cccc(CC(=O)NCc2cccc(c2)c3ccc(O)cc3)c1)NC[C@H](O)c4ccc(O)c(NS(=O)(=O)C)c4";"PPB";"";"99.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011942";"";"0";"519.65";"1";"3.31";"5129";"NC(=O)c1cnc2[nH]c(nc2c1NCCCNC(=O)C3CCC3)c4ccc(OCCN5CCCCC5)cc4";"PPB";"";"78.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1096418";"";"0";"360.83";"0";"2.58";"5610";"Nc1scc2C(=NN(C(=O)c12)c3ccc(Cl)cc3)C(=O)NC4CC4";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL472363";"";"0";"491.94";"1";"5.31";"3048";"FC(F)(F)c1ccc(cc1)n2ccc(CN3CCC(CC3)NC(=O)COc4cccc(Cl)c4)c2";"PPB";"";"99.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2204343";"";"0";"391.95";"";"";"4294";"O[Si]1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2029729";"";"0";"425.57";"0";"3.31";"4454";"CNC(=O)CCCN(C)C(=O)c1ccc2c(c1)c3C[C@@H](CCc3n2C)C4CCOCC4";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL82663";"SIBENADET";"0";"464.61";"0";"2.9";"1566";"Oc1ccc(CCNCCS(=O)(=O)CCCOCCc2ccccc2)c3sc(O)nc13";"PPB";"";"94.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059869";"";"0";"412.49";"0";"4.93";"4988";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4cn(C)c(C)n4";"PPB";"";"94.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL217899";"TOFIMILAST";"2";"339.47";"0";"4.1";"3428";"CCc1nn(C2CCCC2)c3c1CCn4c(nnc34)c5cccs5";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1515178";"";"0";"463.38";"1";"5.43";"2728";"CCn1cc(CNC(=O)c2cc(nc3ccc(Br)cc23)c4ccc(C)cc4)c(C)n1";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205807";"";"0";"480.59";"0";"2.7";"1919";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3c[nH]c4ccccc34)c2C(=O)N5CC[C@@H](O)C5";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL62";"SCH-23390";"0";"287.79";"0";"3.67";"3345";"CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccccc3";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1587607";"";"0";"221.65";"0";"2.32";"5888";"Clc1ccccc1NC(=O)c2cc[nH]n2";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207607";"";"0";"486.55";"0";"2.32";"4327";"COc1cc(OC)c(cc1NC(=O)CCc2nn[nH]n2)S(=O)(=O)N3C(C)CCc4ccccc34";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2208423";"";"0";"448.35";"0";"3.5";"2312";"O[C@H](CNC(=O)c1cccc(c1)C#N)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778636";"";"0";"287.7";"0";"3.34";"3175";"OC(=O)COc1ccc(Cl)cc1c2cccc(c2)C#N";"PPB";"";"99.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL957";"BOSENTAN";"4";"551.63";"1";"4.2";"707";"COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)nc(nc2OCCO)c4ncccn4";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165066";"";"0";"476.51";"0";"1.8";"4478";"F[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916284";"";"0";"508.57";"2";"5.16";"5121";"C[C@H](NC(=O)c1c(NS(=O)(=O)c2ccc(C)cc2)n(nc1C(F)(F)F)c3ccccc3)C(C)(C)C";"PPB";"";"99.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1481866";"";"0";"309.28";"0";"3.03";"3352";"NC(=O)c1ccc(Oc2cccc3cccnc23)c(c1)[N+](=O)[O-]";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934266";"";"0";"406.55";"0";"3.8";"5112";"CCC(CC)NC(=O)c1c(C)nn(C(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL93124";"";"0";"256.33";"0";"3.71";"3214";"CNc1ccc(cc1)c2nc3ccc(O)cc3s2";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL107313";"";"0";"308.33";"0";"1.31";"2860";"CCCc1cc(cc(OC)c1OC)C2=N[C@H](CO2)C(=O)NO";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL361812";"RAMATROBAN";"2";"416.47";"0";"3.09";"2991";"OC(=O)CCn1c2CC[C@H](Cc2c3ccccc13)NS(=O)(=O)c4ccc(F)cc4";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1299757";"";"0";"346.22";"0";"3.6";"691";"Nc1nc(nc(N)c1Cc2ccc(Cl)cc2Cl)c3ccccn3";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4";"299.8";"0";"2";"393";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"PPB";"";"29.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1201335";"GLYCOPYRRONIUM";"4";"318.44";"0";"2.46";"3445";"C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3";"PPB";"";"28.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL7568";"QUINACRINE";"2";"399.97";"1";"5.97";"MEPACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL25554";"";"0";"345.4";"0";"2.51";"868";"COc1cccc(OC)c1OCCNCC2COc3ccccc3O2";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1069";"VALSARTAN";"4";"435.53";"0";"4.16";"1764";"CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3nnn[nH]3)[C@@H](C(C)C)C(=O)O";"PPB";"";"99.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL407";"FLUMAZENIL";"4";"303.29";"0";"1.77";"232";"CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL429";"LABETALOL";"4";"328.41";"0";"2.14";"labetalol";"CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N";"PPB";"";"62.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2171169";"";"0";"540.67";"1";"2.25";"5777";"CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc4c(N)ncnc34";"PPB";"";"71.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL509032";"TAE-684";"0";"614.22";"2";"5.02";"5619";"COc1cc(ccc1Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)N4CCC(CC4)N5CCN(C)CC5";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL644";"TRIMIPRAMINE";"4";"294.44";"0";"4.12";"448";"CC(CN(C)C)CN1c2ccccc2CCc3ccccc13";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1628227";"DOXEPIN";"4";"279.38";"0";"3.96";"2999";"CN(C)CCC=C1c2ccccc2COc3ccccc13";"PPB";"";"76.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164389";"";"0";"455.44";"0";"4.04";"4195";"FC(F)(F)Oc1ccc(CNC(=O)C2N(CCc3ccccn3)C(=O)c4ccccc24)cc1";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL122";"ROFECOXIB";"4";"314.36";"0";"2.56";"1694";"CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4";"276.75";"0";"1.74";"chlorpropamide";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL601719";"CRIZOTINIB";"4";"450.35";"1";"5.04";"4095";"C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4";"531.44";"1";"4.21";"Ketoconazole";"CC(=O)N1CCN(CC1)c2ccc(OCC3COC(Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4";"290.32";"0";"1.26";"57";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL70";"MORPHINE";"4";"285.34";"0";"1.2";"1859";"CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35";"PPB";"";"20.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4";"321.83";"0";"3.67";"1793";"COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL57";"NEVIRAPINE";"4";"266.3";"0";"2.65";"NEV";"Cc1ccnc2N(C3CC3)c4ncccc4C(=O)Nc12";"PPB";"";"44.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL841";"LOPERAMIDE";"4";"477.05";"1";"5.09";"683";"CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"0";"259.35";"0";"2.58";"2630";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL34259";"METHOTREXATE";"4";"454.45";"0";"0.27";"SID56463665";"CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL6966";"VERAPAMIL";"4";"454.61";"1";"5.09";"Verapamil";"COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335903";"";"0";"435.53";"1";"5.72";"4727";"C[C@@H](NC1=CC(=O)CCC1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE";"4";"261.09";"0";"1.88";"Cyclophosphamide";"ClCCN(CCCl)P1(=O)NCCCO1";"PPB";"";"20.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1652621";"";"0";"375.43";"0";"3.69";"5409";"CN(Cc1oc2ccccc2c1C)C(=O)\C=C\c3cnc4NC(=O)CCc4c3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1000";"CETIRIZINE";"4";"388.9";"0";"3.15";"1886";"OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164745";"";"0";"467.53";"0";"0.8";"4213";"COc1ccc2N=CC(=O)N(CCN3CC[C@@H](NCc4cc5OCCOc5cn4)[C@@H](O)C3)c2c1";"PPB";"";"85.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312921";"";"0";"413.48";"0";"4.24";"5195";"CCCN(c1cccc(c1)S(=O)(=O)C)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1304332";"";"0";"449.35";"0";"4.94";"2727";"Cc1ccc(cc1)c2cc(C(=O)NCc3cn(C)nc3C)c4cc(Br)ccc4n2";"PPB";"";"99.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1263";"SALMETEROL";"4";"415.57";"0";"4.11";"1788";"OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL66089";"";"0";"463.34";"0";"3.94";"5353";"Nc1ncnc2nc(cc(c3cccc(Br)c3)c12)c4ccc(nc4)N5CCOCC5";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1923433";"";"0";"403.29";"0";"3.18";"2948";"Cc1[nH]c(C(=O)NC2CCN(CC2)c3ncc(s3)C(=O)O)c(Cl)c1Cl";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4";"308.77";"0";"3.58";"742";"Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL9967";"PIRENZEPINE";"4";"351.41";"0";"1.56";"174";"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc4cccnc24)CC1";"PPB";"";"24.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4";"151.16";"0";"1.35";"81";"CC(=O)Nc1ccc(O)cc1";"PPB";"";"26.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL397237";"";"0";"383.45";"0";"3.03";"2280";"C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc3nc(N)sc13";"PPB";"";"98.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL254129";"CYCLOPAMINE";"0";"411.63";"1";"5";"3459";"C[C@@H]1CN[C@@H]2[C@@H](C1)O[C@]3(CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C)[C@@H]2C";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062573";"";"0";"444.5";"0";"2.25";"5105";"CC(=O)Nc1ccc2ccn(c3cc(NCCN4CCOCC4)n5ncc(C#N)c5n3)c2c1";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL22183";"";"0";"272.42";"0";"3.79";"4862";"CN(C)Cc1ccccc1Sc2ccc(C)cc2N";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338406";"";"0";"429.39";"0";"3.53";"5573";"CC(C)(C)NC(=O)NCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481230";"";"0";"462.91";"0";"3.18";"3307";"COc1cc2c(Nc3ccc(F)c(Cl)c3)c(cnc2cc1OCCN(C)CCO)C(=O)N";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL140684";"";"0";"402.39";"0";"2.76";"2252";"CN(c1ccccc1)S(=O)(=O)c2ccc(NC(=O)C(C)(O)C(F)(F)F)cc2";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331744";"";"0";"500.96";"1";"3.19";"5374";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(C#N)c(Oc4cccc(Cl)c4)c3)C(=O)NC1=O";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1086310";"";"0";"355.4";"0";"1.2";"4925";"CC(C)c1ccc(NC(=O)Cn2cnc3N(C)C(=O)N(C)C(=O)c23)cc1";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1994944";"";"0";"226.24";"0";"1.32";"726";"Cn1ncc2C(=O)NC(=Nc12)c3ccccc3";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL393754";"";"0";"458";"0";"3.1";"2101";"Clc1ccc(cc1C(=O)NCC23CC4CC(CC(C4)C2)C3)C(=O)N5CC6CNCC(C5)O6";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951080";"";"0";"494.59";"0";"2.99";"3895";"COc1cc(OC)c(cc1NC(=O)CSCC(=O)O)S(=O)(=O)N2C(C)CCc3ccccc23";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL564";"PROMAZINE";"4";"284.43";"0";"4.24";"339";"CN(C)CCCN1c2ccccc2Sc3ccccc13";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL267144";"";"0";"262.35";"0";"1.18";"5932";"CC(C)[C@@H]1N(C)c2ccccc2C[C@@H](CO)NC1=O";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151320";"";"0";"338.35";"0";"2.55";"4022";"C[C@H](Nc1ccc2ncn(c3cc(C)[nH]n3)c2n1)c4ncc(F)cn4";"PPB";"";"61.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011912";"";"0";"319.17";"0";"2.41";"4864";"CNc1c(Br)cnc2[nH]c(nc12)c3ccnc(N)c3";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1403871";"";"0";"278.7";"0";"1.67";"3098";"CNC(=O)c1[nH]cnc1C(=O)Nc2ccc(Cl)cc2";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1358402";"";"0";"410.51";"0";"1.52";"2874";"CC(=O)OC1C(O)C2C(C)(C)CCC(O)C2(C)C3(O)C(=O)CC(C)(OC13C)C=C";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402146";"";"0";"268.65";"0";"3.27";"4277";"Fc1ccc(cc1F)C(=O)Nc2ccc(Cl)nc2";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1458025";"";"0";"416.53";"0";"2.98";"2806";"Cc1sc2ncnc(SCC(=O)N3CCN(CC3)C(=O)c4occc4)c2c1C";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL13817";"IBUTAMOREN";"2";"528.68";"1";"1.77";"2595";"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)CN(c4ccccc34)S(=O)(=O)C";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL11";"IMIPRAMINE";"4";"280.42";"0";"3.88";"490";"CN(C)CCCN1c2ccccc2CCc3ccccc13";"PPB";"";"87.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1610495";"";"0";"341.59";"0";"3.02";"1023";"CNC(=O)c1cc(C(=O)c2ccc(Cl)cc2)c(Br)[nH]1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4";"320.34";"0";"2.73";"1823";"COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916545";"";"0";"451.53";"0";"1.83";"3849";"COc1ccc2C=CC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2n1";"PPB";"";"68.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059910";"";"0";"403.47";"0";"1.62";"5665";"CNC(=O)Nc1nc2ccc(cn2n1)c3cncc(c3)S(=O)(=O)NC(C)(C)C";"PPB";"";"64.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL495727";"AT-9283";"2";"381.44";"0";"2.07";"5787";"O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3";"PPB";"";"66.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL218468";"";"0";"510.59";"1";"2.9";"1926";"CC(C)CN1C(=O)N(C)C(=O)c2c1sc(Cc3ccnc4ccc(F)cc34)c2C(=O)N5CC[C@@H](O)C5";"PPB";"";"54.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL210884";"";"0";"315.33";"0";"0.78";"2289";"COCCOc1nc(N)c2NC(=O)N(Cc3ccccc3)c2n1";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1354035";"";"0";"266.38";"0";"1.31";"1773";"COCCNCC(=O)NC12CC3CC(CC(C3)C1)C2";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2087421";"";"0";"496.67";"0";"1.19";"5768";"COc1cc(C)c(c(C)c1)S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC2)C3CCN(C)CC3";"PPB";"";"42.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL74355";"VOLINANSERIN";"3";"373.47";"0";"3.83";"4784";"COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC";"PPB";"";"34.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1201753";"PITAVASTATIN";"4";"421.47";"0";"4.52";"1191";"O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1c3ccc(F)cc3)C4CC4)CC(=O)O";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL562310";"";"0";"409.45";"0";"3.8";"5588";"O=C(Nc1cccc2cccnc12)c3ccc(cc3)N4C(=O)[C@@H]5[C@H]6C[C@H](C=C6)[C@@H]5C4=O";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL715";"OLANZAPINE";"4";"312.44";"0";"3.44";"823";"CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL153064";"";"0";"204.18";"0";"1.7";"719";"CC(=O)C1=Cc2ccc(O)cc2OC1=O";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338400";"";"0";"419.61";"0";"1.79";"5452";"CC(C)(C)NC(=O)NCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4";"459.56";"0";"4.88";"1116";"COCc1c(nc(C(C)C)c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)c1c2ccc(F)cc2)C(C)C";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090090";"VX-702";"2";"404.32";"0";"3.62";"5789";"NC(=O)N(c1ccc(C(=O)N)c(n1)c2ccc(F)cc2F)c3c(F)cccc3F";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158792";"";"0";"503.06";"2";"5.43";"3721";"Cc1cc(OC2CCN(CC3CCN(CC3)[C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC2)ccc1Cl";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL581893";"";"0";"231.26";"0";"1.25";"1542";"COc1ccc2c(C)nc(NC(=N)N)nc2c1";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL440498";"";"0";"425.89";"0";"3.21";"185";"ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164395";"";"0";"470.45";"0";"3.47";"4520";"FC(F)(F)COc1ccc(CNC(=O)C2N(CCc3ccccn3)C(=O)c4ccccc24)cn1";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL17157";"TERFENADINE";"4";"471.69";"1";"6.45";"1573";"CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4";"PPB";"";"99.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL300138";"ENZASTAURIN";"3";"515.62";"1";"4.93";"5607";"Cn1cc(C2=C(C(=O)NC2=O)c3cn(C4CCN(Cc5ccccn5)CC4)c6ccccc36)c7ccccc17";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1489548";"";"0";"396.31";"0";"2.97";"2650";"Brc1ccc(cc1)S(=O)(=O)CCC(=O)NCCc2ccccc2";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2088414";"";"0";"399.29";"0";"3.35";"3134";"OCc1nc2cc(NS(=O)(=O)c3ccc(Br)cc3)ccc2s1";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480456";"";"0";"430.34";"0";"4.14";"3809";"CN1CCN(CC1)c2ccc3ncc(C(=O)N)c(Nc4ccc(Cl)c(Cl)c4)c3c2";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4";"471.55";"1";"-0.73";"2696";"CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3C";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158828";"";"0";"493.43";"1";"5.22";"3142";"OC(=O)COc1ccccc1N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1197658";"";"0";"330.39";"0";"4.89";"2006";"Cc1cccc(Nc2nc(NCc3occc3)c4ccccc4n2)c1";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480814";"";"0";"462.38";"0";"4.76";"3858";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1NCCN(C)C";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL223402";"";"0";"388.4";"0";"3.76";"4790";"Fc1ccccc1NC(=O)N[C@H]2N=C(c3ccccc3)c4ccccc4NC2=O";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL475799";"";"0";"447.93";"0";"4.93";"3460";"Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1C(=O)Nc3cnc(N)c(Cl)c3";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957851";"";"0";"324.38";"0";"1.69";"5164";"Cc1cccc(CN2C=CN3C(=O)C=C(N=C23)N4CCOCC4)c1";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480558";"";"0";"311.86";"0";"2.48";"5570";"CCC(CC)[C@@H](CO)NS(=O)(=O)c1ccc(Cl)s1";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088";"MESORIDAZINE";"4";"386.59";"0";"4.9";"866";"CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-]";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916024";"";"0";"420.45";"0";"2.08";"5615";"Nc1nc(nc(N)c1N2CCOCC2)c3nn(Cc4ccccc4F)c5ncccc35";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481205";"";"0";"467.55";"0";"3.3";"4222";"COCCOc1cc2ncc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479441";"";"0";"471.51";"0";"3.13";"4203";"COCCOc1cc2ncc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1672";"CEFPODOXIME";"0";"427.46";"0";"-0.54";"5856";"COCC1=C(N2[C@H](SC1)[C@H](NC(=O)\C(=N/OC)\c3csc(N)n3)C2=O)C(=O)O";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL430239";"MELATONAN";"0";"1024.2";"";"";"3415";"CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC1=O)C(=O)N";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL204825";"";"0";"349.39";"0";"2.4";"4143";"Oc1nnc(Cc2cccc(c2)C(=O)N3CCOCC3)c4ccccc14";"PPB";"";"58.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1823817";"CE-224535";"2";"480.95";"0";"0.87";"3370";"COC[C@H](O)CN1C(=O)C=NN(C1=O)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"58.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL506";"PRIMAQUINE";"4";"259.35";"0";"2.78";"Primaquine";"COc1cc(NC(C)CCCN)c2ncccc2c1";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916536";"";"0";"470.6";"0";"2.55";"3632";"COc1ccc2SCC(=O)N(CCN3CCC(CC3)NCc4cc5OCCOc5cn4)c2c1";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917433";"";"0";"424.93";"0";"4.21";"2477";"Cc1c(Sc2ccc(Cl)cc2)c3c(NS(=O)(=O)C)cccc3n1CC(=O)O";"PPB";"";"98.96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151324";"";"0";"415.4";"0";"2.94";"4318";"CC(C)Oc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c4ccc(F)cn4)n[nH]1";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL397983";"";"0";"603.6";"2";"5.81";"3365";"CCOc1ccc(cc1)N2C(=O)c3cccnc3N=C2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(OC(F)(F)F)cc5";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059865";"";"0";"384.44";"0";"4.61";"2908";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4ncc[nH]4";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1463345";"CANRENONE";"4";"340.46";"0";"4.37";"4162";"C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1614705";"";"0";"415.86";"0";"3.02";"4945";"OCC(=O)N1CCC(CC1)c2[nH]nc(c3ccc(Cl)cc3F)c2c4ccncn4";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207667";"";"0";"533.41";"1";"2.57";"2445";"NC(=O)c1c(Cl)c(Cl)ccc1OC2CCN(C[C@H](O)CNC(=O)C3=CNC(=O)c4ccccc34)CC2";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL714";"ALBUTEROL";"4";"239.31";"0";"1.31";"426";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"PPB";"";"22.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2348642";"";"0";"406.52";"0";"2.98";"5941";"CNc1nc(C)c(s1)c2nc(Nc3cccc(c3)N4CCNCC4)ncc2C#N";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807849";"";"0";"353.35";"0";"0.18";"3299";"Nc1nc(OCC2CCC2)nc3c1ncn3[C@@H]4O[C@H](CF)[C@@H](O)[C@H]4O";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480822";"";"0";"502.4";"1";"4.45";"3970";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(CC4)C(=O)C";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4";"188.23";"0";"1.48";"766";"CN1N(C(=O)C=C1C)c2ccccc2";"PPB";"";"19.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4";"357.49";"0";"3.34";"1379";"CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4";"270.34";"0";"1.23";"706";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL837";"7-ETHYL-10-HYDROXY-CAMPTOTHECIN";"0";"392.41";"0";"2.35";"3113";"CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(O)cc15)[C@@](O)(CC)C(=O)OC4";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683029";"";"0";"393.23";"0";"3.8";"4268";"COc1cc2nnc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1OC";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179277";"";"0";"584.51";"2";"5.91";"5629";"CC1=CN([C@H]2CCCN(C2)[C@H](CC(C)(C)C)c3ccc(C(=O)O)c(Oc4cccc(Br)c4)c3)C(=O)NC1=O";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL177756";"FLUORESCEIN";"4";"332.31";"0";"3.97";"37";"OC(=O)c1ccccc1C2=C3C=CC(=O)C=C3Oc4cc(O)ccc24";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL23";"DILTIAZEM";"4";"414.53";"0";"3.37";"Diltiazem";"COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(=O)C";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL814";"FLUVOXAMINE";"4";"318.34";"0";"3.2";"1858";"COCCCC\C(=N/OCCN)\c1ccc(cc1)C(F)(F)F";"PPB";"";"75.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL16";"PHENYTOIN";"4";"252.27";"0";"1.97";"phenytoin";"OC1=NC(=O)C(N1)(c2ccccc2)c3ccccc3";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL826";"ENOXACIN";"4";"320.32";"0";"0.66";"ENOXACIN";"CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2103840";"DINACICLIB";"3";"396.5";"0";"2.28";"5922";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4";"265.34";"0";"3.24";"640";"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL580";"LORAZEPAM";"4";"321.16";"0";"3.1";"848";"OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650726";"";"0";"349.76";"0";"2.97";"4435";"C[C@H](Oc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288278";"";"0";"395.49";"0";"2.33";"3461";"NC(=O)c1ccc(cc1)c2cc3c(N[C@H]4CCCNC4)ncc(C(=O)N)c3s2";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL16073";"PHENACETIN";"4";"179.22";"0";"2.04";"505";"CCOc1ccc(NC(=O)C)cc1";"PPB";"";"34.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL54";"HALOPERIDOL";"4";"375.87";"0";"4.43";"SID124880286";"OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL490";"PAROXETINE";"4";"329.37";"0";"3.33";"2753";"Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2018954";"";"0";"551.46";"1";"3.88";"3226";"COc1ccc(COc2nc(Br)cnc2NS(=O)(=O)c3ccc(C)cc3)cc1OCCN(C)C";"PPB";"";"99.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778645";"";"0";"368.84";"0";"3.57";"2456";"CCS(=O)(=O)c1ccc(c(C)c1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650723";"";"0";"364.77";"0";"2.71";"3900";"COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1";"PPB";"";"87.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL423";"BETAXOLOL";"4";"307.43";"0";"2.39";"1767";"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1";"PPB";"";"27.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL638";"VORICONAZOLE";"4";"349.32";"0";"2.18";"VRC";"C[C@@H](c1ncncc1F)[C@](O)(Cn2cncn2)c3ccc(F)cc3F";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2169920";"";"0";"577.55";"1";"4.55";"4647";"Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc3ccc(Cl)c(Cl)c3)c4OCC(=O)Nc14";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL504813";"";"0";"408.45";"0";"3.02";"3972";"CC(C)Cc1c(C(=O)C(=O)N)c2c(OCC(=O)O)cccc2n1Cc3ccccc3";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4";"425.92";"0";"3.35";"1754";"Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1671971";"";"0";"420.37";"0";"4.7";"5154";"COc1cc(\C=C\2/SC(=O)NC2=O)ccc1Oc3ccc(cc3C(F)(F)F)C#N";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1422";"SITAGLIPTIN";"4";"407.32";"0";"2.02";"3325";"N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1309788";"";"0";"312.39";"0";"3.73";"4900";"Cc1ccc(cc1)n2c(C)cc(\C=C\3/SC(=O)NC3=O)c2C";"PPB";"";"99.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1952329";"SGI-1776";"1";"405.42";"0";"4.05";"4967";"CN1CCC(CNc2ccc3ncc(c4cccc(OC(F)(F)F)c4)n3n2)CC1";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1447076";"";"0";"474.36";"0";"4.59";"3079";"NS(=O)(=O)c1ccc(cc1)N2N=C(CC2c3ccc(F)cc3)c4ccc(Br)cc4";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481611";"ODANACATIB";"3";"525.57";"1";"4.63";"4812";"CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)c2ccc(cc2)S(=O)(=O)C)C(F)(F)F)C(=O)NC3(CC3)C#N";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331745";"";"0";"505.98";"1";"3.33";"5450";"COc1ccc(cc1Oc2cccc(Cl)c2)S(=O)(=O)N3CCC[C@@H](C3)N4C=C(C)C(=O)NC4=O";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177113";"";"0";"421.48";"0";"4.57";"5253";"NC1=NC(c2cccc(c2)c3cncnc3)(c4ccnc(c4)C5CC5)c6cccc(F)c16";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335900";"";"0";"452.56";"0";"4.61";"4904";"C[C@@H](NC(=O)[C@H]1CCCNC1)c2ccc(Nc3ncc4cc(ccc4n3)c5ccncc5)cc2";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179283";"";"0";"568.11";"2";"6.58";"5697";"CCCC(C)(C)C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2331741";"";"0";"499.55";"0";"2.67";"5361";"CC1=CN([C@H]2CCCN(C2)S(=O)(=O)c3ccc(C(=O)O)c(Oc4cccc(C)c4)c3)C(=O)NC1=O";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164043";"";"0";"492.4";"0";"3.71";"5305";"Fc1cnc(CCN2C(C(=O)NCc3ccc(F)c(OC(F)(F)F)c3)c4ccccc4C2=O)nc1";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335866";"";"0";"429.48";"0";"3.82";"4103";"COCCNC(=O)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4OC)cc1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL472";"GLYBURIDE";"4";"494.01";"0";"3.64";"454";"COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3";"PPB";"";"99.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1537460";"";"0";"318.38";"0";"3.93";"1910";"COc1ccccc1C(=O)Nc2ccc(Cc3ccncc3)cc2";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313230";"";"0";"337.36";"0";"3.62";"5294";"CCCN(c1cncnc1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2057372";"";"0";"516.58";"1";"0.85";"5664";"CC(C)(C)NS(=O)(=O)c1cncc(c1)c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2";"PPB";"";"54.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1609717";"";"0";"400.27";"0";"3.07";"2926";"Fc1ccc(CNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL258282";"";"0";"494.99";"0";"3.35";"3272";"CN1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL384903";"";"0";"362.23";"0";"4.06";"1784";"Oc1ccc(cc1N2C(=O)Nc3cc(ccc23)C(F)(F)F)C(F)(F)F";"PPB";"";"99.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1509029";"";"0";"332.45";"0";"4.02";"3762";"Cc1ccc(cc1C)S(=O)(=O)Nc2ccc3nc(C)sc3c2";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4";"437.53";"0";"4.31";"472";"OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1254945";"";"0";"501.03";"2";"5.42";"4722";"Clc1cccc2CN(C(=O)c12)c3cccc(c3)C(=O)N4CCC5(CC4)CCN(CC5)c6ccncc6";"PPB";"";"99.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1951072";"";"0";"390.46";"0";"2.8";"2777";"COc1cc(OC)c(cc1NC(=O)C)S(=O)(=O)N2C(C)Cc3ccccc23";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2021696";"";"0";"654.6";"3";"-2.9";"5807";"CN1C(=O)N(N=C1C2=CC(=O)C(=CN2)O)S(=O)(=O)NC(=O)N3C[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)O)\c4csc(N)n4)C3=O";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL578675";"";"0";"244.3";"0";"2.37";"1203";"COc1cnc(nc1NC(C)C)c2ccccn2";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL319111";"LINOPIRDINE";"0";"391.47";"0";"4.88";"1814";"O=C1N(c2ccccc2)c3ccccc3C1(Cc4ccncc4)Cc5ccncc5";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL259850";"";"0";"308.32";"0";"2.38";"1852";"COc1ccc(CNC(=O)Nc2ncc(s2)[N+](=O)[O-])cc1";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL604126";"";"0";"416.81";"0";"4.75";"5019";"Cc1cc(Oc2ncc(cc2Cl)C(F)(F)F)ccc1CC3SC(=O)NC3=O";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1573309";"";"0";"307.4";"0";"2.99";"2772";"CCN(CC)CCn1c2ccccc2c3cnc(N)c(C#N)c13";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL364714";"";"0";"297.25";"0";"1.5";"5457";"C[C@@H](C(=O)N)c1ccc(OS(=O)(=O)C(F)(F)F)cc1";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650730";"";"0";"377.82";"0";"2.76";"4127";"C[C@H](Nc1ncc(Cl)c(Nc2cc([nH]n2)N(C)C)n1)c3ncc(F)cn3";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL972";"SELEGILINE";"4";"187.29";"0";"2.18";"3007";"C[C@H](Cc1ccccc1)N(C)CC#C";"PPB";"";"72.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1222381";"";"0";"234.28";"0";"2.3";"5872";"O=C(NC1CC1)c2cc(on2)c3cccs3";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1950859";"";"0";"447.58";"0";"1.86";"5344";"CN[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CCCN(CCc2ccc(cc2)[N+](=O)[O-])C1)C(C)(C)C";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011123";"";"0";"484.58";"0";"3.22";"4697";"CCOc1ccc(cc1F)[C@@H](C)Nc2nc(nc3C(=O)N(Cc23)C(C)C)N4CCN(CC4)C(=O)C";"PPB";"";"66.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916282";"";"0";"454.6";"0";"4.45";"5087";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3)C(C)(C)C";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158769";"";"0";"516.47";"2";"5.12";"3087";"OC(=O)[C@H](Cc1ccccc1C#N)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"90.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164371";"";"0";"434.41";"0";"3.58";"4485";"FC(F)(F)Oc1ccc(CNC(=O)C2N(C3CCOCC3)C(=O)c4ccccc24)cc1";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1735467";"";"0";"282.75";"0";"3.33";"3654";"CC(=O)Nc1cccc(OCc2cnc(Cl)s2)c1";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178388";"";"0";"403.43";"0";"4.24";"4677";"Cc1nc(C(F)F)c(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=O)N";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207600";"";"0";"512.58";"1";"4.65";"4390";"COc1cc(OC)c(cc1NC(=O)CCC(=O)O)S(=O)(=O)N(c2ccc(C)cc2)c3ccc(C)cc3";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824041";"";"0";"462.51";"0";"1.26";"3656";"O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(cc45)C#N)CC3)nc2N1";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1609026";"";"0";"412.26";"0";"2.98";"4687";"Brc1ccc(cc1)S(=O)(=O)CCC(=O)Nc2ccc3OCOc3c2";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL38182";"";"0";"357.17";"0";"3.24";"2287";"Brc1ccccc1NC(=O)Nc2ccc(C#N)c3[nH]nnc23";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL787";"MONTELUKAST";"4";"586.2";"2";"8.95";"3546";"CC(C)(O)c1ccccc1CC[C@@H](SCC2(CC(=O)O)CC2)c3cccc(\C=C\c4ccc5ccc(Cl)cc5n4)c3";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL406";"INDAPAMIDE";"4";"365.84";"0";"2.08";"1384";"CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL184412";"DRONEDARONE";"4";"556.77";"2";"7.05";"2597";"CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(NS(=O)(=O)C)cc23";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957460";"";"0";"372.82";"0";"4.9";"4927";"Cc1nccc(c1Cl)c2ccc(cc2)c3nc4ccncc4c(O)c3C#N";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921936";"";"0";"495.66";"1";"5.15";"4989";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCCOc4ccc(F)cc4)CCC2CC3)c5ccccc5";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL12952";"";"0";"230.26";"0";"3.04";"729";"COc1ccc2cc(ccc2c1)C(C)C(=O)O";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4";"440.51";"0";"4.22";"5735";"Nc1ncnc2c1c(nn2[C@@H]3CCCN(C3)C(=O)C=C)c4ccc(Oc5ccccc5)cc4";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL247828";"";"0";"549.59";"1";"4.89";"4770";"CC(C)N1C(=O)[C@@H](CCc2ccccc12)NC(=O)[C@@H](Cc3ccccc3OC(F)(F)F)NC(=O)OC(C)(C)C";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2016681";"VELNEPERIT";"2";"407.46";"0";"3.32";"5722";"CC(C)(C)S(=O)(=O)N[C@@H]1CC[C@H](CC1)C(=O)Nc2ccc(cn2)C(F)(F)F";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011924";"";"0";"387.87";"0";"3.03";"2983";"CNc1c(Cl)cnc2[nH]c(nc12)c3ccc(OCCN4CCOCC4)cc3";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824030";"";"0";"453.5";"0";"1.1";"3859";"Oc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824039";"";"0";"521.5";"1";"2.29";"3657";"FC(F)(F)Oc1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818294";"";"0";"552.76";"1";"3.98";"4470";"CN(C)CCN1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2110732";"DACOMITINIB";"3";"469.95";"1";"5.16";"5657";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN4CCCCC4";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL568";"OXAZEPAM";"4";"286.72";"0";"2.45";"445";"OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL247471";"";"0";"511.95";"2";"6.12";"1292";"C[C@@H](N(c1cc(F)ccc1F)S(=O)(=O)c2ccc(Cl)cc2)c3ccc(F)cc3CCCC(=O)O";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325503";"";"0";"529.97";"1";"4.48";"5936";"CS(=O)(=O)c1ccc(nc1)c2nnc(\C=C\c3oc(nn3)c4ccc(cc4)C#N)n2c5ccccc5Cl";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1309562";"";"0";"311.41";"0";"3.5";"3103";"Cc1nc(N2CCOCC2)c3cc(sc3n1)c4ccccc4";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1027";"TIAGABINE";"4";"375.56";"1";"5.04";"1780";"Cc1ccsc1C(=CCCN2CCC[C@H](C2)C(=O)O)c3sccc3C";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1550191";"";"0";"303.16";"0";"3.3";"5179";"Brc1ccc(cc1)C2NC(=O)c3ccccc3N2";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL214957";"";"0";"482.01";"1";"5.25";"3128";"COc1cc(ccc1OCCN2CCCC2)N3C=Nc4cc(sc4C3=O)c5ccc(Cl)cc5";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL595134";"";"0";"331.4";"0";"3.15";"5716";"O=C1N=C2C(=C1C#N)c3ccc(N4CCSCC4)c5cccc2c35";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2144069";"";"0";"451.53";"1";"5.04";"3241";"CN1C=Nc2ccc(Nc3cc(NC(=O)c4cccc(c4)C(C)(C)C#N)ccc3C)cc2C1=O";"PPB";"";"99.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917448";"";"0";"373.43";"0";"3.18";"2420";"COc1cccc(c1)S(=O)(=O)c2c(C)n(CC(=O)O)c3ccc(C)cc23";"PPB";"";"99.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1608462";"";"0";"379.46";"0";"3.54";"5803";"CC(C)n1ncc2c(cc(nc12)C3CC3)C(=O)NCc4c(C)cc(C)nc4O";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207226";"";"0";"535.55";"2";"5.05";"4542";"COc1cc(OC)c(cc1NC(=O)Cc2ccnc(F)c2)S(=O)(=O)N3c4ccccc4Oc5ccccc35";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1360603";"";"0";"245.28";"0";"2.61";"1734";"CCOc1ccccc1C(=O)NCc2occc2";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1592";"QUINAPRIL";"4";"438.52";"0";"2.57";"2854";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069403";"";"0";"432.53";"0";"2.06";"4255";"CN1CCN(CC1)c2cccc3OC[C@H](Cc23)NC(=O)c4nn(nc4C)c5ccccc5";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1801962";"";"0";"306.28";"0";"4.61";"5871";"COc1ccccc1C(=O)\C=C\c2ccccc2C(F)(F)F";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807823";"";"0";"447.63";"0";"2.87";"3615";"O[C@@H](CNCCSCCCNCCc1ccccc1)c2ccc(O)c3NC(=O)Sc23";"PPB";"";"52.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683934";"";"0";"640.82";"2";"6.97";"4247";"O[C@@H](CNCCCCCCCCCN1CCC(CC1)OC(=O)Nc2ccccc2c3ccccc3)c4ccc(O)c5NC(=O)C=Cc45";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1600099";"";"0";"376.84";"0";"4.52";"3777";"Clc1ccc2NC(=O)CN(C(c3ccccc3)c2c1)C(=O)c4ccccc4";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824045";"";"0";"503.56";"1";"2.65";"3937";"O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(cc45)c6occc6)CC3)nc2N1";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL211677";"";"0";"344.41";"0";"4.87";"2155";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3cc(C)nc4ccccc34";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480250";"";"0";"460.37";"0";"4.14";"3901";"COc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3Cl)c2cc1N4CCN(C)CC4";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL398338";"ABT-102";"1";"348.45";"0";"4.67";"5926";"CC(C)(C)c1ccc2[C@@H](CCc2c1)NC(=O)Nc3cccc4[nH]ncc34";"PPB";"";"99.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL865";"VALDECOXIB";"4";"314.37";"0";"2.96";"3892";"Cc1onc(c2ccccc2)c1c3ccc(cc3)S(=O)(=O)N";"PPB";"";"97.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL13485";"SU-11652";"0";"414.94";"0";"3.85";"4246";"CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(Cl)cc23)c1C";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4";"277.27";"0";"1.15";"373";"Cn1cnc(c1Sc2ncnc3nc[nH]c23)[N+](=O)[O-]";"PPB";"";"67.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL907";"CARBOXYLIC ACID METABOLITE";"0";"436.9";"0";"4.47";"210";"CCCCc1nc(Cl)c(C(=O)O)n1Cc2ccc(cc2)c3ccccc3c4nn[nH]n4";"PPB";"";"99.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1072";"BUMETANIDE";"4";"364.42";"0";"3.04";"1506";"CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650734";"";"0";"433.88";"0";"2.84";"4271";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(Cl)c(n1)N3CCOCC3)c4ncc(F)cn4";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1288009";"";"0";"382.49";"0";"3.23";"4000";"COc1ccc(cc1)c2cc3c(N[C@H]4CCCNC4)ncc(C(=O)N)c3s2";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL114";"SAQUINAVIR";"4";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934269";"";"0";"460.52";"0";"4.03";"5461";"C[C@H](NC(=O)c1c(C)nn(CC(F)(F)F)c1NS(=O)(=O)c2ccc(C)cc2)C(C)(C)C";"PPB";"";"98.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL33899";"";"0";"354.45";"1";"6.15";"4718";"CC\C(=C(/c1ccccc1)\c2ccc(\C=C\C(=O)O)cc2)\c3ccccc3";"PPB";"";"99.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1530127";"";"0";"396.31";"0";"3.24";"2651";"Cc1ccc(CNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1164033";"SB611812";"0";"491.75";"1";"5.41";"5916";"CN(C)CCOc1cc(NS(=O)(=O)c2c(Cl)cc(cc2Cl)C(F)(F)F)ccc1Cl";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL260091";"";"0";"437.5";"0";"0.9";"5037";"C[C@@H](O)[C@H](NC(=O)c1ccc(cc1)C#Cc2ccc(CN3CCOCC3)cc2)C(=O)NO";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807829";"";"0";"516.52";"1";"4.18";"3829";"O[C@@H](CNCCSCCCNCCc1cccc(Cl)c1Cl)c2ccc(O)c3NC(=O)Sc23";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2169919";"";"0";"539.68";"1";"2.85";"5751";"CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc4c(N)ncnc34";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2041980";"";"0";"393.39";"0";"3.82";"5870";"CS(=O)(=O)c1ccc(cc1)c2cnc(N)c(c2)c3ccc(nc3)C(F)(F)F";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1789941";"RUXOLITINIB";"4";"306.37";"0";"3.47";"4675";"N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1972466";"";"0";"364.45";"0";"3.01";"3706";"CC(Nc1ccccc1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL562318";"MARDEPODECT";"2";"392.46";"1";"5.28";"4815";"Cn1cc(c2ccncc2)c(n1)c3ccc(OCc4ccc5ccccc5n4)cc3";"PPB";"";"99.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180024";"";"0";"344.39";"0";"3.92";"5202";"CC1=NC(N=C1N)(c2ccc(F)cc2)c3cccc(c3)c4cccnc4";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207664";"";"0";"522.35";"1";"3.64";"2459";"Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)C3=CNC(=O)C=C3C(F)(F)F)CC2)c1Cl";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1890087";"";"0";"298.42";"0";"4.12";"5928";"CC(C)Nc1nc(NCc2ccccc2)c3sccc3n1";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560377";"";"0";"378.44";"1";"5.27";"4522";"C(Oc1ccc(cc1)c2n[nH]cc2c3ccncc3)c4ccc5ccccc5n4";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"0";"280.32";"0";"4.25";"466";"CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3";"PPB";"";"99.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479383";"";"0";"397.5";"0";"3.16";"5278";"OCC(=O)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL604710";"Z160";"2";"460.62";"1";"6.14";"4533";"O=C(CC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL113";"CAFFEINE";"4";"194.19";"0";"-1.03";"caffeine";"CN1C(=O)N(C)c2ncn(C)c2C1=O";"PPB";"";"24.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011120";"";"0";"466.59";"0";"3.08";"4306";"CCOc1ccc(cc1)[C@@H](C)Nc2nc(nc3C(=O)N(Cc23)C(C)C)N4CCN(CC4)C(=O)C";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1086473";"";"0";"330.44";"0";"4.56";"2291";"CCCCc1nc2c(N)nc3ccccc3c2n1Cc4ccccc4";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778637";"";"0";"408.78";"0";"3.89";"3014";"CS(=O)(=O)c1ccc(c(Cl)c1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957841";"";"0";"360.42";"0";"2.53";"5197";"O=C1C=C(N=C2N(Cc3cccc4ccccc34)C=CN12)N5CCOCC5";"PPB";"";"96.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL554";"LAPATINIB";"4";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2";"PPB";"";"99.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL553";"ERLOTINIB";"4";"393.44";"0";"3.41";"ERLOTINIB";"COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1427554";"";"0";"242.3";"0";"3.37";"980";"Cc1ccc(cc1)c2csc3ncnc(O)c23";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957266";"";"0";"457";"1";"5.53";"5838";"Cc1sc2c(C(=N[C@@H](CC(=O)OC(C)(C)C)c3nnc(C)n23)c4ccc(Cl)cc4)c1C";"PPB";"";"99.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1161";"MOMETASONE FUROATE";"4";"521.44";"1";"4.87";"1821";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5occc5)C(=O)CCl";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL502";"DONEPEZIL";"4";"379.5";"0";"4.36";"430";"COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4";"331.35";"0";"1.58";"Ciprofloxacin";"OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4";"306.28";"0";"0.74";"FLU";"OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F";"PPB";"";"14.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL103667";"DORAMAPIMOD";"2";"527.67";"2";"5.99";"5, BIRB-796";"Cc1ccc(cc1)n2nc(cc2NC(=O)Nc3ccc(OCCN4CCOCC4)c5ccccc35)C(C)(C)C";"PPB";"";"99.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL517";"DISOPYRAMIDE";"4";"339.48";"0";"3.36";"Disopyramide";"CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C";"PPB";"";"33.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4";"323.13";"0";"0.91";"Chlorampenicol";"OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-]";"PPB";"";"56.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL193";"NIFEDIPINE";"4";"346.34";"0";"2.18";"nifedipine";"COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL81";"RALOXIFENE";"4";"473.59";"1";"6.08";"RALOXIFENE";"Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL941";"IMATINIB";"4";"493.62";"0";"4.59";"11, imatinib";"CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1464";"WARFARIN";"4";"308.33";"0";"3.61";"511";"CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL894";"BUPROPION";"4";"239.75";"0";"3.3";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL118";"CELECOXIB";"4";"381.38";"0";"3.51";"CELECOXIB";"Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F";"PPB";"";"98.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088752";"LOSMAPIMOD";"3";"383.47";"0";"3.86";"5818";"Cc1c(F)cc(cc1c2ccc(cn2)C(=O)NCC(C)(C)C)C(=O)NC3CC3";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL412142";"CHIR-99021";"0";"465.35";"0";"4.94";"4644";"Cc1c[nH]c(n1)c2cnc(NCCNc3ccc(cn3)C#N)nc2c4ccc(Cl)cc4Cl";"PPB";"";"98.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL447983";"";"0";"211.31";"0";"3.1";"2800";"C[C@](N)(Cc1ccccc1)c2ccccc2";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1081913";"";"0";"360.41";"0";"3.05";"3973";"CC(C)(C)OC(=O)N1CCC(CC1)OCc2onc(n2)c3ccncc3";"PPB";"";"99.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2144205";"";"0";"492.62";"0";"2.81";"5220";"COc1cc2nc(nc(NCCN3CCOCC3)c2cc1OC)c4ccc(cc4)N5CCN(C)CC5";"PPB";"";"55.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158839";"";"0";"509.45";"2";"5.38";"2690";"OC(=O)[C@H](Cc1ccccc1F)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL267894";"AMOBARBITAL";"4";"226.28";"0";"1.39";"403";"CCC1(CCC(C)C)C(=O)NC(=NC1=O)O";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1491";"AMLODIPINE";"4";"408.88";"0";"2.27";"Amlodipine";"CCOC(=O)C1=C(COCCN)NC(=C(C1c2ccccc2Cl)C(=O)OC)C";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2018964";"";"0";"505.02";"1";"4.25";"5662";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)C)c4";"PPB";"";"99.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2030393";"";"0";"334.17";"0";"2.86";"5389";"Brc1ccc2oc3C(=O)NC(=Nc3c2c1)[C@@H]4CCCN4";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL228814";"ISPINESIB";"0";"517.07";"2";"5.59";"2842";"CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)C2=Nc3cc(Cl)ccc3C(=O)N2Cc4ccccc4";"PPB";"";"99.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1824040";"";"0";"479.54";"0";"1.59";"3647";"CC(=O)c1ccc2OCC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL315708";"";"0";"194.24";"0";"3.23";"622";"c1ccc(cc1)c2[nH]nc3ccccc23";"PPB";"";"96.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1586565";"";"0";"342.4";"0";"0.4";"4027";"CN1CCN2C(C1)C3(Cc4ccccc24)C(=O)N(C)C(=O)N(C)C3=O";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1256967";"";"0";"518.49";"2";"-1.41";"5794";"CC1(C)[C@H](NC(=O)\C(=N/OCC2=CC(=O)C(=CN2O)O)\c3csc(N)n3)C(=O)N1OS(=O)(=O)O";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1086580";"";"0";"312.32";"0";"3.66";"SID137275898";"Oc1nc(nc2CCSCc12)c3ccc(cc3)C(F)(F)F";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL14762";"SELICICLIB";"2";"354.46";"0";"3.2";"Roscovitine";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479";"THIORIDAZINE";"4";"370.59";"1";"5.89";"thioridazine";"CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1";"PPB";"";"99.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1515447";"HOMOCHLORCYCLIZINE";"0";"314.86";"0";"4.07";"HOMOCHLORCYCLIZINE";"CN1CCCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1071";"OXAPROZIN";"4";"293.32";"0";"4.03";"OXAPROZIN";"OC(=O)CCc1oc(c2ccccc2)c(n1)c3ccccc3";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1435";"CEFAZOLIN";"4";"454.52";"1";"-0.64";"1749";"Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1017";"TELMISARTAN";"4";"514.63";"2";"7.26";"336";"CCCc1nc2c(C)cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL72";"DESIPRAMINE";"4";"266.39";"0";"3.53";"Desipramine";"CNCCCN1c2ccccc2CCc3ccccc13";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL191003";"JNJ-7706621";"0";"394.36";"0";"1.22";"JNJ-7706621";"Nc1nc(Nc2ccc(cc2)S(=O)(=O)N)nn1C(=O)c3c(F)cccc3F";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL631";"PROPAFENONE";"4";"341.45";"0";"3.24";"SID90341088";"CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL42";"CLOZAPINE";"4";"326.83";"0";"3.72";"211";"CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL229430";"AMG-517";"1";"430.41";"1";"5.52";"4444";"CC(=O)Nc1nc2c(Oc3cc(ncn3)c4ccc(cc4)C(F)(F)F)cccc2s1";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1272";"REPAGLINIDE";"4";"452.6";"1";"5.22";"SID144204272";"CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(=O)O";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4";"429.6";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL12";"DIAZEPAM";"4";"284.75";"0";"3.15";"diazepam";"CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2098183";"";"0";"336.39";"0";"3.25";"5738";"COc1ccc2nc(C)cc(OCC(=O)NCc3ccccc3)c2c1";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4";"458.58";"1";"5.35";"ASTEMIZOLE";"COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL63";"ROLIPRAM";"2";"275.35";"0";"2.62";"1";"COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4";"445.55";"0";"2.08";"973";"Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3";"PPB";"";"99.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL192";"SILDENAFIL";"4";"474.59";"0";"1.61";"sildenafil";"CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4";"180.17";"0";"-1.04";"583";"CN1C(=O)N(C)c2[nH]cnc2C1=O";"PPB";"";"43.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL637";"VENLAFAXINE";"4";"277.41";"0";"3.04";"1883";"COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2";"PPB";"";"18.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1214";"CARBENICILLIN";"4";"378.41";"0";"0.49";"2933";"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"PPB";"";"45.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2205509";"";"0";"284.32";"0";"2.34";"5323";"CC(C)COc1ccc(cc1C#N)c2cc(O)nc(N)n2";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL95";"TACRINE";"4";"198.27";"0";"2.7";"THA. Tacrine";"Nc1c2CCCCc2nc3ccccc13";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL139";"DICLOFENAC";"4";"296.15";"0";"4.36";"114";"OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL669";"CYCLOBENZAPRINE";"4";"275.4";"0";"4.55";"1385";"CN(C)CCC=C1c2ccccc2C=Cc3ccccc13";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL15023";"TRIFLUPERIDOL";"4";"409.42";"0";"4.79";"1576";"OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cccc(c3)C(F)(F)F";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL325041";"BORTEZOMIB";"4";"384.25";"";"";"Bort";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1113";"AMOXAPINE";"4";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4";"392.47";"0";"1.9";"dexamethasone";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"PPB";"";"71.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088751";"PH-797804";"2";"477.31";"0";"4.43";"PH-797804";"CNC(=O)c1ccc(C)c(c1)N2C(=CC(=C(Br)C2=O)OCc3ccc(F)cc3F)C";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4";"248.72";"0";"2.52";"SID855854";"CCc1nc(N)nc(N)c1c2ccc(Cl)cc2";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1444";"LETROZOLE";"4";"285.31";"0";"2.66";"2016";"N#Cc1ccc(cc1)C(c2ccc(cc2)C#N)n3cncn3";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL573";"NIACIN";"4";"123.11";"0";"0.78";"NIACIN";"OC(=O)c1cccnc1";"PPB";"";"44.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2";"PRAZOSIN";"4";"383.41";"0";"1.78";"1, prazosin";"COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4";"404.49";"0";"3.8";"2940";"[O-][S+](CCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)c4ccccc4";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4";"357.44";"0";"2.49";"Rosiglitazone";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3";"PPB";"";"99.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"0";"259.35";"0";"2.58";"SID50104589";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL32";"MOXIFLOXACIN";"4";"401.44";"0";"2.37";"Moxifloxacin";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O";"PPB";"";"30.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4";"297.75";"0";"-0.35";"HCTZ";"NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4";"318.87";"0";"4.89";"chlorpromazine";"CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL35";"FUROSEMIDE";"4";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL126";"LINEZOLID";"4";"337.35";"0";"1.12";"1, Zybox";"CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCOCC3)c(F)c2";"PPB";"";"22.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL860";"E-DOXEPIN";"0";"279.38";"0";"3.96";"SID11113537";"CN(C)CC\C=C\1/c2ccccc2COc3ccccc13";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL7301";"FENRETINIDE";"3";"391.56";"1";"6.86";"SID144204558";"C\C(=C/C=C/C(=C/C(=O)Nc1ccc(O)cc1)/C)\C=C\C2=C(C)CCCC2(C)C";"PPB";"";"99.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
